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Section 1.0
Background
1.1 Introduction
This guidance was originally commissioned by the
Association of Paediatric Anaesthetists of Great Brit-
ain and Ireland (APA). It is intended to be used by
professionals involved in the acute care of children
undergoing pain management after surgery or for
painful medical procedures. It is designed to provide
evidence-based information on the efﬁcacy of analgesic
strategies such that an informed choice of analgesics
that are appropriate for the patient and clinical setting
can be made. The document includes advice on the
assessment of pain, a summary of current evidence for
the efﬁcacy of analgesic strategies, including evidence-
based recommendations grouped according to named
procedures, and a resume of analgesic pharmacology.
This is the second edition of the guidelines – it was last
published in 2008.
1.2 Guideline development committee
Richard Howard Pediatric Anesthetist
Pain medicine specialist
Chair
Bernadette Carter Professor of Children’s Nursing
Representing RCN
Joe Curry Pediatric Surgeon
Representing BAPS
Anoo Jain Neonatologist
Representing RCPCH
Christina Liossi Pediatric Psychologist
Senior Lecturer in Health Psychology
Neil Morton Pediatric Anesthetist
Pain medicine specialist
Kate Rivett Lay Representative
Mary Rose Pediatric Anesthetist
Pain medicine specialist, Representing BPS
Jennifer Tyrrell Pediatrician
Representing RCPCH
Suellen Walker Pediatric Anesthetist
Senior Lecturer in Pain Medicine
Glyn Williams Pediatric Anesthetist
Pain medicine specialist
1.3 Use, scope, and intention
This guidance was developed by a committee of health
professionals with the assistance of a patient representa-
tive. It was published following a period of open public
consultation, including advice from representatives
from patient groups and professional organisations. It
is intended for use by qualiﬁed heath professionals who
are involved in the management of acute pain in chil-
dren. In its present form, it is not suitable for use by
other groups. At the present time, and largely because
of resource limitations, no consumer guide is planned to
enable the recommendations to be easily interpreted by
those who do not already possess knowledge and train-
ing in the ﬁeld of children’s acute pain management.
The guidance is relevant to the management of chil-
dren 0–18 years undergoing surgery or painful proce-
dures in hospital settings. It includes recommendations
for pain assessment, general principles of pain manage-
ment, and advice on the use of pharmacological and
nonpharmacological pain management strategies for
speciﬁc medical and surgical procedures.
Procedures
The procedures are divided into two categories, painful
diagnostic and therapeutic (Medical procedures; Sec-
tion 4) and surgical procedures (Postoperative pain;
Section 5). Guidance covers the management of acute
pain during medical procedures and after surgery. It
does not include advice on the intraoperative manage-
ment of pain unless it is relevant to postoperative man-
agement or is otherwise stated, for example, the use of
perioperative nerve blocks.
The procedures that have been included are not
exhaustive and were selected by the committee because
they are relatively commonplace and, or, because it was
expected that there would be sufﬁcient publications to
allow recommendations to be made on the basis of an
adequate level of evidence. For each procedure, there is
a brief description, list of recommendations, and ‘good
practice points’ followed by a discussion of the relevant
published evidence including Evidence tables (see below)
summarizing the level of evidence available for the efﬁ-
cacy individual analgesic strategies.
doi: 10.1111/j.1460-9592.2012.3838.x
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Evidence tables
Evidence tables are intended to allow the reader a rapid
assessment of the strength of supporting evidence for indi-
vidual analgesics or analgesic strategies relevant to the
procedure in question. Evidence tabled as ‘Direct’ is that
derived from studies that have speciﬁcally investigated the
procedure in question. ‘Indirect’ evidence is derived from
studies of procedures that the committee considered to be
sufﬁciently similar, in terms of expected pain intensity, to
allow extrapolation of evidence. Recommendations have
not been formulated on the basis of indirect evidence.
1.4 Methodology and evidence grading,
good practice points
Systematic methods were used to search for evidence.
Electronic searches were performed on the published
literature between January 2006 and December 2011.
Search strategies including databases and keywords are
described in detail in Appendix 1, the technical report.
The bibliographies of meta-analyses, systematic
reviews, and review articles published during this per-
iod were also scrutinized for relevant articles. Studies
in English were included if they were directly relevant
to the patient population and procedures. Abstracts
were obtained to conﬁrm inclusion or exclusion where
necessary. Full text versions of included articles were
obtained, a tabulated data extraction method was used
to summarize the articles, and they were graded from
1 to 4 according to the criteria in Table 1.
Recommendations were formulated, where appropri-
ate, and graded from A to D according to the crite-
ria described in Table 2 using guidance published by
the Scottish Intercollegiate Guidelines Network
(SIGN), which are available at: http://www.sign.
ac.uk/methodology/index.html and the National Insti-
tute of Clinical Evidence (NICE) http://guidance.
nice.org.uk.
Good practice points indicate best practice based on
the clinical experience and opinion of the guideline
development committee but not necessarily supported
by research evidence; they are provided in situations
where published evidence is insufﬁcient to make a
formal recommendation but the committee wish to
emphasize an important aspect of good practice.
1.5 Supplementary material
The following supplementary material is available for
this guideline:
Appendix 1. Technical Report
Appendix 2. Implementation, cost effectiveness and
audit
Appendix 3. Research implications
Please note: Wiley-Blackwell are not responsible for
the content or functionality of any supplementary
materials supplied by the authors. Any queries (other
than missing material) should be directed to the corre-
sponding author for the article.
Table 2 Grading of recommendations
A At least one meta analysis, systematic review, or RCT rated
as 1++, and directly applicable to the target population; or A
systematic review of RCTs or a body of evidence consisting
principally of studies rated as 1+, directly applicable to the target
population, and demonstrating overall consistency of results
B A body of evidence including studies rated as 2++, directly
applicable to the target population, and demonstrating overall
consistency of results; or Extrapolated evidence from
studies rated as 1++ or 1+
C A body of evidence including studies rated as 2+, directly applicable
to the target population and demonstrating overall consistency of
results; or Extrapolated evidence from studies rated as 2++
D Evidence level 3 or 4; or Extrapolated evidence from studies rated
as 2+
Table 1 Criteria for assigning levels of evidence
Evidence levels
1 1++ High quality meta-analyses, systematic reviews of RCTs,
or RCTs with a very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews of RCTs,
or RCTs with a low risk of bias
1) Meta-analyses, systematic reviews of RCTs, or RCTs with a
high risk of bias
2 2++ High quality systematic reviews of case–control or cohort
studies. High quality case–control or cohort studies with a very
low risk of confounding, bias, or chance and a high probability
that the relationship is causal
2+ Well-conducted case–control or cohort studies with a low
risk of confounding, bias, or chance and a moderate probability
that the relationship is causal
2) Case–control or cohort studies with a high risk of
confounding, bias, or chance and a significant risk that the
relationship is not causal
3 Non-analytic studies, e.g. case reports, case series
4 Expert opinion
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1.6 Contact information
Correspondence in relation to this guideline should be
addressed to:
Dr RF Howard FRCA FFPMRCA
Association of Paediatric Anaesthetists of Great
Britain and Ireland
21 Portland Place
London W1B 1PY, UK
apagbiadministration@aagbi.org
1.7 Conflicts of interest
Dr Richard Howard has acted as a Consultant and/or
his department has received research or educational
funding support from the following: Johnson and
Johnson Pharmaceutical Research LLD, Grunenthal
Ltd, Napp Pharmaceuticals Ltd and Wochardt UK
Ltd. Dr Neil S. Morton is Editor-in-Chief, Pediatric
Anesthesia and has received consultancy fees from
AstraZeneca, Smith & Nephew and Schering-Plough.
His department has received research funding from
Abbott, AstraZeneca, Smith & Nephew and Carefu-
sion (Alaris). The remaining members of the guideline
development committee conﬁrm that they have no con-
ﬂicts of interest to declare.
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Section 2.0
Executive Summary and Quick Reference Guide
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2.1 Introduction
2.2 Pain assessment
2.3 Medical procedures
2.4 Procedural pain in the neonate: general recommendations
2.5 Procedural pain in the neonate: specific recommendations
2.6 Procedural pain in older children
2.7 Postoperative pain
2.1 Introduction
This evidence-based guideline for the management of
postoperative and procedural pain in children was devel-
oped by a multidisciplinary guideline development group
of the Association of Paediatric Anaesthetists of Great
Britain and Ireland with representation from consumers,
the Royal College of Paediatrics and Child Health
(RCPCH), the British Pain Society (BPS), the Royal
College of Nursing (RCN) and the Faculty of PainMedi-
cine of the Royal College of Anaesthetists (FPMRCA).
The guideline was complied using methodology devel-
oped by the Scottish Intercollegiate Guideline Network
(SIGN). Descriptions of levels of evidence, grading of
recommendations and their associated symbols can be
found in Section 1.0 and in the technical report, Appen-
dix 1, of the supplementary materials. The guideline was
developed for the use of health professionals. It is
intended to inform decision making in the management
of acute postoperative and procedural pain. This is the
second edition of the guideline, it supersedes previous
versions. The guideline will be updated every 5 years.
The guideline comprises evidence-based ‘Recommenda-
tions’ and ‘Good practice points’. Recommendations are
graded A–D according to the strength of evidence under-
pinning them, the grading does not reﬂect the impor-
tance of the recommendation. Good practice points
indicate best practice according to the clinical experience
and opinion of the guideline development committee.
Not all recommendations are included in this quick
reference guide, common abbreviations and complete
details are available in the relevant sections of the
guideline.
2.2 Pain assessment
Pain assessment and measurement of pain intensity are
vital components of good pain management practice.
Self-report of pain by children who are able to do so,
observation of behaviors or physiological parameters that
are known to reﬂect pain intensity using a standardized
pain ‘measure’, ‘instrument’, or ‘tool’ are options. To
select an appropriate method, the principles and limita-
tions of standardizedpainmeasuresmust beunderstood.
A simple guide to valid measures for postoperative
and procedural pain is given in Table 1. But please
note that reliance on chronological age as the sole
indicator of a child’s capacity to self-report will inevi-
tably generate both false positives (invalid scores from
children who do not understand the scale) and false
negatives (not obtaining valid scores from children
who do understand the scale but were not asked).
Good practice points
To assess pain, effective communication should occur
between the child whenever feasible, their family or ca-
rers, and the professionals in themulti-disciplinary team.
Standardized instruments should be used in their ﬁnal
validated form. Even minor modiﬁcations that alter
the psychometric properties of the tool may bias clini-
cal assessments and render comparison between stud-
ies invalid.
Table 1 Recommended measures for procedural and postopera-
tive pain assessment as a function of the child’s chronological age
Child’s age* Measure
Newborn–3 years old COMFORT or FLACC
4 years old FPS-R + COMFORT or FLACC
5–7 years old FPS-R
7 years old + VAS or NRS or FPS-R
*With normal or assumed normal cognitive development
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Recommendations
Children’s self-report of their pain is the preferred
approach: Grade B
No individual measure can be broadly recommended for
pain assessment across all children or all contexts:
Grade B
An observational measure should be used in conjunction
with self-report with 3–5-year-olds as there is limited evi-
dence for the reliability and validity of self-report mea-
sures of pain intensity in this age group: Grade B
2.3 Medical procedures
Routine medical care involving blood sampling and
other painful diagnostic and therapeutic procedures
can cause great distress for children and their families.
When such procedures are essential, it is important
that they should be achieved with as little pain as pos-
sible. There are 10 general considerations to remember
prior to planning the management of a painful proce-
dure: see Box 1.
Box 1: Planning a painful procedure
1. Infants and children of all ages, including pre-
mature neonates, are capable of feeling pain and
require analgesia for painful procedures.
2. Developmental differences in the response to
pain and analgesic efﬁcacy should be considered
when planning analgesia.
3. Consider whether the planned procedure is nec-
essary, and how the information it will provide
might inﬂuence care? Avoid multiple procedures if
possible.
4. Plan the timing of procedures to minimize the
frequency of a painful procedure.
5. Is sedation or even general anesthesia likely to
be required for a safe and satisfactory outcome?
6. Would modiﬁcation of the procedure reduce
pain? For example, venepuncture is less painful than
heel lance for blood sampling in infants.
7. Is the planned environment suitable? Ideally,
this should be a quiet, calm place with suitable toys
and distractions.
8. Ensure that appropriate personnel who possess
the necessary skills are available, enlist experienced
help when necessary.
9. Allow sufﬁcient time for analgesic drugs and
other analgesic measures to be effective.
10. Formulate a clear plan of action should the
procedure fail or pain become unmanageable using
the techniques selected.
Good practice points
Pain management for procedures should include both
pharmacological and nonpharmacological strategies
whenever possible.
Children and their parents/carers beneﬁt from psycho-
logical preparation prior to painful procedures.
2.4 Procedural pain in the neonate:
general recommendations
Breast-feeding should be encouraged during the proce-
dure, if feasible: Grade A
Nonpharmacological measures including nonnutritive
sucking, ‘kangaroo care’, swaddling/facilitated tucking,
tactile stimulation, and heel massage can be used for
brief procedures: Grade A
2.5 Procedural pain in the neonate:
specific recommendations
2.5.1 Blood Sampling including percutaneous central
venous catheter insertion
Sucrose or other sweet solutions can be used: Grade A
Venepuncture (by a trained practitioner) is preferred to heel
lance for larger samples as it is less painful: Grade A
Topical local anesthetics can be used for venepuncture
pain: Grade B
Nonpharmacological measures including tactile stimula-
tion, breast-feeding, nonnutritive sucking, ‘kangaroo
care’, and massage of the heel can be used for heelprick
blood sampling: Grade A
Topical local anesthetics alone are insufﬁcient for heel
lance pain: Grade A
Using the whole plantar surface of the heel reduces the
pain of heelprick blood sampling: Grade B
Topical tetracaine plus morphine is superior to topical
analgesia alone for CVC insertion pain in ventilated
infants: Grade B
2.5.2 Ocular examination for retinopathy of
prematurity (ROP)
Sucrose may contribute to pain response reduction in
examination for retinopathy: Grade A
Infants undergoing examination for retinopathy should
receive local anesthetic drops in combination with other
measures if an eyelid speculum is used: Grade B
Swaddling, developmental care, nonnutritive sucking,
paciﬁer should be considered for neonates undergoing
examination for retinopathy: Grade B
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2.5.3 Lumbar puncture
Topical local anesthesia is effective in reducing LP pain:
Grade A
2.5.4 Urine sampling
Transurethral catheterization with local anesthetic gel is
preferred as it is less painful than suprapubic catheteri-
zation with topical local anesthesia: Grade B
Sucrose reduces the pain response to urethral catheteri-
zation: Grade C
2.5.5 Chest drain (tube) insertion and removal
See older children below
2.5.6 Nasogastric tube placement (See also; older
children, below)
Sucrose can reduce the pain response from NGT inser-
tion: Grade B
2.5.7 Immunization and intramuscular injection
Swaddling, breast-feeding or paciﬁer, and sucrose
should be considered in neonates undergoing vaccination:
Grade A
2.6 Procedural pain in older children
This section includes all infants and children outside
the neonatal period. Painful procedures are often iden-
tiﬁed as the most feared and distressing component of
medical care for children and their families. When
managing procedural pain in infants, older children
and adolescents special emphasis should given not only
to proven analgesic strategies but also to reduction in
anticipatory and procedural anxiety by suitable prepa-
ratory measures. Families, play therapists, nursing staff
and other team members play key roles in reducing
anxiety by suitable preparation.
Speciﬁc Recommendations
2.6.1 Blood sampling and intravenous cannulation
Topical local anesthesia should be used for intravenous
cannulation: Grade A
Psychological strategies, for example, distraction or hyp-
nosis, to reduce pain and anxiety should be used: Grade A
2.6.2 Lumbar puncture
Behavioral techniques of pain management should be
used to reduce LP pain: Grade A
Topical LA and LA inﬁltration are effective for LP pain
and do not decrease success rates: Grade B
50% nitrous oxide in oxygen should be offered to chil-
dren willing and able to cooperate: Grade C
2.6.3 Chest drain (tube) insertion and removal
There is little published evidence looking at analgesic
options for chest drain insertion or removal.
Good practice points
For chest drain insertion, consider general anesthesia or
sedation combined with subcutaneous inﬁltration of buf-
fered lidocaine. Selection of appropriate drain type may
reduce pain by facilitating easy insertion.
For chest drain removal, consider a combination of two
or more strategies known to be effective for painful pro-
cedures such as psychological interventions, sucrose
or paciﬁer (in neonates), opioids, nitrous oxide, and
NSAIDs
2.6.4 Bladder catheterization and related urine sam-
pling procedures
Psychological preparation and psychological and behav-
ioral interventions should be used during bladder cathe-
terization and invasive investigations of the renal tract:
Grade B
Infants: consider procedure modiﬁcation as urethral
catheterization is less painful than SPA for urine
sampling: Grade B
2.6.5 Insertion of nasogastric tubes
Good practice point
Topical local anesthetics such as lidocaine containing
lubricant gel applied prior to placement are likely to
reduce the pain and discomfort of NGT insertion.
2.6.6 Immunization and intramuscular injection
Psychological strategies such as distraction should be
used for infants and children undergoing vaccination:
Grade A
Consider additional procedure modiﬁcations such as vac-
cine formulation, order of vaccines (least painful ﬁrst)
needle size, depth of injection (25–mm, 25-gauge needle)
or the use of vapocoolant spay: Grade A
Swaddling, breast-feeding or paciﬁer, and sucrose should
be considered in infants undergoing vaccination: Grade A
2.6.7 Repair of lacerations
For repair of simple low-tension lacerations, tissue adhe-
sives should be considered as they are less painful, quick
to use, and have a similar cosmetic outcome to sutures
or adhesive skin closures (steri-strips): Grade A
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Topical anesthetic preparations, for example, LAT (lido-
caine–adrenaline–tetracaine) if available, can be used in
preference to injected LA, as they are less painful to
apply; it is not necessary to use a preparation containing
cocaine: Grade A
Buffering injected lidocaine with sodium bicarbonate
should be considered: Grade A
‘HAT’ should be considered for scalp lacerations. It is
less painful than suturing, does not require shaving, and
produces a similar outcome: Grade B
If injected lidocaine is used, pretreatment of the wound
with a topical anesthetic preparation, for example, lido-
caine–adrenaline–tetracaine (LAT) gel reduces the pain
of subsequent injection: Grade B
50% nitrous oxide reduces pain and anxiety during lac-
eration repair: Grade B
2.6.8 Change of dressings in children with burns
Potent opioid analgesia given by oral, transmucosal,
or nasal routes according to patient preference and
availability of suitable preparations should be consid-
ered for dressing changes in burned children: Grade A
Nonpharmacological therapies such as distraction and
relaxation should be considered as part of pain man-
agement for dressing changes in burned children:
Grade B
2.6.9 Botulinum injections for children with muscle
spasm
Good practice point
50% Nitrous oxide/oxygen should be considered in chil-
dren who are able to cooperate with self-administration.
2.7 Postoperative pain
Postoperative care is frequently shared between heath
professionals from different disciplines: they should
understand the general principles of pain assessment
and pain management in children. Postoperative anal-
gesia should be planned and organized prior to surgery
in consultation with patients and their families or
carers, and other members of the perioperative team.
Good practice points
Providers of postoperative care should understand the
general principles of good pain management in children;
this includes knowledge of assessment techniques and the
use of analgesics at different developmental ages.
Pediatric anesthetists are responsible for initiating post-
operative analgesia. They should liaise with patients and
their families/carers, surgeons, and other members of the
team providing postoperative care to ensure that pain is
assessed, and suitable ongoing analgesia is administered.
Postoperative analgesia should be appropriate to devel-
opmental age, surgical procedure, and clinical setting to
provide safe, sufﬁciently potent, and ﬂexible pain relief
with a low incidence of side effects.
Combinations of analgesics should be used unless there
are speciﬁc contraindications, for example; local anes-
thetics, opioids, NSAIDs, and paracetamol can be given
in conjunction, not exceeding maximum recommended
dose.
Recommendations
2.7.1 ENT surgery
Myringotomy
Oral paracetamol or NSAIDS (ibuprofen, diclofenac, or
ketorolac) in suitable doses can achieve adequate early
postoperative analgesia: Grade B
Opioids are effective but not recommended for routine
use because of side effects: Grade B
Tonsillectomy
A combination of individually titrated intraoperative opi-
oids, dexamethasone, and regularly administered periop-
erative mild analgesics (NSAIDS and /or paracetamol)
is recommended for management of tonsillectomy pain:
Grade A
Topical application or injection of local anesthetic in the
tonsillar fossa improves early pain scores following ton-
sillectomy: Grade A
Implementation of standardized protocols including intra-
operative opioid ± anti-emetic, perioperative NSAID
(diclofenac or ibuprofen) and paracetamol are associated
with acceptable pain relief and low rates of PONV:
Grade C
Mastoid and middle ear surgery
Great auricular nerve block can provide similar analge-
sia and reduced PONV compared with morphine. Prein-
cision timing of the block confers no additional beneﬁt:
Grade B
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2.7.2 Opthalmology
Strabismus surgery
Intraoperative LA blocks (subtenon’s or peribulbar)
reduce PONV and may improve perioperative analgesia
in comparison with IV opioid but provide no beneﬁt over
topical LA: Grade B
Topical NSAIDS do not improve pain scores or postop-
erative analgesic requirements when compared with topi-
cal LA or placebo: Grade B
Intraoperative opioid and NSAID provide similar post-
operative analgesia but opioid use is associated with
increased PONV: Grade B
Vitreoretinal surgery
In vitreoretinal surgery NSAID can provide similar anal-
gesia but lower rates of PONV compared with opioid:
Grade C
Peribulbar block improves early analgesia and may
reduce PONV compared with opioid: Grade C
2.7.3 Dental procedures
NSAIDS with or without paracetamol reduce pain fol-
lowing dental extractions: Grade B
Swabs soaked with bupivacaine on exposed tooth sockets
following extraction produce no or minor improvements
in pain in the immediate postoperative period: Grade B
Intraoperative LA inﬁltration reduces postoperative pain
following dental extractions, but provides little addi-
tional beneﬁt over NSAIDS and paracetamol alone:
Grade B
2.7.4 General surgery and urology (minor and
intermediate)
Sub-umbilical surgery
LA should be used when feasible: wound inﬁltration,
transversus abdominis plane (TAP) block, ilio-inguinal
nerve block and caudal analgesia are effective in the
early postoperative period following sub-umbilical sur-
gery: Grade A
Circumcision
Caudal epidural and dorsal nerve block are effective in
the early postoperative period, with low rates of compli-
cations and side effects: Grade A
Neonatal circumcision
LA should be used as it is superior to other techniques
for circumcision pain: Grade A
Dorsal nerve block is more effective than subcutaneous
ring block or topical LA: Grade A
When using topical local anesthetic it must be applied
correctly and sufﬁcient time allowed for it to become
effective: Grade A
Hypospadias repair
LA central neuraxial or dorsal nerve block is effective
reducing the need for postoperative supplementary opioid
administration following hypospadias surgery: Grade A
Orchidopexy
Caudal block is effective in the early postoperative per-
iod for orchidopexy with low rates of complications and
side effects: Grade A
Open inguinal hernia repair
LA wound inﬁltration, ilio-inguinal nerve block, paraver-
tebral block or caudal analgesia are effective in the early
postoperative period: Grade A
2.7.5 General surgery and urology (Major)
Major intra-abdominal surgery
Intravenous opioids either as continuous infusion, NCA,
or PCA are effective following major abdominal surgery:
Grade A
Epidural analgesia with LA should be considered for
major abdominal surgery. The addition of neuraxial
clonidine or opioid may further improve analgesia but
side effects may also be increased: Grade B
Appendicectomy (open)
PCA combined with NSAID is effective for postappen-
dicectomy pain: Grade B
Fundoplication (open)
Epidural LA + opioid is effective and may be associ-
ated with improved clinical outcome in selected patients
following fundoplication: grade D
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2.7.6 Laparoscopic surgery
Good practice points
Inﬁltration of port sites with LA as part of a multimodal
analgesic strategy may reduce postoperative pain follow-
ing laparoscopy.
Although overall postoperative analgesic requirements
appear to be reduced following laparoscopy, pain may
be equivalent to the equivalent open procedure in some
circumstances, particularly during the ﬁrst 24 h.
2.7.7 Orthopaedics, spinal and plastic surgery
Good practice point
There is no evidence from studies in children that
NSAIDs have a deleterious effect on bone fusion. The
analgesic beneﬁt of short-term NSAID use has been
demonstrated and may frequently outweigh any hypo-
thetical risk.
Lower limb surgery
Peripheral nerve blocks provide superior analgesia and
are associated with fewer adverse effects compared with
intravenous opioids: Grade B
Continuous peripheral nerve blocks are feasible, effective
and safe, and are associated with lower pain scores:
Grade B
Epidural opioids are effective, reduce the dose require-
ments of local anesthetic, and rescue IV opioids but
increase the incidence of side effects: Grade B
Epidural techniques are associated with lower pain
scores than intravenous opioid analgesia: Grade C
Systemic paracetamol and NSAID reduce intravenous
opioid requirements: Grade C
Upper Limb Surgery
Brachial plexus blocks provide satisfactory analgesia for
hand and forearm surgery extending into the postopera-
tive period: Grade B
The axillary, infraclavicular, supraclavicular, and inter-
scalene approach are feasible and effective: Grade B
Spinal surgery
Epidural techniques produce a modest improvement in
pain control, compared with intravenous opioids in
patients undergoing corrective surgery for adolescent idi-
opathic scoliosis: Grade B
Intrathecal opioids decrease intra-operative blood loss
and IV opioid consumption postoperatively. The duration
of action is 18–24 h: Grade C
Dual catheter epidural techniques should be considered, as
this permits coverage of multiple spinal levels: Grade C
The use of LA + lipophilic opioid in the epidural space
with a single epidural catheter does not show an analge-
sic beneﬁt over intravenous opioid techniques: Grade C
The use of LA + hydrophilic opioids in the epidural
space has a favorable analgesic proﬁle compared with
IV opioid, but at the expense of increased adverse
effects: Grade D
Cleft lip and palate and related procedures of head
and neck
Infraorbital nerve block provides effective analgesia for
cleft lip repair in the early postoperative period: Grade
A
2.7.8 Cardiothoracic surgery
Cardiac surgery (sternotomy)
Epidural and intrathecal techniques with opioid and/or
LA are effective for sternotomy pain but only marginal
beneﬁts have been demonstrated, and there is insufﬁcient
data concerning the incidence of serious complications:
Grade B
Thoracotomy
Epidural analgesia is effective for post-thoracotomy
pain: Grade D
2.7.9 Neurosurgery
Craniotomy and major neurosurgery
Good practice point
Analgesia following neurosurgery requires good commu-
nication and close cooperation between members of the
perioperative team. Frequent pain assessments should be
a routine part of postoperative care. A multimodal anal-
gesic approach is suitable, which may include the use of
LA inﬁltration, paracetamol, NSAID (when not contra-
indicated), and parenteral or oral opioid as determined
by assessed analgesic requirements.
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Section 3.0
Pain Assessment
Contents
3.1 General principles of pain assessment
3.2 Pain measurement tools
Children’s pain should be assessed. Effective pain
assessment is essential both in terms of its contribution to
the prevention and relief of a child’s pain (1–4) and also
in its role as a diagnostic aid. The centrality of pain
assessment to high-quality pain management is enshrined
in many current pain management recommendations,
position statements, reports, and guidelines (5–9).
Assessment refers to a broad endeavor aiming to
identify the factors that shape the pain experience
including physiological, cognitive, affective, behavioral
and contextual, and their dynamic interactions.
Measurement refers to the application of a metric
on one aspect of pain, usually intensity. This guideline
focuses primarily on pain measurement assuming that
the appropriate pain assessment as per clinical practice
takes place.
Existing guidelines: An evidence-based guideline ‘The
Recognition and Assessment of Pain in Children was
ﬁrst produced by the Royal College of Nursing (RCN),
UK, in 1999 and was revised in 2009 (10). The RCN
guideline was endorsed in 2001 by the Royal College of
Paediatrics and Child Health that produced ‘Guidelines
for Good Practice’ (11), which were the recommenda-
tions based on the original RCN guideline. We suggest
that both these documents be consulted for further and
more detailed information; the evidence and recommen-
dations presented here are intended to support and sup-
plement this existing guidance.
Technical note for this section of the guideline: in
addition to the SIGN criteria, and in line with current
practice, instruments were also evaluated based on a set
of evaluation criteria for the assessment of quality of
evidence for IMMPACT reviews (12) (see Table 1, and
Appendix 1, Technical Report for further information).
3.1 General principles of pain assessment
Good pain assessment contributes to the prevention
and/or early recognition of pain as well as the effective
management of pain (1,4). There are three fundamen-
tal approaches to pain assessment in children:
Self-report: measuring expressed experience of pain.
Observational/Behavioral: measuring behavioral dis-
tress associated with pain or measuring the perceived
experience of pain by parent or carer report.
Physiological: primarily measuring physiological
arousal consequent to pain
As self-report is the only truly direct measure of
pain, it is often considered the ‘gold standard’ of mea-
surement. However, for developmental reasons, self-
report may be difﬁcult or impossible in some children
and therefore a proxy measure must be used. For pain
to be measured as accurately as possible, the principles
underpinning assessment at different developmental
ages and in different settings must be appreciated.
Good practice points
Children’s pain should be assessed, documented, and
appropriate action taken. This requires both training of
healthcare professionals in pain assessment and measure-
ment with standardized instruments.
Table 1 Evaluation criteria for IMMPACT reviews (12)
Criteria for categories
I. A well-
established
assessment
The measure must have been presented in at
least 2 peer-reviewed articles by different
investigators or investigatory teams.
Sufficient detail about the measure to allow
critical evaluation and replication.
Detailed information indicating good validity
and reliability in at least 1 peer-reviewed
article.
II. Approaching
well-established
assessment
The measure must have been presented
in at least 2 peer-reviewed articles, which
might be by the same investigator or
investigatory team.
Sufficient detail about the measure to allow
critical evaluation and replication.
Validity and reliability information either
presented in vague terms (e.g., no statistics
presented) or only moderate values
presented.
III. Promising
assessment
The measure must have been presented in at
least 1 peer-reviewed article.
Sufficient detail about the measure to allow
critical evaluation and replication.
Validity and reliability information either
presented in vague terms or only moderate
values presented.
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In order to assess pain, effective communication should
occur between the child whenever feasible, their family or
carers, and the professionals in the multidisciplinary team.
Standardized instruments should be used in their ﬁnal
validated form. Even minor modiﬁcations alter the psy-
chometric properties of the tool and render comparisons
between studies invalid and clinical assessment biased.
Recommendations
No individual measure can be broadly recommended for
pain assessment across all children or all contexts:
Grade B (12–14).
Children’s self-report of their pain, is the preferred
approach, where feasible: Grade B (13).
An observational measure should be used in conjunction
with self-report with 3–5 year olds as there is limited evi-
dence for the reliability and validity of self-report mea-
sures of pain intensity in this age group: Grade B (15).
Sole use of physiological measures in clinical practice is
unproven and therefore not recommended: Grade D (16,17).
Evidence
The results of pain assessment must be documented,
acted upon, reassessed, and re-evaluated to determine
the effectiveness of interventions (1,18–21). Improved
documentation can result in improved pain manage-
ment (22–25). Studies demonstrate that there is low uti-
lization of pain tools and policies (26) and that pain is
under-assessed (3,27) and poorly documented (28,29),
resulting in children being under-medicated and/or
their pain being poorly managed (3,27,30–32). Regular
pain evaluation can contribute to the safety and efﬁ-
cacy of the management of acute pain (33).
Self-report: Pain is a highly complex and multidimen-
sional experience, and pain intensity scores are a neces-
sary oversimpliﬁcation. Children’s self-report of pain is
regarded as the gold standard, and in most circum-
stances, it is the preferred approach. Children’s self-
report of pain may differ to that of their parents or the
nurse caring for them (34). However, it must also be
recognized that self-report in both children and adults
is complex (13,35), dependent upon age and/or level of
cognition (36), affected by a range of social and other
inﬂuences (37–39), and is subject to biases (15,37,40).
Nevertheless, although children’s subjective reports of
pain are probably the best way of documenting the pres-
ence and intensity of pain, it requires quite advanced
cognitive skills (including classiﬁcation, seriation, and
matching) for children to be able to provide reliable and
valid self-reports of pain intensity. Faces scales may not
require the ability to seriate or estimate quantities
because the task can be handled by matching how one
feels to one of the faces, which is presumed to be easier
than quantitative estimation (41). However, self-report
is subject to individual response biases, reﬂecting the
person’s appraisal of the consequences of the pain report
(36). Although children of preschool age are often asked
to conﬁrm or deny that they are feeling internal states
such as hunger or thirst, they are rarely, if at all, asked
to make quantitative estimates of these states. Thus,
using a self-report pain scale is an unusual experience
for most young children (15). Alternative strategies for
answering confusing questions are frequently adopted
by young children. Response bias is a propensity to
respond systematically to test items in ways unrelated to
the item content. Response biases that have been docu-
mented in the pediatric literature include:
l Anchor effects which refer to the inﬂuence of sur-
rounding conditions or prior experience on the estima-
tion of a quantity. For example, pain ratings on faces
scales are inﬂuenced by whether the lower anchor face
is smiling or not.
l Sequence bias such as the child selecting (for exam-
ple) the leftmost face to answer the ﬁrst question, and
then picks the adjacent face to the right in response to
each successive question, in a sequence of responses
that would be scored in an ascending or descending
series (e.g., 0–2–4–6–8).
l Giving the same answer to all questions (15,42–44).
In experimental situations where children were asked
to rate hypothetical pain situations, it has been demon-
strated that young children from four to seven cannot
distinguish as many faces as proposed by the majority
of available faces scales (45). These results strongly
recommend a reduction in the number of response lev-
els of faces scales for pain assessment in children.
It should be noted that not all inaccurate responses
indicate the occurrence of response biases as inaccurate
responses can occur for other reasons such as failure
to understand the question, deliberate random or
incorrect responding, lack of motivation and attention
to the task, or undetected learning or cognitive difﬁcul-
ties (15). Clinicians should be aware that young chil-
dren’s pain scores can be misleading, particularly when
a pain scale is used only once to measure pain on a
single occasion, making it difﬁcult for the clinician to
detect any underlying response bias. Therefore, self-
report pain scores from children below 5 years of age
should generally be treated with caution and should be
corroborated by observational measures.
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Choice of assessment tool: No individual observational
(14), self-report (13), or physiological measure is
broadly recommended for pain assessment across all
children or all contexts. Some validated pain measures,
primarily developed for use within pain research studies,
do not transition easily in everyday practice as they can
be challenging to use in clinical settings (46). Therefore,
healthcare professionals need to make informed choices
about which tool to use to assess each individual child’s
pain. Composite measures using self-report and at least
one other measure may be a better approach (13).
Table 3 provides guidance, as a function of a child’s
chronological age, on measures that have good psycho-
metric properties and can be used for the assessment of
procedural and postoperative pain.
Education: Healthcare professionals require appropriate
levels of education about pain (27,47–49). They also
need adequate training/preparation in the use of pain
assessment tools and proﬁciency in using them
(23,50,51). Improved working practices (52), organiza-
tional commitment (23), quality improvement strategies
(23), and one-to-one coaching (53) have been shown to
enhance pain assessment. Studies have demonstrated
that health professionals’ assessment of children’s pain
is subject to a range of individual, social, and contextual
inﬂuences (54–57). Professionals need to be ﬂexible and
willing to develop more positive attitudes and beliefs
regarding the attributes of children’s pain (19). Percep-
tions about the pain experienced by particular groups of
children, such as children with neurological impairment
may need to be challenged (58,59).
Parents and other carers should also be given appro-
priate information about their child’s pain (55,60–62)
and emotional support and clariﬁcation of their role in
their child’s pain (61,63). Their beliefs about their
child’s pain need to be taken into consideration as
these beliefs may impact their child’s care. Parents/
carers of children with cognitive impairment may have
mistaken beliefs about their child’s pain, which need to
be carefully explored (59). Parents/carers also need
appropriate information and teaching in the use of
pain assessment tools if they are to be effective in
assessing and managing their child’s pain (59,63,64).
3.2 Pain measurement tools
A bewildering number of acute pain measurement
tools exist. Tools vary in relation to three broad
groups of factors: child-related, user-related, and struc-
tural. For example, the age, cognitive level, language,
ethnic/cultural background of the child, the setting for
which they are to be used, and the tool’s psychometric
properties (e.g., validity and reliability) in that context
(13,14,35,65–67). Such factors should be taken into
consideration when making choices about which acute
pain measurement tool to use.
Despite the proliferation and availability of tools,
they are not always used consistently or well (68–70)
and inconsistencies have been identiﬁed between
reported assessment practice and documented practice
(3,26,27,29,71).
The following provides a brief guide to some of the
best evaluated and commonly used tools in current
clinical practice. The tools are broadly divided into
self-report and observational/behavioral tools and then
further subdivided into their suitability for type of pain
(acute procedural, postoperative, or disease-related)
and/or setting. Brief information of the intended age
ranges for which the tool has been developed and/or
information on the ages for which the tool has been
validated are presented (look at the data extraction
tables for more information on each measure’s psycho-
metric properties and relevant studies).
3.2.1 Self-report tools (5 years and above)
The most psychometrically sound and feasible self-
report tools, based on age/developmental level and type
of pain, have been recommended for use in clinical trials
(marked * below) (13). However, other tools, while not
necessarily suitable for clinical trials, have been shown
to have good clinical utility and have been validated.
Procedural pain
l Wong and Baker FACES Pain Scale (72): intended
for 3–18 year olds.
l Faces Pain Scale-Revised* (44): see also (43,73):
intended for 4–12 year olds.
Table 2 Recommended measures for procedural and postopera-
tive pain assessment as a function of the child’s chronological age
Child’s age* Measure
Newborn–3 years old COMFORT or FLACC
4 years old FPS-R +
COMFORT or FLACC
5–7 years old FPS-R
7 years old + VAS or NRS or FPS-R
*with normal or assumed normal cognitive development
Note: Reliance on chronological age as the sole indicator of a
child’s capacity to self-report will inevitably generate both false
positives (invalid scores from children who do not understand
the scale) and false negatives (not obtaining valid scores from
children who do understand the scale but were not asked).
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l Visual analogue* and numerical rating scales:
intended for 8 years plus.
l Pieces of Hurt Tool* (74), see also (75), intended
for 3–8 year olds.
• MSPCT (The Multiple Size Poker Chip Tool) (76),
intended for 4–6 year olds.
Postoperative pain
l Wong and Baker FACES Pain Scale (72): intended
for 3–18 year olds.
l Faces Pain Scale-Revised* (44), see also (43,73),
intended for 4–12 year olds.
l Visual analogue* and numerical rating scales:
intended for 8 years plus.
• Pieces of Hurt Tool* (74) see also (75), intended for
3–8 year olds.
Disease-related pain
l Wong and Baker FACES Pain Scale (72): intended
for 3–18 year olds.
l Faces Pain Scale-Revised (44), see also (43,73):
intended for 4–12 year olds.
• Visual analogue and numerical rating scales:
intended for 8 year olds and older.
3.2.2 Observational/behavioral measures
Pain and pain-related distress cannot be easily sepa-
rated either conceptually or at a practical level; for
example, cry and scream can be the indicative of fear
or pain. Therefore, each of the scales below should be
viewed as a measure of pain and distress, regardless of
the title of the scale (77).
A. Premature infants and neonates
Not all neonatal pain assessment tools have been rig-
orously tested for construct validity, feasibility, and
clinical utility (78). However, the following tools are
widely used for neonatal pain assessment and used
within neonatal intensive care/special care baby units.
Acute procedural pain
l PIPP (Premature Infant Pain Proﬁle) (79): See also
(80,81).
l CRIES (82).
• NFCS (Neonatal Facial Coding Scale) (83,84).
Postoperative pain
l PIPP (Premature Infant Pain Proﬁle) (79): see also
(85).
l CRIES (82): see also (85).
• COMFORT scale (86–88).
B. Children and young people without cognitive
impairment
On the basis of the highest evidence of validity, reliabil-
ity, and clinical utility and use within practice settings,
the following behavioral tools can be recommended for
children and young people without cognitive impairment
aged 3–18 years in the following speciﬁc situations (14).
Procedural pain
l FLACC (Face, Legs, Arms, Cry, and Consolability)
(89); see also (50,90–92): intended for 1–18 year olds.
• CHEOPS (Children’s Hospital of Eastern Ontario
Pain Scale) (93); see also (94): intended for 1–18 year olds.
Postoperative pain (in the hospital setting)
• FLACC (89): intended for 1–18 year olds.
Postoperative pain (being managed by parents/carers
at home)
• PPPM (Parents Postoperative Pain Measure) (95);
see also (96,97): intended for 1–12 year olds.
Pain in the critical care setting
• COMFORT scale (86): intended for newborn–
17 year olds.
C. Children and young people with cognitive impair-
ment
While there is less substantive evidence of reliability,
validity, clinical utility, and widespread use within
practice settings, the following tools are suitable for
use with children and young people with cognitive
impairment in the following situations:
Procedural/disease-related pain
l NCCPC-R (Non-Communicating Children’s Pain
Checklist) (59,98–100): intended for 3–18 year olds
• PPP (The Pediatric Pain Proﬁle) (101): See also
(102): intended for 1–18 year olds.
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Postoperative pain
l NCCPC-PV (Non-Communicating Children’s Pain
Checklist – Postoperative Version) (100): intended for
3–19 year olds.
l PPP (The Pediatric Pain Proﬁle) (101): intended for
1–18 year olds.
• Revised FLACC (50): intended for 4–19 year olds.
Parent report of their child’s postoperative pain
intensity
The most psychometrically sound and feasible parent
report tool, based on age/developmental level and type
of pain, has been recommended for use in clinical trials
(13). However, this may not necessarily directly trans-
fer to clinical utility and more research is needed.
• PPPM (Parents Postoperative Pain Measure) (95);
see also (96,97).
3.2.3 Physiological measures
Physiological parameters such as heart rate variability,
skin conductance, and changes in salivary cortisol can
be used indirectly to indicate the presence of pain (103–
106). However, blood pressure, heart rate, and respira-
tory rate have been shown to be unreliable indicators in
newborns, infants, and young children with wide inter-
individual behavior–physiology correlations after major
surgery in 0–3-year-old infants (16). More recently, the
magnitude of evoked cortical activity has been suggested
as a possible indicator of pain (107). While the method
appears promising and correlations with other pain
measures have been found to be good, similarly to the
measurement of other physiological parameters such as
cortisol changes, it has limited clinical utility. It is ques-
tionable whether the pain experience can be meaning-
fully reduced to physiological activation alone;
therefore, physiological measures should be used in con-
junction with other tools/measures to determine the
presence and intensity of pain.
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Section 4.0
Medical Procedures
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4.3.9 Botulinum injections for children with muscle spasm
4.1 General considerations
Routine medical care involving blood sampling and
other painful diagnostic and therapeutic procedures
can cause great distress for children and their families.
When such procedures are essential, it is important
that they should be achieved with as little pain as pos-
sible. For many children who have chronic illness,
these procedures often need to be repeated, and this
can generate very high levels of anxiety and distress if
their previous experience has been poor. The 10 gen-
eral principles, which apply to the management of all
procedures at any age, are listed below. Further advice
for use in speciﬁc age-groups, and speciﬁcally for some
of the most common procedures, is described in sec-
tions 4.2 and 4.3.
1. Infants and children of all ages, including premature
neonates, are capable of feeling pain and require anal-
gesia for painful procedures.
2. Developmental differences in the response to pain
and analgesic efﬁcacy should be considered when
planning analgesia.
3. Consider whether the planned procedure is neces-
sary, and how the information it will provide might
inﬂuence care? Avoid multiple procedures if possible.
4. Plan the timing of procedures to minimize the fre-
quency of a painful procedure.
5. Are sedation or even general anesthesia likely to be
required for a safe and satisfactory outcome?
6. Would modiﬁcation of the procedure reduce pain?
For example, venepuncture is less painful than heel
lance.
7. Is the planned environment suitable? Ideally, this
should be a quiet, calm place with suitable toys and
distractions.
8. Ensure that appropriate personnel who possess the
necessary skills are available, and enlist experienced
help when necessary.
9. Allow sufﬁcient time for analgesic drugs and other
analgesic measures to be effective.
10. Formulate a clear plan of action should the proce-
dure fail or pain become unmanageable using the tech-
niques selected.
Good practice point
Pain management for procedures should include both
pharmacological and nonpharmacological strategies
whenever possible.
4.2 Procedural pain in the neonate
Premature neonates are able to perceive pain, but the
response to both pain and analgesia is dependant on
developmental age. Because of this, pain assessment in
this age-group is particularly difﬁcult (see section 3),
and the low sensitivity of many pain measurement
tools can complicate the interpretation of evidence.
Clinically, neonates appear to be sensitive to the
adverse effects of many drugs, including analgesics;
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however, reductions in the response to pain have been
observed following nontraditional analgesia such as
sucrose and physical and environmental measures, for
example, suckling or tactile stimulation, which are cur-
rently not known to have potentially harmful effects.
A number of documents including reviews, guideline,
and policy statements have been published recently on
the subject of procedural pain management in the neo-
nate (1–4). On the basis of the currently available evi-
dence, the following measures can be generally
recommended for the management of procedural pain
in the neonate:
Recommendations
Breast-feeding should be encouraged during the proce-
dure, if feasible: Grade A (5–9).
Nonpharmacological measures including non-nutritive
sucking, ‘kangaroo care’, swaddling/facilitated tucking,
tactile stimulation, and heel massage can be used for
brief procedures: Grade A (5,6,10–30).
4.2.1 Blood sampling in the neonate
(includes peripheral venous, arterial, and
percutaneous central venous cannulation)
Blood sampling is a necessary and routine part of neo-
natal care. Where an indwelling arterial catheter is not
available, then venepuncture (VP) or heel prick blood
sampling (HPBS) is used. All newborn babies in the
UK have a HPBS as part of the UK screening regime.
Neonates admitted to intensive care or who are cared
for on postnatal wards will require frequent blood
sampling that has been identiﬁed in many studies as a
signiﬁcant cause of pain and morbidity. HPBS requires
appropriate training and is used to collect small blood
samples such as blood glucose, bilirubin newborn
screening tests, and capillary blood gases. VP also
requires training but is technically more difﬁcult and is
used to collect larger blood samples. The principles
and techniques of pain relief are applicable to other
invasive procedures such as peripheral arterial line
insertion and percutaneous central venous catheters
(i.e., long line). Please also see sections 4.0 and 4.1 on
the general management of procedural pain.
Recommendations
Sucrose or other sweet solutions can be used: Grade A
(5,6,10–18,22,29,31–40).
Nonpharmacological measures including tactile stimula-
tion, breast-feeding, non-nutritive sucking, ‘kangaroo
care’, and massage of the heel can be used for heel prick
blood sampling: Grade A (12,19–28,30).
Venepuncture (by a trained practitioner) is preferred to
heel lance for larger samples as it is less painful: Grade
A (18,41–43).
Topical local anesthetics alone are insufﬁcient for heel
lance pain: Grade A (44,45).
Topical local anesthetics can be used for venepuncture
pain: Grade B (44–47).
Using the whole plantar surface of the heel reduces the
pain of heel prick blood sampling: Grade B (48,49).
Remifentanil and sucrose decreased central venous cath-
eter pain: Grade B: (36).
Topical tetracaine plus morphine is superior to topical
analgesia alone for central venous catheter pain in venti-
lated infants: Grade B (50,51).
Evidence
A large number of studies have demonstrated that
sucrose before VP or HPBS reduces the behavioral
pain scores measured by a range of validated assess-
ments (5,6,10–18,22,29,31–40,52). The dose of sucrose
differed across these studies.
Relieving the pain of HPBS has been challenging
with pharmacological methods. However, nonpharma-
cological methods including breast-feeding, non-nutri-
tive sucking, kangaroo care, and premassage of the
heel before and during HPBS have consistently demon-
strated reduced behavioral pain scores and physiologi-
cal markers (12,19–28).
VP appears to be less painful than HPBS so is the
preferred option whenever practical (18,41,43). Topical
local anesthesia (LA) can reduce the pain of VP and
insertion of central venous catheters (44–46,51,53).
However, topical LA is not effective for HPBS (45).
Morphine with topical LA was more effective than LA
alone for central venous line placement in ventilated
neonates (50,51). In addition, low-dose remifentanil
combined with sucrose reduced the pain of insertion of
central venous catheters (36).
HPBS pain can be reduced with procedure modiﬁca-
tion such as using an automated spring-loaded device,
avoiding squeezing the heel, and using a wider area of
the plantar surface of the heel (48,49,54–56).
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Analgesia Table 4.2.1a
Blood sampling and peripheral cannulation in the neonate
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1+
Sucrose 1++
Nonpharmacological 1+
Procedure modifications 1+
Analgesia Table 4.2.1b
Percutaneous central venous catheter insertion
Direct
evidence
Indirect
evidence
Local anesthesiaa Topical 1+
Opioids Intravenous 1+
Sucrosea 1+ 1++
aCombined with Opioids.
4.2.2 Ocular examination for retinopathy of prematu-
rity
Preterm infants ‘at risk’ of retinopathy of prematurity
(ROP) should have regular ocular examination. An
eyelid speculum is inserted to hold the eye open, and
the retina is examined by indirect fundoscopy through
a dilated pupil. In addition, a small proportion will
require laser ablation of signiﬁcant disease.
Recommendations
Sucrose may contribute to pain response reduction in
examination for retinopathy: Grade A (57–60).
Infants undergoing examination for retinopathy should
receive local anesthetic drops in combination with other
measures if an eyelid speculum is used: Grade B (61–
65).
Swaddling, developmental care, non-nutritive sucking,
and paciﬁer should be considered for neonates under-
going examination for retinopathy: Grade B
(57,60,63,66).
Laser treatment should be with general anesthesia if
timely treatment is needed: Grade D (63).
Evidence
A combined analgesic approach using LA, a paciﬁer,
swaddling, and the addition of a sweet solution is
likely to be most effective for ROP screening exami-
nation pain (57,65). Oral sucrose prior to the screen
reduced the behavioral pain scores in small groups
of infants (59,60). Laser treatment is painful, and
appropriate pain-relieving strategies should be
employed (63). Laser treatment may be more rapidly
available if sedation, analgesia, ventilation, and
muscle relaxation are possible on the neonatal unit
(63). See section 6.7 for further information on the
use of sucrose.
Analgesia Table 4.2.2 Retinopathy of prematurity
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1+
Sucrose 1+
Non-nutritive sucking 1+
Comfort care package 1)
4.2.3 Lumbar puncture (LP) in the neonate
Sampling of cerebrospinal ﬂuid is often regarded as a
minor procedure in infants; nevertheless, it is associ-
ated with pain that can be reduced by suitable analge-
sia (67).
Recommendation
Topical local anesthesia is effective in reducing lumbar
puncture pain: Grade A (67,68).
Evidence
There have been few studies directly investigating LP
pain in the neonate. Topical local anesthetic has
been found to be effective (67). Indirect evidence
suggests that subcutaneous inﬁltration of LA would
also be effective, but it has not been ‘consistently’
shown to be superior to placebo in the neonate, in
contrast to positive effects in older children and
adults (69). A nomogram of weight to midspinal
depth allows estimation of the depth of insertion of
an LP needle (70,71). This has been correlated with
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increased success rate (i.e., less red cell contamina-
tion).
Analgesia Table 4.2.3 Lumbar puncture in the neonate
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1+
Infiltrationa 1+
Sucrose 1++
Non-nutritive sucking 1+
Nonpharmacological 1+
Procedure Modification 2+
aOlder children and adults.
4.2.4 Urine sampling in the neonate
Urine sampling can be important to detect urinary
tract infection in neonates and must be collected
avoiding sample contamination. Direct catheteriza-
tion of the urethra or catheterization of the bladder
by the percutaneous suprapubic route is often pre-
ferred because some types of urine collection bags
have a high rate of contamination, and ‘clean catch’
specimens can be difﬁcult or time-consuming to col-
lect.
Recommendations
Transurethral catheterization with local anesthetic gel is
preferred as it is less painful than suprapubic catheteri-
zation with topical local anesthesia: Grade B (72,73).
Sucrose reduces the pain response to urethral catheteri-
zation: Grade C (74).
Evidence
Pain responses were observed in neonates and infants
having either urethral or suprapubic catheterization
with local anesthesia (72). Transurethral catheteriza-
tion appeared to be less painful (72). Sucrose analgesia
immediately before bladder catheterization in neonates
and infants up to 3 months old was not effective at
abolishing pain responses; however, a reduction in
response was observed in the subgroup of those
<30 days old (74). See section 6.8 for advice on the
use and administration of sucrose.
Analgesia Table 4.2.4 Urine sampling in the neonate
Direct
evidence
Indirect
evidence
Local anesthesia Topical
lubricant gela
1+
Sucrose 1) 1++
Non-nutritive sucking 1+
Nonpharmacological 1+
Procedure modificationa 1+
aUrethral catheterization.
4.2.5 Chest drain (tube) insertion and removal
The management of this procedure in the neonate
is discussed with that of older children in section 4.3.3.
4.2.6 Nasogastric tube placement
Nasogastric tube (NGT) insertion is a painful and
distressing procedure frequently performed with little
attention to pain-relieving strategies (75). Neonates
who have not fully established enteral feeding or
who have not developed a coordinated suck will
require NGT feeds. In addition, the NGT is replaced
to prevent nosocomial infection and when displaced.
Passing a NGT is a skilled procedure, and in the
UK, the Department of Health has published guide-
lines (CMO Update no.39, publ DoH, UK). In addi-
tion, the National Patient Safety Agency has
recommended that only Medicina NGT is used to
avoid erroneous intravenous drug delivery by the
NGT route (NPSA/2007/19). See also sections 4.0,
4.1, and 4.2 for advice on the general management
of painful procedures in neonates, infants, and chil-
dren. The management of this procedure is also
discussed with that of older children in section 4.3.5.
Recommendation
Sucrose can reduce the pain response from NGT
insertion: Grade B (76).
Evidence
Sucrose (0.5 ml of 24%) given 2 min before NGT
insertion reduced the behavioral pain score and physio-
logical responses in a small number of stable preterm
infants (76).
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Analgesia Table 4.2.6 Nasogastric tube insertion
Direct evidence Indirect evidence
Sucrose 1+ 1++
Non-nutritive sucking 1+
Nonpharmacological 1+
4.2.7 Immunization and intramuscular injection
The management of this procedure is also discussed
with that of older children in section 4.3.6. There are
two indications for IM injections: routine immuniza-
tion and administration of vitamin K. In any other sit-
uation, an alternative route of administration should
be used. The UK routine immunization schedule
advises that vaccinations are given at 2, 3, and
4 months of age. A premature neonate born at
<33 weeks of gestation is likely to receive these immu-
nizations at the above ages on neonatal intensive care
units.
Recommendation
Swaddling, breast-feeding or paciﬁer, and sucrose
should be considered in neonates undergoing vaccination:
Grade A (24,77,78).
4.3 Procedural pain management in infants
and older children
Painful procedures are often identiﬁed as the most
feared and distressing component of medical care for
children and their families. See also general consider-
ation for the management of procedural pain at the
start of section 4.0, and section 4.1 for the manage-
ment of procedural pain in the neonate. When manag-
ing procedural pain in infants, older children, and
adolescents, special emphasis should be given not only
to proven analgesic strategies but also to reduction in
anticipatory and procedural anxiety by suitable prepa-
ratory measures. Families, play therapists, nursing
staff, and other team members play key roles in reduc-
ing anxiety by suitable preparation. The personality,
previous experience, and analgesic preferences of the
child will inﬂuence management strategies. Analgesia/
sedation with 50% nitrous oxide/oxygen by supervised
self-administration should be considered where indi-
cated, especially in children older than 6 years who
can cooperate: see section 6.7. Sedation or general
anesthesia may be needed for complex, invasive, or
multiple procedures. See NICE Guideline CG112
‘Sedation in Children and Young People’ available at:
http://www.nice.org.uk/CG112.
Good practice points
Children and their parents/carers beneﬁt from psycho-
logical preparation prior to painful procedures.
Pain management for procedures should include both
pharmacological and nonpharmacological strategies
where possible.
50% nitrous oxide/oxygen should be considered for
painful procedures in children who are able to cooper-
ate with self-administration.
Sedation or general anesthesia should be considered,
particularly for invasive, multiple, and repeated
procedures.
4.3.1 Blood sampling and intravenous cannula-
tion in children
For most children, venepuncture or intravenous cannu-
lation may be a ‘one-off’ event, but children with
chronic illness are likely to require multiple procedures,
and this can be very distressing for the child, the family,
and the medical team. When managing such pain in
infants, older children, and adolescents, special emphasis
should be given not only to proven analgesic strategies
but also to reduction in anticipatory anxiety by suitable
preparatory measures. Venepuncture or intravenous
cannulation may be technically difﬁcult – practitioners
should not continue to try multiple cannulation sites
unless the procedure is urgent or a more experienced
practitioner is not available. In nonurgent cases, con-
sider whether the test can be rescheduled, and enlist the
help of a more experienced practitioner. See also section
4.0: general management of procedures, and 4.2: proce-
dural pain in infants, older children, and adolescents.
Recommendations
Topical local anesthesia should be used for intravenous
cannulation: Grade A (79–84).
Psychological strategies to reduce pain and anxiety
should be used: Grade A (83,85,86).
Evidence
Topical LA, such as EMLA or AMETOP (ametho-
caine), has an established place in the management of
venous cannulation with high-quality evidence for efﬁ-
cacy (79–82). Recent evidence suggests that ametho-
caine has an advantage over EMLA for cannulation
(83,87). Amethocaine has a faster onset of action.
ª 2012 Blackwell Publishing Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 21
Newer preparations such as liposomal encapsulated
LA or newer LA delivery systems may offer
advantages in some situations. Buffered injected LA,
for example, lidocaine + bicarbonate 10:1, adminis-
tered with a ﬁne 30-g needle subcutaneously prior to
cannulation is faster in onset and may be as acceptable
and effective as topical preparations (81,82,88).
Nitrous oxide (50–70%) inhalation has been used in
children older than 6 years who can self-administer
during venepuncture in some circumstances. 70%
nitrous oxide is not routinely available for self-
administration in the UK. 50% nitrous oxide and
EMLA have been shown to be equally effective for
venepuncture with further improvements in pain reduc-
tion using a combination of the two (79,89).
The efﬁcacy of vapocoolant topical spray has not
been clearly established. Vapocoolant spray was not
effective in reducing pain in one study of intravenous
cannulation but did show a modest reduction in pain in
a later study (90,91). In a study of children’s prefer-
ences, children who had experienced both methods
selected both ethyl chloride and Ametop equally (92).
A combination of cooling and vibration (Buzzy) with
or without LA reduced pain and distress of venepunc-
ture in one study (93).
Psychological approaches such as distraction should
be offered to all children as it is easy to administer.
Hypnosis can also be very effective for children requir-
ing repeated interventions (83,86).
Analgesia Table 4.3.1
Blood sampling and IV cannulation in children
Direct
evidence
Local anesthesia Topical 1++
Infiltration 1++
50% nitrous oxide/oxygen 1+
Psychological preparation 1)
Psychological intervention 1++
4.3.2 Lumbar puncture in children
Lumbar puncture (LP) is necessary in acutely ill chil-
dren in whom meningitis is suspected. These children
are likely to be unwell and anxious, and they may also
undergo other painful procedures such as venepuncture
as part of diagnosis and treatment.
Other children require ‘elective’ or ‘planned’ LP:
This may be for diagnostic reasons, such as evaluation
of possible raised intracranial pressure, or for intrathe-
cal treatments such as chemotherapy.
Positioning of the child is very important for suc-
cess, and it is helpful to have assistance from trained
staff with experience of correct positioning. Children
who require multiple LPs may cope better with the
addition of sedation (see NICE Guideline CG112
‘Sedation in Children and Young People’ available at:
http://www.nice.org.uk/CG112) or general anesthesia.
See also section 4.0 and 4.2 on the general manage-
ment of painful procedures.
Recommendations
Behavioral techniques of pain management should be
used to reduce LP pain: Grade A (85,94).
Topical LA and LA inﬁltration are effective for LP pain
and do not decrease success rates: Grade B (82,95,96).
50% nitrous oxide/oxygen should be offered to children
willing and able to cooperate: Grade C (97).
Evidence
Few studies have directly examined the efﬁcacy of anal-
gesics in awake children undergoing lumbar puncture.
Most commonly, local anesthesia is combined with sed-
ative agents, such as midazolam, or biobehavioral tech-
niques, such as distraction or other cognitive–behavioral
interventions (85,94,95,98), is effective for LP pain, and
may also be used in combination with LA (either topical
or inﬁltration) and other strategies (97). Ketamine anal-
gesia/sedation or general anesthesia is sometimes used in
emergency departments and oncology units with appro-
priate facilities (99–101). However, recent studies indi-
cate that analgesia practice for LP in emergency
departments could be improved (102,103). It seems
likely that older children, especially those who may only
need to undergo this procedure once, may tolerate LP
with appropriate behavioral techniques and local anes-
thesia, whereas children requiring multiple LPs should
be offered sedation or GA (98).
There is some evidence that technique modiﬁcation
using pencil point needles instead of standard nee-
dles may reduce the incidence of post-LP headaches
(104).
Analgesia Table 4.3.2 Lumbar puncture in children
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1+
Infiltration 1)
50% nitrous oxide/oxygen 2+
Psychological interventions 1++
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4.3.3 Chest drain (tube) insertion and removal
Chest drains are necessary in children with pneumotho-
rax, empyema, pleural effusions, following chest trauma
and surgery. Pediatricians are most likely to need to
insert chest drains in the Neonatal Intensive Care Unit
to infants with pneumothorax. This procedure is
becoming increasingly rare because of improvements in
the management of Respiratory Distress Syndrome, e.g.
the use of surfactant and ventilating infants at lower
pressures. Older children require drains for manage-
ment of empyema or for pneumothorax. Chest drains
have become easier to insert recently with the develop-
ment of small-bore Seldinger-type drains that reduce
the need for blunt dissection of the chest wall: They are
available for both neonates and older children.
Sedation (see NICE Guideline CG112 ‘Sedation in
Children and Young People’ available at: http://
www.nice.org.uk/CG112) or general anesthesia should
be considered for chest drain insertion; however, in an
emergency, some children may tolerate this procedure
using inﬁltration of buffered LA.
Studies agree that chest drain removal also causes
signiﬁcant pain. No single analgesic strategy has been
shown to satisfactorily alleviate this pain in children,
and it is likely that the optimum effects will be
achieved using a combination of strategies.
See also section 4.0 and 4.2 for advice on the general
management of painful procedures.
Good practice points
For chest drain insertion, consider general anesthesia
or sedation combined with subcutaneous inﬁltration of
buffered lidocaine. Selection of appropriate drain type
may reduce pain by facilitating easy insertion.
For chest drain removal, consider a combination of
two or more strategies known to be effective for pain-
ful procedures such as psychological interventions,
sucrose or paciﬁer (in neonates), opioids, nitrous
oxide, and NSAIDs.1
Evidence
There is little published evidence looking at analgesic
options for chest drain insertion or removal. Chest
drain insertion may require general anesthesia or seda-
tion in combination with LA inﬁltration. Analgesia for
removal of chest drains has included IV opioid, local
anesthetics, and NSAIDs, but despite the use of these
1It is important to allow enough time for the chosen agent to reach their
peak effect and to use adequate doses (105).
analgesics, signiﬁcant pain is still reported (106,107).
Inhalation agents such as nitrous oxide or isoﬂurane
may have a role in these procedures, but further study
is needed (108,109). N.B. Nitrous oxide is contraindi-
cated in the presence of pneumothorax. Multimodal
therapy, for example, IV morphine, nitrous oxide, top-
ical LA, and NSAID, is likely to be superior to a sin-
gle agent, but such combinations, although in clinical
use, have not been studied.
Analgesia Table 4.3.3 Chest drain insertion and removal
Direct
evidence
Indirect
evidence
LA: buffered lidocaine infiltration (insertion) 1++
LA: topicala (removal) 1+
Opioidsa (removal) 1+
NSAIDSa (removal) 1+
50% nitrous oxidea,b (removal) 1)
Psychological interventions 1++
Procedure modification (insertion) 3
aMay reduce but not abolish pain of chest drain removal.
bContraindicated in the presence of pneumothorax.
4.3.4 Bladder catheterization and related urine
sampling procedures
Urine specimens are usually obtained by ‘clean catch’ or
midstream specimen (MSU). Urine may be obtained
from young infants by means of suprapubic aspirate
(SPA). Sampling by urethral catheterization appears to
be less painful than SPA (72,110). Bladder catheteriza-
tion may be required for radiological or other investiga-
tion of the renal tract, for example, micturating
cystourethrogram (MCUG) also known as voiding cys-
tourethrogram (VCUG). Consider whether MCUG is
really necessary – it is a distressing procedure for the
child and other less invasive techniques, such as dynamic
renal scanning may provide the same information.
Bladder catheterization may also be required in chil-
dren who develop urinary retention, particularly those
receiving epidural analgesia postoperatively. Very ill
patients in ICU may also require catheterization to
monitor urine output. For children who are to receive
postoperative epidural opioids after major surgery,
consider ‘prophylactic’ bladder catheterization under
general anesthesia at the time of surgery.
Sedation may also be indicated for some children; see
NICE Guideline CG112 ‘Sedation in Children and
Young People’ available at http://www.nice.org.uk/
CG112 for advice on sedation practice, and sections 4.0
and 4.2 on the general management of procedural pain.
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Good practice point
Lubricant containing local anesthesia should be
applied to the urethral mucosa prior to bladder
catheterization.
Recommendations
Psychological preparation and psychological and behav-
ioral interventions should be used during bladder cathe-
terization and invasive investigations of the renal tract:
Grade B (111,112).
Infants: Consider procedure modiﬁcation as urethral
catheterization is less painful than SPA for urine sam-
pling: Grade B (72,73).
Evidence
Bladder catheterization has been shown to cause signiﬁ-
cant pain and distress, but analgesia is not part of rou-
tine care in many institutions (113). More complex
interventions, which include bladder catheterizations
such as MCUG or VCUG, have also been shown to
cause signiﬁcant distress, which can be reduced by psy-
chological preparation and behavioral pain manage-
ment techniques such as distraction or hypnosis
(111,112,114). Local anesthetics incorporated into lubri-
cant gels are frequently used in adults to reduce the pain
and discomfort of catheterization, but this has not been
well studied in children. Pretreatment of the urethra
with lidocaine 10 min before catheterization reduced
pain in a group of children (16 girls, four boys) with a
mean age of 7.7 years (115). However, in younger chil-
dren (mean age 2 years), application of lidocaine gel to
the ‘genital mucosa’ for only 2–3 min before the proce-
dure and its subsequent use as a lubricant did not
decrease pain (113). Techniques combining adequate
preparation, local anesthesia, and behavioral interven-
tions are likely to be more effective (116).
Analgesia Table 4.3.4
Bladder catheterization and urine sampling in children
Direct
evidence
Indirect
evidence
Local anesthesia Topical gela 1+
50% nitrous oxide 1+
Psychological preparation 1+
Psychological intervention 1+
Procedure modificationb 1+
aApplied 10 min before catheterization.
bUrethral catheterization instead of SPA.
4.3.5 Nasogastric tube insertion
See also sections 4.1, 4.2 and 4.3 for advice on the gen-
eral management of painful procedures in neonates,
infants, and children and 4.2.7 for NGT insertion in
neonates. NGT insertion is a painful and distressing
procedure frequently performed with little attention to
pain-relieving strategies (75). Infants who are unwell
and unable to feed, particularly those with respiratory
problems such as bronchiolitis, may need to be ‘tube
fed’ for a short period. NGT is often maintained in the
postoperative period and may need to be re-inserted if
they become displaced. Older children may also be fed
via NGT, for example, in patients with cystic ﬁbrosis
who sometimes require supplementary feeding on multi-
ple occasions. Clearly, it is particularly important to
optimize pain management in those patients who are
likely to need repeated NGT placement.
Passing a NGT is a skilled procedure, and in the
UK, the Department of Health has published guide-
lines (CMO Update no.39, publ DoH, UK; NPSA/
2007/19), which should be followed.
Good practice point
Topical local anesthetics such as lubricant gel contain-
ing lidocaine, applied prior to placement, are likely to
reduce the pain and discomfort of NGT insertion.
Evidence
NGT insertion has been little studied in children. In the
adult, topical local anesthesia and lubricants have been
shown to reduce pain and facilitate placement (117–
119). 10% nebulized lidocaine is also effective in adults
but may also slightly increase the incidence of epistaxis
(120). A recent RCT did not ﬁnd any beneﬁt from nebu-
lized lidocaine in children between 1 and 5 years (121).
The additional use of vasoconstrictors such as topical
phenylephrine or cocaine may reduce this risk, ﬁndings
that have not been conﬁrmed in children. Indirect evi-
dence also suggests that the use of psychological/behav-
ioral techniques may be of beneﬁt in older children.
Analgesia Table 4.3.5 Nasogastric tube insertion
Direct
evidence
Indirect
evidence
Topical LA 1++
Non-nutritive suckinga 1+
Tactile stimulationa 1+
Psychological preparation 1+
Psychological intervention 1+
aInfants.
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4.3.6 Immunization and intramuscular injection
Immunization schedules result in increasing numbers
of intramuscular injections being administered to
infants and children. At 2 and 3 months, infants are
offered diphtheria, tetanus, pertussis, hemophilus
(Hib), and polio immunization as one vaccination,
with a separate meningococcal or pneumococcal vac-
cine. All 3 are given at 4 months. Children receive fur-
ther immunizations at 1 year and 15 months, again at
preschool, and ﬁnally at school leaving. Intramuscular
administration of asparaginase to children with leuke-
mia, and long-acting penicillin therapy are other exam-
ples. The pain of these injections is widely
acknowledged and contributes to anxiety in patients
and their parents/carers, particularly regarding vacci-
nations. There is now evidence that such pain may be
reduced by a number of strategies. Knowledge that
practitioners have considered the use of these strategies
may help parents in their decisions about immuniza-
tion. It is important that treatable pain is not a barrier
to the childhood immunization program.
See also sections 4.0, 4.1, and 4.2 on the general
management of procedural pain.
Good practice point
Intramuscular injections should be avoided in children
as part of routine care. If intramuscular injection is
unavoidable, pharmacological and nonpharmacologi-
cal strategies should be employed to reduce pain.
Recommendations
Psychological strategies such as distraction should be
used for infants and children undergoing vaccination:
Grade A (85,122–124).
Consider additional procedure modiﬁcations such as vac-
cine formulation, order of vaccines (least painful ﬁrst)
needle size, depth of injection (25 mm 25 gauge needle),
or the use of vapocoolant spay: Grade A (125–132).
Swaddling, breast-feeding or paciﬁer, and sucrose should
be considered in infants undergoing vaccination: Grade
A (7,78,133,134).
Evidence
There are two phases of immunization pain: the initial
pain of the needle piercing the skin and injection of a
volume of vaccine into the muscle or subcutaneous tis-
sue, followed by a later phase of soreness and swelling at
the vaccination site because of subsequent inﬂammatory
reaction. Studies have generally investigated strategies
designed to deal with the former, presumably because
this is perceived to be the most unpleasant component.
Children typically dread needle-related pain; the use of
either nonpharmacological or pharmacological pain
reduction strategies may reduce subsequent negative
recall (123). There is good evidence that nonpharmaco-
logical methods, particularly distraction, can reduce
immunization pain (85,122,123,135). There is also evi-
dence of beneﬁt from nonpharmacological strategies in
neonates and young infants <2 months including swad-
dling, non-nutritive sucking, and sucrose and glucose
(7,133,134,136). The optimal dose of sucrose has not yet
been determined, and its effectiveness in infants from
1 month is uncertain (137). See section 6.7 for informa-
tion on the use of sucrose.
Procedure modiﬁcations may alter pain responses.
Some combined vaccine formulations (MMR-Priorix,
lower dose DTP vaccine booster Tdap) appear to be less
painful, and this requires further study (127,129,138).
Longer (25 mm) needles and deeper intramuscular
rather than subcutaneous injection can reduce local reac-
tivity following immunization (126,130). Swab-applied
vapocoolant (Fluori-methane) was as effective as topical
analgesia when both were combined with distraction
(125). Simultaneous, rather than sequential injection of
multiple vaccines was less painful in one study (139).
Topical local anesthesia (EMLA, Ametop) is
clearly capable of reducing components of vaccination
pain in both infants and older children, but the efﬁ-
cacy and the balance of effectiveness against cost are
difﬁcult to determine from the studies presently avail-
able (7,140–143). Lidocaine local anesthesia added to
asparaginase or benzyl penicillin injection reduced the
pain response in two studies; again, this approach
requires further investigation (144,145).
Analgesia Table 4.3.6 Immunization and intramuscular injection
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1+
Sucrose 1)
Psychological interventions 1++
Psychological preparation 1+
Procedure modifications 1+
4.3.7 Repair of lacerations in children
Traumatic lacerations of the skin and scalp are com-
mon presentations in the emergency department.
Acceptable, safe, and effective repair is often a consid-
erable challenge. For minor lacerations without general
anesthesia or sedation, a combination of pharmacolog-
ical and nonpharmacological techniques is likely to be
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most effective. There are a number of less painful
alternatives to simple wound suture in the awake
patient: Tissue adhesives in simple low-tension wounds
and the hair apposition technique (HAT) in scalp lac-
erations are examples.
Also see section 4.0 and 4.2 for general consider-
ations in procedural pain management.
Good practice point
For extensive wounds or children who are very anx-
ious consider sedation or general anesthesia.
Recommendations
For repair of simple low-tension lacerations, tissue adhe-
sives should be considered as they are less painful, quick
to use, and have a similar cosmetic outcome to sutures or
adhesive skin closures (steri-strips): Grade A (146–148).
Topical anesthetic preparations, for example, LAT (lido-
caine–adrenaline–tetracaine) if available, can be used in
preference to injected LA, as they are less painful to
apply; it is not necessary to use a preparation containing
cocaine: Grade A (149–153).
Buffering injected lidocaine with sodium bicarbonate
should be considered: Grade A (88).
‘HAT’ should be considered for scalp lacerations. It is
less painful than suturing, does not require shaving, and
produces a similar outcome: Grade B (154).
If injected lidocaine is used, pretreatment of the wound
with a topical anesthetic preparation, for example, lido-
caine–adrenaline–tetracaine (LAT) gel, reduces the pain
of subsequent injection: Grade B (155,156).
50% nitrous oxide reduces pain and anxiety during lac-
eration repair: Grade B (157–159).
Evidence
Laceration repair has been relatively well studied in
children. There are a number of alternatives to simple
wound suture in the awake patient. Tissue adhesives in
simple low-tension wounds and the hair apposition
technique (HAT) in scalp lacerations are less painful
alternatives (147,154). A number of topical local anes-
thetic mixtures are available; they can give equivalent
analgesia to inﬁltrated local anesthetic and are less
painful to apply although a recent systematic review in
adults and children concluded that there was insufﬁ-
cient evidence to unreservedly recommend topical LA
in preference to injected LA (82,153). A systematic
review including trials in adults and children found that
‘buffering’ local anesthetics with sodium bicarbonate
signiﬁcantly reduces the pain of injection (88). Nitrous
oxide has been shown to be effective in reducing pain,
anxiety, and distress in cooperative children (157,158).
See section 6.7 for information on the use of nitrous
oxide. Psychological techniques such as distraction and
relaxation are also likely to be useful (85).
Analgesia Table 4.3.7 Repair of lacerations in children
Direct
evidence
Indirect
evidence
Local anesthesia Topical 1++
Infiltration 1++
Buffered
infiltration
1++
50% nitrous oxide 1+
Procedure modification 1++
Psychological intervention 1++
4.3.8 Dressing changes in the burned child
Children with burns often require repeated, often
extremely painful, dressing changes. Children with
severe burns are normally cared for in a specialist unit,
but some children will be seen in Emergency Depart-
ments. Initial dressing changes are likely to be per-
formed under general anesthesia, and if children
remain very distressed, this option may be favored for
subsequent procedures. Sedation is sometimes used to
supplement analgesia for burns dressings, see NICE
Guideline CG112 ‘Sedation in Children and Young
People’ available at: http://www.nice.org.uk/CG112. In
the early stages of burn pain management, children
may require continuous infusion of potent opioids
such as morphine, and additional analgesia will be
required prior to dressing changes (160).
Both pharmacological and nonpharmacological tech-
niques should be used in the management of painful
dressing changes, see section 4.0, 4.1, and 4.2 for advice
on the general management of painful procedures.
Recommendations
Potent opioid analgesia given by oral, transmucosal, or
nasal routes according to patient preference and avail-
ability of suitable preparations should be considered for
dressing changes in burned children: Grade A (161–
164).
Nonpharmacological therapies such as distraction and
relaxation should be considered as part of pain manage-
ment for dressing changes in burned children: Grade B
(165–170).
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Evidence
The evidence base for managing burn pain in children
is small and incomplete. Opioids are used extensively
and should be given as necessary by intravenous or
other routes (160). There are a number of small studies
comparing different opioid formulations and routes of
administration, such as transmucosal or intranasal fen-
tanyl, hydromorphone, oxycodone and morphine by
the oral route (161–164).
There is evidence for distraction with children using
a variety of devices – such as helmet Visual Reality
devices or hand-held multimodal devices where the
child is an active participant in the game they are play-
ing being more effective than standard distraction
when burns dressings are being changed (168–173).
Small studies have investigated different creams or
dressings with some being less painful – more research
is needed in this area (174–176). Nitrous oxide is used
extensively for single painful procedure in children
who are able to cooperate; multiple or frequent admin-
istration may lead to bone marrow toxicity. Nitrous
oxide has not been directly studied in this patient
group, although there is one small cohort study assess-
ing parent and patient satisfaction (177). See section
6.7 for more information on the use of nitrous oxide.
Analgesia Table 4.3.8 Dressing changes in burned child
Direct
evidence
Indirect
evidence
Opioids 1++
Nitrous oxidea 1++
Psychological preparation 1+
Psychological intervention 1+
aNo data for multiple administrations.
4.3.9 Botulinum injections for children with
muscle spasm
Botulinum toxin is used to relieve muscle spasm; in
pediatric practice, this is most often the spasticity asso-
ciated with cerebral palsy. These injections can take a
long time – usually, multiple sites are chosen, and
there are three phases to the procedure: initial punc-
ture, localization of correct muscle point, and then
injection. There is very little evidence for pain manage-
ment strategies: In practice, many children are likely to
be offered general anesthesia or sedation.
One observational study was identiﬁed, which inves-
tigated the level of pain felt by children undergoing
this procedure with local anesthetic cream and 50%
nitrous oxide. In this study, half the children experi-
enced severe pain, but the rest of the children managed
well with this combination (178). Further research is
needed.
Good practice point
50% nitrous oxide/oxygen should be considered in chil-
dren who are able to cooperate with self-administration.
Analgesia Table 4.3.9 Botulinum toxin injections
Direct
evidence
Indirect
evidence
50% nitrous oxide 1+
Topical LA 1+
Psychological preparation 1+
Psychological intervention 1+
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Section 5.0
Postoperative pain
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5.1 General principles of postoperative
pain management
Good practice points
Providers of postoperative care should understand the
general principles of good pain management in chil-
dren; this includes knowledge of assessment techniques
and the use of analgesics at different developmental
ages.
Pediatric anesthetists are responsible for initiating
postoperative analgesia. They should liaise with
patients and their families/carers, surgeons, and other
members of the team providing postoperative care to
ensure that pain is assessed and suitable ongoing
analgesia is administered.
Postoperative analgesia should be appropriate to
developmental age, surgical procedure, and clinical
setting to provide safe, sufﬁciently potent, and ﬂexible
pain relief with a low incidence of side effects.
Combinations of analgesics should be used unless
there are speciﬁc contra-indications, for example;
local anesthetics, opioids, NSAIDs, and paracetamol
can be given in conjunction, not exceeding maximum
recommended doses.
Introduction
Postoperative care is frequently shared between heath
professionals from different disciplines: they should be
suitably qualiﬁed, including an awareness of the gen-
eral principles of pain assessment and pain manage-
ment in children. Postoperative analgesia should be
planned and organised prior to surgery in consultation
with patients and their families or carers, and other
members of the perioperative team. The pediatric anes-
thetist is responsible for initiating suitable postopera-
tive analgesia; this should be considered to be part of
the overall plan of anesthesia.
Analgesia is an integral part of surgical anesthesia,
and therefore, potent analgesics are administered dur-
ing general anesthesia in the form of opioids, local
anesthetics, and other drugs. Patients and carers
should be made aware that the effects of these analge-
sics will wear off in the postoperative period, leading
to an increase in pain and the need for further analge-
sia. Patients should not be discharged from the Post-
operative Care Unit (postanesthesia recovery area)
until satisfactory pain control is established and ongo-
ing analgesia is available.
Prior to discharge from the hospital, patients and
their families should be given clearly presented infor-
mation and advice regarding the assessment of pain
and the administration of analgesia at home. It is also
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necessary to ensure that the patient will have access to
suitable analgesia.
Pain after surgery is usually most severe in the ﬁrst
24–72 h but may persist for several days or weeks.
Analgesia can be given regularly (by the clock) in the
early postoperative period and then ‘as required’
according to assessed pain. Drugs to counteract
unwanted effects of analgesia or other side effects of
surgery such as PONV should also be available and
administered when necessary.
Postoperative pain should be assessed frequently: see
section 3.0 for further information. Analgesic regimens
should be sufﬁciently ﬂexible to allow for inter-individ-
ual differences in the response to analgesics and the
variation in the requirement for pain relief that occurs
during the postoperative period.
5.2 ENT surgery
5.2.1 Myringotomy
Drainage of the middle ear, usually with insertion of a
tube, is a treatment for otitis media. Myringotomy is
usually considered to be a minor procedure, under-
taken on a day-case basis. See also section 5.1 for the
general principles of postoperative pain management.
Good practice point
As myringotomy is a brief procedure, oral paraceta-
mol or NSAID should be administered preoperatively
to ensure adequate analgesia at the end of surgery.
Recommendations
Oral paracetamol or NSAIDS (ibuprofen, diclofenac, or
ketorolac) in suitable doses can achieve adequate early
postoperative analgesia: Grade B (1–4).
Opioids are effective but not recommended for routine
use because of side effects: Grade B (1,5–8).
Evidence
Paracetamol (oral) produces dose-related analgesia;
10 mgÆkg)1 is no better than placebo (3) or is associated
with higher supplemental requirements (8), whereas pain
scores are lower with 15–20 mgÆkg)1 (1,2,4,5,9).
Ibuprofen and diclofenac appear to provide similar
analgesia to paracetamol (2,10), but the combination
has not been tested.
Ketorolac 1 mgÆkg)1 (intravenous) provides minor
improvements in analgesia when compared with low
doses of paracetamol, 10 mgÆkg)1 (3,8); paracetamol
10 mgÆkg)1 + codeine 1 mgÆkg)1 (8); paracetamol
15 mgÆkg)1 (but only ﬁrst 10 min there was no differ-
ence at 20 min) (4). See section 6.5 for recommended
doses of ketorolac and other NSAIDS.
Opioids, for example codeine, butorphanol, or
fentanyl, have been associated with increased side
effects when compared with NSAIDs or paracetamol,
without clinically signiﬁcant improvements in analgesia;
therefore, their use is not warranted for routine
myringotomy:
i. increased sedation and time to discharge for oral
codeine: (1), nasal fentanyl (7) and nasal butorphanol (6)
ii. increased vomiting with oral codeine or nasal but-
orphanol (8).
LA block of the auricular branch of the vagus pro-
vided equivalent analgesia to intranasal fentanyl (11).
Analgesia Table 5.2.1
Direct
evidence
Opioida 1)
NSAID 1)
Paracetamol 1)
aNot routinely recommended because of side effects: see text.
5.2.2 Tonsillectomy
Tonsillectomy (±adenoidectomy) is one of the most
frequently performed procedures in children. Chronic
or recurrent tonsillitis with tonsillar hyperplasia lead-
ing to upper airway obstruction, for example in sleep
apnea syndromes, is the most frequent indication for
tonsillectomy. The choice of analgesia, postoperative
monitoring, and duration of hospital admission is
inﬂuenced by the potential for serious complications
such as apnea, perioperative bleeding, and postopera-
tive nausea and vomiting (PONV). Pain after tonsillec-
tomy can persist for many days. See also section 5.1
for the general management of postoperative pain.
Good practice point
As signiﬁcant levels of pain, behavioral disturbance, sleep
disruption, and altered activity can persist for 5–8 days
following tonsillectomy, regular administration of analge-
sia may be necessary during this period. Information for
families about pain assessment and medication use follow-
ing discharge is particularly important.
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Recommendations
A combination of individually titrated intraoperative opi-
oids, dexamethasone, and regularly administered periop-
erative mild analgesics (NSAIDS and/or paracetamol) is
recommended for management of tonsillectomy pain:
Grade A (12,13).
Topical application or injection of local anesthetic in the
tonsillar fossa improves early pain scores following ton-
sillectomy: Grade A (14,15).
Tramadol can produce similar analgesia to morphine or
pethidine: Grade B (16–18).
Peritonsillar injection of tramadol has no advantage over
systemic administration: Grade B (19,20).
Intraoperative intravenous ketamine does not provide
signiﬁcant postoperative advantage compared with opi-
oid: Grade B (16,17,21,22).
Implementation of standardised protocols including in-
traoperative opioid ± anti-emetic, perioperative NSAID
(diclofenac or ibuprofen), and paracetamol is associated
with acceptable pain relief and low rates of PONV:
Grade C (23,24).
Evidence
Signiﬁcant levels of pain, behavioral disturbance, sleep
disruption, and altered activity can persist for 5–8 days
following tonsillectomy (25–28). Regular administra-
tion of paracetamol and NSAID is necessary for sev-
eral days postoperatively, and adequate parental
education about pain assessment and medication use is
required.
Opioids: Intraoperative opioids are given during ton-
sillectomy and may be required in the postoperative
period (12). Morphine is the prototype opioid, but
there has been some interest in the use of tramadol fol-
lowing tonsillectomy.
Tramadol produces similar analgesia and side effects
to morphine (29) and pethidine (16). Tramadol
1 mgÆkg)1 was equianalgesic with IV paracetamol
15 mgÆkg)1 in one study (30). One study reported less
nausea with tramadol than morphine (18). In patients
with sleep apnea tramadol was associated with fewer
episodes of oxygen desaturation at one time point
postoperatively (1–2 h, no difference at earlier or later
time points to 6 h) (29). Comparison of intravenous
and peritonsillar injection of tramadol 2 mgÆkg)1
reported minor improvements with peritonsillar injec-
tion (19), but effects are likely to be related to systemic
absorption. Tramadol 1 mgÆkg)1 (IV), 2 mgÆkg)1 (IM),
or 3 mgÆkg)1 by peri-tonsillar injection reduced pain
scores when compared with placebo (20,31). Of partic-
ular concern, children in these placebo groups received
no intra-operative analgesia. However, tramadol was
less effective than ketoprofen (higher pain scores and
higher postoperative PCA fentanyl) and did not differ
from placebo in one study (32).
NSAIDS improve analgesia when compared with
placebo (10/11 studies) and provide similar analgesia
to opioids (7/8 studies) and paracetamol (3/3 studies)
(33). A systematic review found that heterogeneity of
the data precluded meta-analysis, and many studies
comparing two active treatments were not sensitive
enough to show a difference (12). Subsequent studies
have reported similar analgesia with ketorolac and
fentanyl (34), no improvement with addition of rofec-
oxib to opioid and paracetamol (35), and no differ-
ence in pain scores but increased rescue analgesic
requirements with IV paracetamol compared with
pethidine (36). Ketoprofen improved analgesia in the
ﬁrst 6 h postoperatively in comparison with tramadol
or placebo (32).
Paracetamol is more effective given orally prior to
surgery than rectally after induction of anesthesia, it
reduces opioid requirements and PONV (37–39).
Local anesthesia: Two recent meta-analyses reported
statistically signiﬁcant reductions in postoperative pain
scores with local anesthetic techniques for up to 48 h,
but the effect size decreased after the ﬁrst 4–6 h
(14,15). Topical application and inﬁltration were
equally effective (14), and no difference was found
between LA inﬁltration before or after removal of the
tonsils (15). Postoperative analgesic requirements were
reduced (15), but there was no signiﬁcant difference in
adverse events (14) or PONV (15). In additional stud-
ies, bupivacaine inﬁltration and topical levobupiva-
caine swabs improved pain scores but did not alter
PONV (40,41). Others reported no beneﬁt with peri-
tonsillar LA inﬁltration (42) and similar analgesia
when topical 2% viscous lignocane was compared with
rectal diclofenac (43).
Ketamine (IV) improves analgesia when compared
with placebo (21,44,45) but provides no advantage
when compared with equianalgesic opioid (17,46) and
may increase side effects (22). Addition of ketamine
0.25 mgÆkg)1 to morphine 0.1 mgÆkg)1 did not signiﬁ-
cantly improve analgesia (47). Topical application on
swabs (ketamine 20 mg in children aged 3–12 years)
(48) or peritonsillar inﬁltration reduced very early
pain scores and opioid requirements (49), effects may
relate to systemic absorption. The combination of ke-
tamine 0.5 mgÆkg)1 IV and topical bupivacaine inﬁl-
tration resulted in minor reductions in pain scores
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when compared with LA alone and saline control
groups (41).
Dexmedetomidine (IV) may reduce opioid require-
ments and respiratory side effects in children after ton-
sillectomy, this may particularly beneﬁt those with
obstructive sleep apnea (OSA) or respiratory compro-
mise. One microgram per kilogram produced less respi-
ratory depression than 100 lgÆkg)1 morphine but less
effective analgesia (50). Higher doses, 2 and 4 lgÆkg)1,
lengthened time to rescue opioid analgesia but
increased sedation in the early postoperative period
when compared to fentanyl 1 or 2 lgÆkg)1 IV (51).
Dexmedetomidine 2 lgÆkg)1 + 0.7 lgÆkg)1Æh)1 intra-
operative reduced early postoperative opioid require-
ments and agitation in children with OSA compared
with fentanyl 1 lgÆkg)1 (52).
Dexamethasone reduces PONV and postoperative
pain scores following tonsillectomy (13,53).
Most meta-analyses of posttonsillectomy analgesia
have focused on PONV and bleeding rather than anal-
gesic efﬁcacy. PONV following tonsillectomy is reduced
by NSAID presumably because of a reduction in
opioid requirement (33,54), and by intraoperative dexa-
methasone (see above). As posttonsillectomy bleeding
is relatively rare, meta-analyses have included different
trials and reached different conclusions:
l Bleeding is increased by aspirin but not ibuprofen or
diclofenac (seven trials) (55).
l Risk of bleeding and reoperation increased (NNH
29), and NSAIDS should not be used (seven trials)
(56).
l Risk of reoperation (NNH 60) but not bleeding
increased, and NSAIDS should be used cautiously (25
trials) (33)
l NSAIDS do not increase risk of bleeding or reopera-
tion but further studies required (13 pediatric trials)
(54).
Although meta-analyses are currently inconclusive,
perioperative diclofenac and ibuprofen appear to be
associated with minimal risk of posttonsillectomy
bleeding. Early studies using high doses of ketorolac
have been included in the meta-analyses, but there are
insufﬁcient data to assess the risks associated with dif-
ferent NSAIDS.
Analgesia Table 5.2.2
Agent Technique
Direct
evidence
LAa Tonsillar fossa injection 1+*
Topical 1+*
Opioid 1+
Tramadol 1+
Dexamethasone 1+
Ketamine 1+
NSAIDS 1+
Paracetamol 1+
aNo differences have been demonstrated based on route (topi-
cal vs infiltration), type of LA, or time of injection (pre- vs pos-
tremoval).
5.2.3 Mastoid and middle ear surgery
Mastoidectomy may be performed to remove infected
tissue or cholesteatoma. As the incidence of chronic
suppurative otitis media is declining in many popula-
tions, this surgery is now less frequently required in
the UK. Middle ear surgery, such as reconstruction of
a damaged tympanic membrane by placement of surgi-
cal grafts, may be associated with signiﬁcant PONV.
See also section 5.1 for the general management of
postoperative pain.
Recommendations
Great auricular nerve block can provide similar analge-
sia and reduced PONV compared with morphine. Prein-
cision timing of the block confers no additional beneﬁt:
Grade B (57,58).
Evidence
There are relatively few controlled trials speciﬁcally
investigating pain during and after mastoidectomy and
invasive middle ear surgery, and no further studies
since the last edition of this guideline. As NSAIDS
and paracetamol improve analgesia for middle ear pro-
cedures, there is indirect evidence that they provide
beneﬁcial supplemental analgesia for mastoid surgery.
However, compared with middle ear surgery, mastoid
surgery is associated with increased pain: patients are
therefore more likely to require opioids, treatment for
PONV and hospital admission (59). In procedures that
require a postauricular incision, LA block of the great
auricular nerve can provide similar analgesia and
reduced PONV compared with morphine (57). No dif-
ference was found between performing the block prein-
cision vs prior to the end of surgery (58).
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Analgesia Table 5.2.3
Agent Technique
Direct
evidence
Indirect
evidence
LA Greater auricular
nerve block
1)
Opioid 1)
NSAID 1)
Paracetamol 1)
5.3 Opthalmology
5.3.1 Strabismus surgery
Strabismus surgery (correction of squint) is associated
with a high incidence of PONV, and intraoperative
tension on ocular muscles may provoke a vagal
response (oculocardiac reﬂex). See also section 5.1 for
the general management of postoperative pain.
Recommendations
Intraoperative LA blocks (subtenon’s or peribulbar)
reduce PONV and may improve perioperative analgesia
in comparison with IV opioid but provide no beneﬁt over
topical LA: Grade B (60–64).
Topical NSAIDS do not improve pain scores or postoper-
ative analgesic requirements when compared with topical
LA or placebo: Grade B (65–67).
Intraoperative opioid and NSAID provide similar post-
operative analgesia, but opioid use is associated with
increased PONV: Grade B (68–71).
Evidence
In many trials, reduction of PONV rather than
improvement in analgesia has been the primary out-
come. The duration of surgery varies from 25 to
80 min in the reported studies, and many do not dis-
criminate between unilateral or bilateral surgery or
procedures involving single or multiple muscles. This
may contribute to the variability across studies in the
incidence of side effects and analgesic requirements.
Peribulbar or subtenon’s LA blocks reduce intraopera-
tive oculocardiac reﬂex responses (60,62,63) and PONV
(60,62,63) when compared with intraoperative opioid.
Peribulbar or subtenon blocks reduce perioperative anal-
gesic requirements when compared with opioid in some
(60,63) but not all (61,62) trials. No complications of LA
injections were reported in these studies, but patient
numbers are small. Sub-tenon’s block provided no bene-
ﬁt compared with less invasive topical tetracaine applica-
tion (64). Topical LA applied prior to and at the
completion of surgery reduced early distress (ﬁrst
30 min) but did not inﬂuence pain at later time points or
reduce supplemental analgesic requirements (72).
No difference in postoperative pain scores or analge-
sic requirement has been detected between topical LA
drops and topical NSAIDS (65,67). Pain scores (CHE-
OPS) were not reduced by topical NSAIDS when com-
pared with placebo (66,67), but the authors questioned
the sensitivity of this measure for ocular pain.
Direct comparisons of intraoperative NSAID and
opioid (PR diclofenac vs IV morphine) (71) (IV ketoro-
lac vs IV pethidine) (70) (IV ketorolac vs IV fentanyl)
(68) have reported no difference in postoperative pain
scores or supplemental analgesic requirements but
increases in PONV in patients given opioids. Compari-
son of intraoperative remifentanil and fentanyl reported
higher early pain scores but less PONV with remifenta-
nil (73). Comparisons of NSAID and placebo have
shown minor improvements in pain score and reduc-
tions in supplemental analgesic requirements (69,74).
Analgesia Table 5.3.1
Agent Technique
Direct
evidence
Indirect
evidence
LA Subtenon blocka 1)
LA Peribulbara 1)
LA Topicala 1+
Opioid Parenteralb 1)
NSAID Topical 1)
Systemicb 1)
Paracetamol 1)
aFew comparisons, but no advantage of subtenon over topical
in one trial.
bSimilar analgesia with systemic NSAID and opioid but
increased PONV with opioid; oral or rectal paracetamol given
as part of multimodal analgesia to all patients in several trials
but efficacy not directly compared with other agents.
5.3.2 Vitreoretinal surgery
Vitreoretinal and retinal detachment surgery are asso-
ciated with signiﬁcant postoperative pain and PONV.
Supplemental local anesthetic techniques may have a
role, but the relative beneﬁt vs risk has not been fully
evaluated. See also section 5.1 for the general manage-
ment of postoperative pain.
Recommendations
In vitreoretinal surgery, NSAID can provide similar
analgesia but lower rates of PONV compared with opi-
oid: Grade C (75).
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Peribulbar block improves early analgesia and
may reduce PONV compared with opioid: Grade C
(60,76–78).
Evidence
Ketoprofen and pethidine provided similar levels of
analgesia, but PONV was less with ketoprofen (75).
Peribulbar LA block appears to be effective (60,76).
Concerns have been expressed that peribulbar block
may present a higher risk in children than subtenon’s
block as the eye occupies a relatively greater volume of
the bony orbit in a child, and large volumes of LA have
been used in trials of peribulbar block (79). Compared
with fentanyl, subtenon’s LA block reduces the inci-
dence of intra-operative oculo-cardiac reﬂexes and
improves early analgesia (77,80), but only one trial
showed a reduction in analgesic requirements and
PONV (77). There has been no evaluation of the risk vs
beneﬁt of these procedures in children.
Topical LA gel at the beginning of surgery reduced
intra-operative, but not postoperative, analgesic
requirements (81).
Analgesia Table 5.3.2
Agent Technique
Direct
evidence
Indirect
evidence
LA Peribulbar blocka 2+
Subtenon block 1)
Opioid 1)
NSAID 1)
Paracetamol 1)
aNo analysis of risk–benefit for peribulbar block.
5.4 Dental procedures
Dental procedures in children may range from minor
restoration and conservation requiring little or no
postoperative analgesia, to variable numbers of extrac-
tions, and sometimes more extensive surgery leading to
signiﬁcant postoperative pain. See also section 5.1 for
the general management of postoperative pain.
Recommendations
NSAIDS with or without paracetamol reduce pain fol-
lowing dental extractions: Grade B (82–84).
Swabs soaked with bupivacaine on exposed tooth sockets
following extraction produce no or minor improvements
in pain in the immediate postoperative period: Grade B
(85,86).
Intraoperative LA inﬁltration reduces postoperative pain
following dental extractions, but provides little addi-
tional beneﬁt over NSAIDS and paracetamol alone:
Grade B (83,84,87,88).
Evidence
The degree of postoperative pain following dental
extractions increases with the number of teeth removed
(89,90).
NSAIDS (82,91,92) and combinations of NSAID
and paracetamol (83,84,88) reduce pain following den-
tal extractions. However, adding paracetamol to ibu-
profen did not improve early analgesia (15 min
postoperatively) compared with ibuprofen alone in one
study (82).
Opioids: no differences in analgesia were shown in
comparisons with NSAIDS for extractions (93,94), but
opioids may produce increased PONV (94). Similarly,
for dental restorations without extractions, paraceta-
mol provided adequate analgesia, pain scores were
slightly lower with pethidine, but sedation was
increased (95).
LA inﬁltration (2% lignocaine with adrenaline)
added to NSAID ± paracetamol (83,84,88,92) pro-
vides little additional beneﬁt following dental extrac-
tions, but less postoperative bleeding in the recovery
room (reduced need for suctioning rather than quanti-
ﬁed losses) was noted in one trial (88). Addition of
morphine (25 lgÆkg)1) to the local anesthetic injection
did not improve analgesia (96). The soft tissue numb-
ness associated with LA inﬁltration may produce dis-
tress and increase biting of lips and cheeks in young
children (92). Distressing numbness was avoided by in-
traligamental injection of LA, but adding this to
NSAID and paracetamol provided no additional bene-
ﬁt (83) or minor improvements in early analgesia
(5 min) only (84). No improvements in analgesia or
distress were found when bupivacaine-soaked swabs in
the dental socket were added to paracetamol
15 mgÆkg)1 (86) or diclofenac (85).
Analgesia Table 5.4
Agent Technique
Direct
Evidence
LA Local infiltrationa 1+
Soaked swabsa 1)
Opioid 1)
NSAID 1+
Paracetamol 1)
aImprovements in early analgesia and no additional benefit over
NSAID ± paracetamol.
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5.5 General surgery and urology (minor
and intermediate)
5.5.1 Sub-umbilical surgery
This category has been included because many studies
have used a combination of different surgical proce-
dures from the sub-umbilical area as the operative
model, for example, repair of inguinal hernia, orchido-
pexy, orchidectomy, circumcision, phimosis, hypospa-
dias, hydrocoele, vesico-ureteric reﬂux, testicular
tortion, appendicectomy. Postoperative pain is unlikely
to be equivalent following each of these different pro-
cedures (97), but they are not uniformly distributed
between studies and the numbers of individual proce-
dures in each study are often low, thereby making it
impractical to look at each procedure in isolation.
Refer to other pages in this section for more informa-
tion on speciﬁc procedures, see also section 5.1 for the
general management of postoperative pain.
Recommendation
LA should be used when feasible: wound inﬁltration,
transversus abdominis plane (TAP) block, ilio-inguinal
nerve block, and caudal analgesia are effective in the
early postoperative period following sub-umbilical sur-
gery: Grade A (98–103).
Evidence
The majority of studies compared differing drug com-
binations in central or peripheral nerve blockade. Cau-
dal epidural neuraxial block was the most commonly
studied technique and demonstrated good efﬁcacy in
all studies with a low failure and serious complication
rate. This is in agreement with large case series of this
technique (104–107). Efﬁcacy was equivalent irrespec-
tive of the local anesthetic agent used, and there was
little difference in the rate of side effects, caudal anal-
gesia has been used with either general anesthesia or
sedation for surgery (100,102,107–109). The optimal
concentration and volume of LA has not been eluci-
dated, but concentrations of levobupivacaine and ropi-
vacaine below 0.2% have been associated with lower
efﬁcacy in some studies (110–112).
Caudal neuraxial analgesic additives1: with LA: the
addition of caudal S-ketamine, neostigmine, clonidine,
dexmedetomidine, midazolam, buprenorphine, fentanyl,
and morphine increased analgesic efﬁcacy and prolonged
the duration of the block, with little reported increase in
side effects in most studies (113–123). In contrast, other
studies show that there is no beneﬁt to adding midazo-
lam, magnesium, or sufentanil to LA via the caudal route
(124–126). Clonidine, S-ketamine, and buprenorphine
were more effective when given by the caudal route com-
pared with the intravenous route (115,120,127). In direct
comparisons, either caudal clonidine or midazolam were
better than morphine (113,128).
Without LA: a combination of S-ketamine and
clonidine demonstrated better analgesic efﬁcacy than
S-ketamine alone via the caudal route (129). The use
of such adjunctive analgesia requires further research
to better identify safety proﬁle, risk–beneﬁt and dose;
see also section 6.3 for a further discussion of neuraxial
analgesia.
Ilio-inguinal nerve block was shown to be effective,
but overall efﬁcacy was generally lower than in studies
of caudal block (98,130). The use of ultrasound to
place the ilio-inguinal block improved the quality of
the block, decreased supplementary opioid use, and
decreased the amount of local anesthetic used (131).
No beneﬁt was seen from adding clonidine to the local
anesthetic in ilio-inguinal nerve block (100,132).
TAP block is feasible with initial reports of good
efﬁcacy. An ultrasound-guided technique was shown
to be effective in the intraoperative and early postoper-
ative period, though efﬁcacy was less when compared
with ultrasound-guided ilio-inguinal nerve block for
inguinal surgery (103).
LA wound inﬁltration/instillation is effective in the
early postoperative period, it was equivalent to ilio-
inguinal block with no further beneﬁt from using them
in combination in one study (98,101).
1Note on caudal additives: not all additives have undergone rigorous
safety testing and concerns regarding potential toxic effects have been
expressed. See Section 6. 3
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Analgesia Table 5.5.1 Sub-umbilical Surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Wound infiltrationa 1+
LA Ilio-inguinal nerve blocka 1+
LA TAP Block 1)
LA Caudal epidural 1+
LA + Ketamineb Caudal epidural 1+
LA + Clonidineb Caudal epidural 1+
Opioidc 1+
NSAIDc 1+
Paracetamolc 1+
aPossibly lower efficacy than caudal block: more studies are
required.
bNote on caudal additives: not all additives have undergone rig-
orous safety testing, and concerns regarding potential toxic
effects have been expressed. See Section 6.
cAs part of a multi-modal technique
5.5.2 Circumcision
Circumcision is regarded as a relatively minor surgical
procedure, but it may be associated with signiﬁcant
postoperative pain and distress. It is usually under-
taken on an out-patient or day-case basis. Circumci-
sion in the neonate is considered separately in section
5.5.3. See sections 5.1 for the general management of
postoperative pain and 5.5.1 for a discussion of sub-
umbilical surgery.
Good practice point
Analgesia with opioid alone should be avoided if pos-
sible because of lower efﬁcacy and higher incidence of
side effects in comparison with LA techniques.
Recommendation
Caudal epidural and dorsal nerve block are effective in
the early postoperative period, with low rates of compli-
cations and side effects: Grade A (133).
Evidence
Local anesthetic techniques involving a regional block
or topical application can provide good analgesic efﬁ-
cacy in the early postoperative period (133–135).
Analgesia following caudal or dorsal nerve block was
equivalent and was superior to subcutaneous ‘ring’
block (133,136–139). Caudal and dorsal nerve block
demonstrated a low failure and serious complication
rate in all studies. This is in agreement with larger
case series of both techniques (104,140). In some
studies, a caudal block reportedly increased the time
to micturition and incidence of motor block
compared with dorsal nerve block and subcutaneous
ring block, but this ﬁnding was not seen in other
investigations (133,136–139). The ideal agent, dose, or
concentration for a caudal block has not been eluci-
dated. The use of ultrasound for dorsal nerve block has
been shown to improve the efﬁcacy and decrease the
incidence of failed blocks (141) The use of subcutaneous
ring block was associated with a higher failure and com-
plication rate than caudal or dorsal nerve block
(136,137). Pundendal nerve block has also been shown
to provide effective perioperative analgesia for circumci-
sion (142,143). One study compared topical local anes-
thesia with dorsal nerve block for 6 h postoperatively
and showed no difference in analgesia (144).
Caudal neuraxial analgesic additives1: Keta-
mine + LA showed increased analgesic efﬁcacy but
also increased motor block when compared with a LA
dorsal nerve block (145). The addition of ketamine or
clondine conferred no additional beneﬁt compared
with LA alone in other studies (146,147).
Parenteral opioids are associated with lower analge-
sic efﬁcacy and increased postoperative nausea and
vomiting compared with LA techniques (135).
NSAID (Diclofenac) as a sole agent was inferior to
dorsal nerve block, but the combination may decrease
supplementary analgesic use compared with either
technique in isolation (134).
Analgesia Table 5.5.2 Circumcision
Agent Technique
Direct
evidence
LA Topicala 1+
LA Subcutaneous ‘ring’ blocka 1)
LA Pudendal nerve block 1)
LA Dorsal n. block 1+
LA Caudal epidural 1+
Opioidb 1+
NSAIDSb 1+
Paracetamolb 1+
alower efficacy than caudal epidural or dorsal nerve block.
bAs part of a multi-modal technique.
5.5.3 Neonatal Circumcision
Neonatal circumcision is considered separately from
circumcision in older children because of differences in
clinical practice and evidence base. Premature neonates
can experience pain and therefore require good
1Note on caudal additives: not all additives have undergone rigorous
safety testing, and concerns regarding potential toxic effects have been
expressed. See Section 6.3.
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perioperative analgesia for surgical interventions.
Many circumcisions are done in the awake neonate in
the ﬁrst few hours or days of life; this is reﬂected in
the literature as studies have generally evaluated pain
during the procedure. However, for neonatal circumci-
sion, no single technique has been shown to reliably
alleviate pain in the awake patient, which therefore
presents a clinical challenge. Circumcision in infants
and older children is invariably performed under gen-
eral anesthesia (see section 5.5.1), the debate regarding
the necessity for general anesthesia in the neonate
remains unresolved. See sections 5.1 for the general
management of postoperative pain and 5.5.1 for a
further discussion of sub-umbilical surgery.
Good practice point
General anesthesia should be considered for neonatal
circumcision. A multi-modal analgesic approach
should include a local anesthetic technique at the time
of the procedure in combination with sucrose and par-
acetamol.
Recommendations
LA should be used as it is superior to other techniques
for circumcision pain: Grade A (148).
Dorsal nerve block is more effective than subcutaneous
ring block or topical LA: Grade A (148).
When using topical local anesthetic, it must be applied
correctly and sufﬁcient time allowed for it to become
effective: Grade A (148).
Evidence
Postoperative pain after circumcision in the neonate
has not been well investigated, and available studies
have all examined pain during the procedure in awake
neonates. It has been suggested that the procedure be
performed in awake infants only during the ﬁrst week
of life as pain scores during the procedure have been
shown to increase to unacceptable levels with increas-
ing neonatal age (149). For all techniques studied,
there was a signiﬁcant failure rate (148,150). The use
of LA was superior to either placebo or simple analge-
sics and sucrose (148). Dorsal nerve block appears to
be superior to subcutaneous ring block or topical local
anesthesia (caudal epidural analgesia has not been
studied, see (107)) and was associated with lower corti-
sol levels in one study, but was operator dependent
and not totally reliable (148,150). Efﬁcacy of topical
local anesthetic agents was very dependent on the tech-
nique of application and time allowed (148,151,152).
No increased incidence of complications was seen in
one technique compared with another (148). The dura-
tion of surgery (and therefore duration of intra-opera-
tive pain) was dependent on the surgical technique
with the ‘Mogen Clamp’ associated with faster proce-
dures (148,150).
Analgesia Table 5.5.3 Neonatal Circumcision
Agent Technique
Direct
evidence
Indirect
evidence
LA Topical 1++
LA Subcutaneous ‘ring’ block 1++
LA Dorsal nerve block 1++
LA Caudal epidural 1+
Paracetamola 1+
Sucroseb 1+
aFor postprocedure pain.
bAs part of multimodal technique.
5.5.4 Hypospadias repair
Hypospadias surgery may be either relatively superﬁ-
cial and minor, or more major reconstructive surgery
involving the entire penile urethra may be undertaken,
which will inﬂuence postoperative analgesia require-
ments. Some procedures are suitable for day-case sur-
gery whilst others require hospital admission overnight
or longer, with the possibility of prolonged urethral
catheterisation and painful postoperative dressing
changes. See sections 5.1 and 5.5.1 for the general
management of postoperative pain and for a further
discussion of sub-umbilical surgery.
Recommendation
LA central neuraxial or dorsal nerve block is effective
reducing the need for postoperative supplementary opioid
administration following hypospadias surgery: Grade A
(153–158).
Evidence
Caudal LA was most commonly investigated for hypo-
spadias repair. Good efﬁcacy for the technique was
demonstrated with a low failure and serious complica-
tion rate; this is in agreement with large case series of
this technique (104–106). Bupivacaine 0.25%,
0.5 mlÆkg)1 was most frequently studied, but there
were few comparisons with other local anesthetics or
between different concentrations or volumes. One
study found that caudal ropivacaine 0.1%, 1.8 mlÆkg)1,
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was more effective with less motor block than ropiva-
caine 0.375%, 0.5 mlÆkg)1 (159).
Caudal neuraxial analgesic additivesa: With LA: the
addition of neostigmine or diamorphine to caudal bup-
ivacaine increased analgesic efﬁcacy (154,157,160) but
also increased the rate of nausea and vomiting in two
of the studies (154,160). Adding tramadol to bupivav-
caine increased the analgesic efﬁcacy in the ﬁrst 24 h
postoperatively (161). In other studies, the addition of
tramadol, clonidine, or sufentinil did not increase efﬁ-
cacy (153,162,163).
Without LA: ketamine or mixture of ketamine/alfen-
tanil was superior to alfentanil alone, and higher doses
of neostigmine increased efﬁcacy but also increased
nausea and vomiting (164,165). In general, the use of
neuraxial analgesics has not been comprehensively
studied, further research to identify safety proﬁle, risk–
beneﬁt and dose are required (see also section 6.0).
Only one study compared different techniques and
showed that tramadol given by the caudal route
demonstrated better analgesic efﬁcacy and less
postoperative nausea and vomiting than when given by
the intravenous route (166).
Epidural analgesia was shown to provide good
analgesia both intra- and postoperatively irrespective
of the local anesthetic agent used: bupivacaine, levo-
bupivacaine, or ropivacaine, there was an exclusion
rate of 10% in one study (167) and patients having
an abdominal incision were included in another (168).
The addition of fentanyl to ropivacaine demonstrated
increased analgesic efﬁcacy for postoperative epidural
infusions at low (0.125%) concentrations of ropiva-
caine (158).
Dorsal nerve block is effective for distal hypospadias
repair. An investigation of the timing of dorsal nerve
block either pre or postsurgery found that placing the
block prior to surgery improved analgesic efﬁcacy
(169).
Spinal intrathecal neuraxial analgesia using hyper-
baric 0.5% bupivacaine is effective both intra- and
postoperatively. The addition of morphine to the LA
increased the efﬁcacy with no increase in adverse
effects in one study (170).
Paracetamol given alongside caudal block did not
improve analgesia in the ﬁrst six postoperative hours
compared with a caudal block alone in one study
(171). Overall, there are insufﬁcient data to evaluate
the use of supplementary analgesia in either the early
or late postoperative period. In clinical practice, a
multi-modal analgesic technique for this procedure is
suggested, with regular supplementary analgesia given
in the postoperative period.
Analgesia Table 5.5.4 Hypospadias Repair
Agent Technique
Direct
evidence
Indirect
evidence
LA Dorsal n. block 1+
LA Caudal epidural 1+
LA Lumbar epidural 1+
LA Spinal 1)
LA + neostigminea,b Caudal epidural 1+
LA + opioidb Caudal epidural 1+
LA + opioid Intrathecal 1)
Opioidc 1+
NSAIDc 1+
Paracetamolc 1+
aNote on caudal additives: not all additives have undergone rig-
orous safety testing, and concerns regarding potential toxic
effects have been expressed. See Section 6.3.
bSmall improvements in efficacy must be balanced against
increased PONV.
cAs part of a multi-modal technique.
5.5.5 Orchidopexy
Orchidopexy usually involves surgical exploration of
the inguinal region, dissection, and traction of the
spermatic cord and scrotal incision may also be
required. Orchidopexy is generally performed on a
day-case basis. See sections 5.1 and 5.5.1 for the gen-
eral management of postoperative pain and for a fur-
ther discussion of sub-umbilical surgery.
Recommendation
Caudal block is effective in the early postoperative per-
iod for orchidopexy with low rates of complications and
side effects: Grade A (172–174).
Evidence
There are few studies investigating analgesia for orchi-
dopexy alone. Postoperative analgesic requirements
may be greater than that required for inguinal hernia
repair (97).
LA caudal block using 1 mlÆkg)1 of 0.125–0.25%
bupivacaine or 1–1.5 mlÆkg)1 of ropivacaine 0.15–
0.225% has shown good efﬁcacy and low complication
rates (172–175). This is in agreement with large case
series of this technique (104–106). It was associated
with greater efﬁcacy, less supplementary analgesic use
and lower levels of stress hormones when compared
with ilioinguinal nerve block plus local inﬁltration
(172,173). There was also no difference in time to mic-
turition, motor block or nausea and vomiting between
the two techniques (172). A higher volume of local
anesthetic (1 mlÆkg)1) was associated with less response
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to cord traction, but not with improved postoperative
analgesia (174).
Neuraxial analgesic additives: the addition of keta-
mine 0.25–1 mgÆkg)1 as an adjunct to bupivacaine
increased analgesic efﬁcacy but was associated with
‘short-lived psychomotor effects’ at higher doses (176).
The addition of IV dexamethasone with ropivav-
caine caudal block was associated with increased anal-
gesic efﬁcacy (177).
Transverse abdominal plane (TAP) block using plain
LA, as part of a multi-modal analgesic technique, has
demonstrated perioperative analgesic efﬁcacy with no
complications in a small case series (178).
Analgesia Table 5.5.5 Orchidopexy
Agent Technique
Direct
evidence
Indirect
evidence
LA Wound infiltrationa 1+
LA Ilioinguinal blocka 1+
LA Caudal epidural 1+
LA TAP block 3
Opioidb 1+
NSAIDb 1+
Paracetamolb 1+
aLess effective than caudal block.
bAs part of a multi-modal technique.
5.5.6 Inguinal hernia repair (open)
Surgical repair of inguinal hernia is generally per-
formed on a day-case basis. The following refers to the
conventional ‘open’ technique, rather than laparo-
scopic repair that is becoming more popular. See sec-
tions 5.1 and 5.5.1 for the general management of
postoperative pain and for a further discussion of sub-
umbilical surgery.
Good practice point
The use of an ultrasound-guided technique for the
placement of an ilio-inguinal nerve block may decrease
the failure rate and improve analgesic efﬁcacy.
Recommendations
LA wound inﬁltration, ilio-inguinal nerve block, paraver-
tebral block, or caudal analgesia are effective in the
early postoperative period: Grade A (179–184).
Evidence
Caudal block was the most commonly studied technique
with good efﬁcacy and a low failure complication rate in
all studies. This is in agreement with large case series of
this technique (104–106). Bupivacaine 0.25% was the
most studied and compared LA, ropivacaine 0.25% was
found to be equivalent in one study (185). Another
study comparing different concentrations of bupiva-
caine with and without adjunctive opioid showed lower
efﬁcacy for 0.125% bupivacaine (186). In a study of
bupivacaine 0.175% (+adrenaline 1 : 10 000), there
was no difference in efﬁcacy or side effects at volumes of
between 0.7 and 1.3 mlÆkg)1 (187).
Neuraxial analgesic additives: With LA; midazolam,
ketamine, clonidine, fentanyl, neostigmine, adrenaline,
morphine and tramadol have all been studied as
adjuncts to local anesthesia for caudal block. They all
show good efﬁcacy, but evidence of overall beneﬁt is
equivocal as in most studies few patients required fur-
ther analgesia following caudal block with plain LA
(166,175,181,188–195). In studies where no comparison
was made with plain LA: increasing the dose of keta-
mine also increased efﬁcacy, but neuro-behavioral side
effects were seen at higher doses (196). Increasing clo-
nidine dose from 1 to 2 lgÆkg)1 had limited or no
effects on efﬁcacy, time to 1st analgesia was prolonged
in one study, but not in another (188,197).
Without LA: S (+) ketamine without local anes-
thetic was equivalent to bupivacaine + adrenaline
mixture, and S (+) ketamine + clonidine mixture
showed increased efﬁcacy over ketamine alone
(198,199). Another study comparing caudal with
intramuscular S-ketamine showed increased efﬁcacy in
the caudal group (200). Tramadol without local anes-
thetic showed reduced efﬁcacy compared with plain
bupivacaine or a bupivacaine + tramadol mixture
(191).
Placement of caudal block prior to surgery was also
shown to have better efﬁcacy in the postoperative per-
iod than placement at the end of surgery in one study
(201).
Comparison of paravertebral block with caudal LA
or intraoperative opioid (fentanyl) showed increased
postoperative analgesic efﬁcacy, patient satisfaction,
and earlier hospital discharge with the paravertebral
block (184,202).
Ilioinguinal nerve block shows good efﬁcacy and
safety, although a preferred agent, dose, or volume has
not been demonstrated, although Levobupivacaine
concentrations below 0.25% show decreased efﬁcacy
(182,203–205). High failure rates have been associated
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with using landmark techniques (205,206). Ultrasound-
guided techniques may increase the success rate and
allow placement of the LA closer to the nerves with
lower volumes being required for efﬁcacy thereby
decreasing the potential for systemic toxicity (206–
208). No advantage was seen postoperatively with the
addition of genitofemoral nerve block or by using a
‘double shot technique’ (182,203). In one study, the
success rate of the block using surface landmarks was
quoted as only 72% (203).
Wound inﬁltration is effective when compared to
caudal block with plain LA or placebo, although in
one study postoperative opioid use was comparatively
high (179,180,209). The timing of wound inﬁltration,
either pre or postsurgery, did not inﬂuence efﬁcacy
(180,209,210). The use of Tramadol without LA for
inﬁltration was effective in one study (211).
When using a perioperative opioid-based regimen
(without LA block), multi-modal analgesia adding
both paracetamol and a NSAID is more effective than
either opioid alone or opioid plus either paracetamol
or NSAID (212,213).
Analgesia Table 5.5.6 Inguinal Hernia Repair (Open)
Agent Technique
Direct
evidence
Indirect
evidence
LA Wound infiltration 1+
LA Ilioinguinal Block 1+
LA Paravertebral Block 1)
LA Caudal Epidural 1+
Opioid Wound infiltration 1)
Opioida 1) 1+
NSAIDa 1) 1+
Paracetamola 1) 1+
aAs part of a multi-modal technique.
5.5.7 Umbilical hernia repair
Umbilical hernia repair is usually regarded as a rela-
tively minor surgical procedure, but it may be associ-
ated with signiﬁcant postoperative pain. It is often
undertaken on an out-patient or day-case basis. See
sections 5.1 for the general management of postopera-
tive pain.
Good practice point
A multi-modal analgesic regimen combining local
anesthesia and simple analgesics perioperatively is
recommended, opioid supplementation may be
required. Paracetamol and/or NSAID should be con-
tinued postoperatively for at least 48 h.
Evidence
Local anesthesia techniques including wound inﬁltra-
tion, rectus sheath block, and paraumbilical block are
effective with few complications. Ultrasound-guided
rectus sheath block showed increased intraoperative
analgesic efﬁcacy when compared with wound inﬁltra-
tion (214). Either bupivacaine or levobupivacaine
0.25% were used in the studies, but there has been no
comparison between these agents or concentrations or
volumes (215–218). Ultrasound demonstrates the inter-
individual variability in umbilical anatomy, its use may
increase the rate of correct needle placement, improved
efﬁcacy and reduce the volume of LA required
(216,218).
Analgesia Table 5.5.7 Umbilical Hernia Repair
Agent Technique
Direct
evidence
Indirect
evidence
LA Wound infiltration 2)
LA Paraumbilical block 3
LA Rectus sheath block 2)
Opioida 1+
NSAIDa 1+
Paracetamola 1+
aAs part of a multi-modal technique.
5.6 General surgery and urology (major)
5.6.1 Intra-abdominal surgery
This group includes a heterogeneous mixture of
abdominal procedures on the gastro-intestinal (GI)
and genitourinary (GU) tracts including nephrectomy,
pyeloplasty, ureteric reimplantation, and cystoplasty
for all of which a signiﬁcant level of postoperative pain
is expected. Intravenous opioid techniques or epidural
analgesia are acceptable for postoperative pain man-
agement; in clinical practice, supplementary analgesia
with NSAID and paracetamol is usually also adminis-
tered.
Appendicectomy and fundoplication are considered
separately in sections 5.6.2, 5.6.3 and laparoscopic
techniques in section 5.7. See also section 5.1 for gen-
eral management of postoperative pain.
Good practice point
Multimodal analgesia using parenteral opioids, central
neuraxial analgesia together with systemic NSAIDs
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and paracetamol should be used unless speciﬁcally
contraindicated.
Recommendations
Intravenous opioids either as continuous infusion, NCA
or PCA are effective following major abdominal surgery:
Grade A (219–223).
Epidural analgesia with LA should be considered for
major abdominal surgery. The addition of neuraxial clo-
nidine or opioid may further improve analgesia, but side
effects may also be increased: Grade B (168,224–229).
Evidence
There is a considerable descriptive literature (predating
the time limits of this guideline 1996–2011) describing
the use of opioid infusions, PCA, NCA, and LA epidu-
ral infusion with or without opioid for major surgery
such that these techniques have become part of everyday
practice. For suitable regimens, see section 6. Paraverte-
bral LA block has also been described and is a feasible
alternative. There are very few well-designed clinical tri-
als comparing these analgesic techniques. A variety of
surgical procedures are included in most studies, the
exact surgical incision employed is frequently not stated.
Intravenous opioids as a continuous infusion, PCA
or NCA are effective following abdominal surgery: the
analgesic response is a function of dose and develop-
mental age (219–223). See Section 6.1 for information
on doses and regimens.
Continuous epidural analgesia with LA is accept-
able. Bupivacaine, ropivacaine, and levobupivacaine
have been shown to be effective in a variety of infusion
concentrations and dose rates (168,224,226,230,231).
Epidural LA + opioid also provides good analgesia.
Morphine, fentanyl, hydromorphone, and diamorphine
have been the most frequently described; the side effect
proﬁle depends on the dose and particular opioid that
is used (168,226,228,232).
Single-shot caudal epidural LA + clonidine has been
compared to LA alone, LA + opioid, LA + dexmede-
tomidine and clonidine alone. Clonidine causes dose-
dependant sedation and hypotension. Clonidine or clo-
nidine + LA were equally effective as part of a multi-
modal strategy in combination with ketoprofen (233).
Clonidine (1)2 lgÆkg)1) + LA has fewer side effects
compared to opioid + LA, efﬁcacy may also be lower
(228,234). Caudal epidural clonidine 2 lgÆkg)1 or dex-
medetomidine 2 lgÆkg)1 with LA prolonged the dura-
tion of LA without increasing side effects (235).
Epidural opioid (without LA):
Single doses of epidural opioid can improve postop-
erative analgesia and reduce requirements for ongoing
analgesia (236,237). Intermittent epidural morphine
was superior to intramuscular morphine in one study
(238), but is less effective than LA containing (bupiva-
caine + fentanyl) infusion (224).
Peripheral nerve blocks (PNB): There is an
increasing interest in the use of single-shot and con-
tinuous peripheral nerve blocks. Paravertebral block
is feasible for abdominal surgery and has been
shown to decrease opioid requirements following
appendicectomy, see Section 5.6.2 (239,240). Trans-
versus abdominis plane (TAP) block is feasible for
abdominal surgery in neonates and children and
appears to provide satisfactory analgesia in some cir-
cumstances (241–243). A systematic review in adults
and children that included TAP and rectus sheath
block did not draw conclusions regarding the efﬁcacy
of these techniques because of the small number of
studies available (244). See also Sections 5.5.1, 5.6.2
and 5.7.
Analgesia Table 5.6.1 Abdominal surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Epidural 1+
LA Paravertebral block 1+
TAP block 2)
LA + opioid Epidural 1+
LA + clonidine Epidural 1+
Opioid Epidural 1+
Clonidine Epidural 1)
Opioid Intravenous 1+
NSAIDa 1)
Paracetamola 1+
aAs part of a multimodal technique.
5.6.2 Appendicectomy (open)
Appendicectomy is the most common indication for
laparotomy in children. Under normal circumstances,
this procedure is performed through an incision in the
right lower quadrant. In the majority of cases, appen-
dicectomy will be performed as an emergency or
unplanned procedure. See also sections 5.6 and 5.6.1
for information on the general management of postop-
erative pain, and a further discussion of analgesia fol-
lowing abdominal surgery.
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Good practice point
Wound inﬁltration with LA following appendicectomy
is a simple procedure that may be of beneﬁt in the
early postoperative period as part of a multimodal
analgesic technique.
Recommendation
PCA combined with NSAID is effective for postappen-
dicectomy pain: grade B (245).
Evidence
Intravenous opioids as a continuous infusion, PCA or
NCA, together with a multimodal analgesic strategy
including LA wound inﬁltration, NSAID and paracet-
amol is currently suggested practice following appendi-
cectomy (245–250).
Morphine PCA has been previously shown to be
effective, supplementation with NSAID improves
analgesia, particularly for pain on movement (245).
The addition of ketamine to morphine did not
improve analgesia in one study and neurobehavioral
side effects were increased (248). Antiemetic additives
to the opioid such as droperidol or ondansetron
offered no advantage but may increase side effects
(247,251).
Wound inﬁltration with LA has previously been
found to be of beneﬁt (252), but results from more
recent studies are inconclusive. Neither pre nor postinci-
sion bupivacaine 0.25–0.5% reduced postoperative mor-
phine requirement in the ﬁrst 24 h when compared with
placebo or no inﬁltration (250,253). Bupivacaine 0.25%
0.5 mlÆkg)1 may not confer additional beneﬁt in chil-
dren receiving effective multi-modal analgesia with opi-
oid, NSAID, and paracetamol (254). However,
preincision bupivacaine followed by inﬁltration of the
muscle layer on closure reduced pain scores for up to
48 h in another study that included children and adults
(255).
Paravertebral block reduced time to ﬁrst dose and
total postoperative opioid requirements compared to
placebo (240).
TAP block reduced pain scores and morphine
requirements in ﬁrst 24 h compared to placebo (243).
Analgesia Table 5.6.2 Appendicectomy
Agent Technique
Direct
evidence
Indirect
evidence
LA* Wound infiltration 1)
Paravertebral 1+
TAP Block 1+
Opioid Intravenous 1+
NSAIDa 1+
Paracetamola 1+
aAs part of a multimodal technique.
5.6.3 Fundoplication (open)
This procedure usually involves an incision of the upper
abdomen utilising either a midline, transverse supra-
umbilical, or left sub-costal approach. Increasingly lapa-
roscopic techniques have been used for fundoplication,
see section 5.7. The patient population is diverse, includ-
ing signiﬁcant numbers of children with neurodevelop-
mental delay and communication difﬁculties, which
may inﬂuence the choice of analgesic regime. See also
sections 5.1 and 5.6.1 for information on the general
management of postoperative pain, and a further dis-
cussion of analgesia following abdominal surgery.
Good practice point
Multimodal analgesia using parenteral opioids or epi-
dural analgesia together with systemic NSAIDs and
paracetamol should be used unless speciﬁcally contra-
indicated.
Recommendation
Epidural LA + opioid is effective and may be associ-
ated with improved clinical outcome in selected patients
following fundoplication: grade D (256–258).
Evidence
Some of the studies quoted have included other major
procedures as well as fundoplication. There are no
prospective studies comparing analgesic techniques fol-
lowing open fundoplication.
Epidural analgesia has been favored following
fundoplication as this group of patients is at high risk
of respiratory complications and includes signiﬁcant
numbers with neurodevelopmental delay (258–260).
Epidural LA: Ropivacaine without opioid provided
satisfactory analgesia for neonates and infants after
major thoracic and abdominal surgery including four
patients following fundoplication (231).
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Epidural LA + opioid: buivacaine + fentanyl
appears to be effective; higher pain scores were noted
in patients who had had fundoplication in one of the
studies but overall the regimen was considered to be
‘satisfactory’ (257,260).
Epidural clonidine or LA + clonidine: both were
found to be effective for a mixed surgical group as
part of a multimodal strategy including ketoprofen,
although after fundoplication (n = 9) there was an
increased need for supplementary opioid on the ﬁrst
postoperative night (233).
Intravenous opioid by continuous infusion PCA or
NCA appears to be effective, but may be inferior for
nonpain outcomes: see ‘epidural analgesia vs paren-
teral opioid’ below (256,261,262).
Epidural analgesia vs parenteral opioid.
Two retrospective observational studies have found
that duration of hospital stay is prolonged in patients
selected for opioid analgesia even when spinal defor-
mity patients (scoliosis) were excluded in one study
(256,258).
Analgesia Table 5.6.3 Fundoplication (open)
Agent Technique
Direct
evidence
Indirect
evidence
LA Epidural 3
LA + opioid Epidural 3
LA + clonidinea Epidural 3
Clonidinea Epidural 3
Opioida Intravenous 1+
NSAIDa 1+
Paracetamola 1+
aAs part of a multimodal technique.
5.6.4 Major urology
This category has been included because studies have
used a combination of different urological procedures
as the operative model, for example pyeloplasty,
nephrectomy, heminephrectomy, hypospadias, bladder
augmentation/reconstruction, ureteric reimplantation.
Postoperative pain is unlikely to be equivalent follow-
ing each of these different procedures, but they are not
uniformly distributed between studies, and the num-
bers of individual procedures in each study are often
low, thereby making it impractical to look at each pro-
cedure in isolation. See section 5.1 for the general
management of postoperative pain.
Good practice point
Multimodal analgesia using parenteral opioids or
regional analgesia together with systemic NSAIDs
and paracetamol should be used unless speciﬁcally
contraindicated.
Evidence
LA techniques are commonly used perioperatively for
major urological surgery. Comparison with parenteral
opioid techniques is limited, and little good evidence
exists with regard to the optimum analgesic regimen.
Epidural LA± opioid: For a variety of urological
procedures, perioperative ropivacaine infusions, with
or without opioid, have shown good analgesic efﬁcacy
with low pain scores and complication rates (263,264).
Comparisons of fentanyl or sufentanil added to ropi-
vacaine, and fentanyl or butorphanol added to bupiva-
caine showed no difference in efﬁcacy or pain scores
between these regimens (229,263).
Epidural LA vs Parenteral Opioid: Comparison of
postoperative epidural ropivacaine infusions with regu-
lar bolus tramadol or oxycodone plus paracetamol and
NSAID showed no difference in pain scores up to 48 h
but increased rescue analgesia between 48 and 72 h
(264).
Caudal neuraxial analgesic additives: In children
undergoing ureteric reimplantation, caudal analgesia
with LA + clonidine or opioid was effective. There
was no difference in efﬁcacy or pain scores from add-
ing clonidine, morphine, or hydromorphone to caudal
ropivacaine 0.2% + epinephrine, patients receiving
clonidine experienced fewer side effects (234).
Paravertebral Block: Use of a ‘single-shot’ intraoper-
ative paravertebral block with levobupivacaine and
regular paracetamol postoperatively was associated
with low pain scores and low opioid use in the early
postoperative period in patients undergoing major
renal surgery (239).
Wound Inﬁltration: A multimodal analgesic tech-
nique using LA inﬁltration alongside opioids, NSAID,
and paracetamol was associated with low pain scores
in children undergoing pyeloplasty and ureteric reim-
plantation (265,266).
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Analgesia Table 5.6.4 Urological Surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Epidural 1)
LA + opioid Epidural 1)
LA Caudal epidural 1)
LA Paravertebral block 2)
LAa Wound infiltration 3
Opioida Intravenous 3 1+
NSAIDa 3 1+
Paracetamola 3 1+
aAs part of a multimodal technique.
5.7 Laparoscopic surgery
There has been a dramatic increase in the amount of
pediatric laparoscopic surgery in the last decade. This
is performed mainly through the body cavities (chest
and abdomen) or potential spaces. Inguinal hernia
repair, appendicectomy, fundoplication, urological and
adrenal surgery are examples. For general management
of postoperative pain, see section 5.1.
Good practice points
Inﬁltration of port sites with LA as part of a multi-
modal analgesic strategy may reduce postoperative
pain following laparoscopy.
Although overall postoperative analgesic requirements
appear to be reduced following laparoscopy, pain may
be equivalent to the equivalent open procedure in
some circumstances, particularly during the ﬁrst 24 h.
Evidence
Advantages of laparoscopic surgery may include faster
recovery and overall reduction in pain and use of opi-
oid analgesia in comparison with the open surgical
counterpart (246,267–272). Although the overall dura-
tion of postoperative pain appears to be reduced, anal-
gesic requirements may be at least as great on the ﬁrst
postoperative day as the equivalent open procedure
(261,267,273–275). The use of robotic laparoscopic
techniques may also decrease postoperative opioid
requirements after ureteric reimplantation surgery
(276). The anatomical approach to laparoscopic sur-
gery has not been shown to effect analgesic require-
ments (277,278).
Multimodal analgesia including LA inﬁltration, opi-
oid, NSAID, and paracetamol is suitable, and the use
of carefully designed protocols may improve efﬁcacy
(279). Demand-led opioid regimens such as PCA or
NCA are feasible and effective for some procedures
and require further evaluation (246,262).
LA inﬁltration of port sites when combined with
NSAID provided equivalent analgesia to caudal block
for minor diagnostic and therapeutic laparoscopic pro-
cedures and to TAP block following appendicectomy
(280,281). Use of aerosolised bupivacaine after port
insertion, as part of a multimodal analgesic regimen,
demonstrated some opioid sparing effect (282).
Perioperative regional LA techniques have also been
shown to be effective and again require further evalua-
tion (271,279). Little good evidence exists with regard
to the optimum analgesic regimen.
Analgesia Table 5.7 Laparoscopic surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA* Infiltration 1)
LA* Aerosolised 3
LA Caudal 1)
Opioid Parenteral/oral 3
NSAIDa 1)
Paracetamola 3
aAs part of a multimodal technique.
5.8 Orthopedics, spinal and plastic surgery
5.8.1 Lower limb surgery
The surgery covered in this section ranges from rela-
tively minor single site orthopedic surgery to more
major procedures such as multiple level osteotomies.
The population of patients requiring femoral and
pelvic osteotomies includes those suffering from cere-
bral palsy; pain in this population can also precipitate
painful muscle spasm requiring speciﬁc management
with benzodiazepines.
Multimodal analgesia is suitable: there is particularly
extensive experience of the use of local anesthetic tech-
niques for this type of surgery. Concerns have been
expressed that NSAIDs may inhibit new bone growth
following orthopedic surgery; this is addressed below.
Good practice point
There is no evidence from studies in children that
NSAIDs have a deleterious effect on bone fusion. The
analgesic beneﬁt of short-term NSAID use has been
demonstrated and may frequently outweigh any hypo-
thetical risk.
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Recommendations
Peripheral nerve blocks provide superior analgesia and
are associated with fewer adverse effects compared with
intravenous opioids: Grade B (283,284).
Epidural opioids are effective, reduce the dose require-
ments of local anesthetic, and rescue IV opioids but
increase the incidence of side effects: Grade B
(259,285,286).
Continuous peripheral nerve blocks are feasible, effec-
tive, and safe and are associated with lower pain scores:
Grade B (287–295).
Epidural techniques are associated with lower pain
scores than intravenous opioid analgesia: Grade C
(237,257,296,297).
Systemic paracetamol and NSAID reduce intravenous
opioid requirements: Grade C (298,299).
Evidence
Studies have shown epidural analgesia using opioids,
local anesthesia or a mixture of the two are effective
but differences in efﬁcacy and side effects between reg-
imens are observed. Epidural opioids improve analge-
sia but side effects are more frequent. The side effect
proﬁle may be related to the individual properties of
speciﬁc opioids: morphine, fentanyl, and hydromor-
phone were of comparable analgesic efﬁcacy in one
study; respiratory depression, somnolence, and reten-
tion of urine were higher in the morphine group;
PONV and urinary retention had the lowest incidence
with hydromorphone (285). Single-dose epidural mor-
phine was equianalgesic with increasing dose (11.2, 15,
and 20 lgÆkg)1), but the incidence of PONV increased
with dose (300). In a study comparing bupiva-
caine + fentanyl with bupivacaine (both with adrena-
line), the fentanyl group had superior analgesia and
did not require rescue opioid but had a higher inci-
dence of PONV, whereas the bupivacaine group
required more bupivacaine and 10/26 (38%) required
rescue opiates and antiemetic therapy, itching only
occurred in the fentanyl group (286).
Epidural vs peripheral nerve block
A comparison of continuous epidural block with continu-
ous popliteal nerve block for major foot surgery showed
no difference in pain or rescue analgesia, but adverse
effects and patient satisfaction were improved with
peripheral nerve block (290). In congenital club foot sur-
gery, a comparison of single-shot caudal anesthesia with
single-shot peripheral nerve blocks (combined sciatic fem-
oral, combined sciatic saphenous, and saphenous com-
bined with local inﬁltration) showed no difference in the
duration of analgesia and no difference in morphine con-
sumption within the ﬁrst 24 h, there was no difference in
the incidence of nausea and vomiting between any of the
groups (301). Single-shot Psoas Compartment Block
showed moderate reduction in postoperative opioid
requirements compared to caudal epidural following
open hip reduction or osteotomy (302).
Epidural compared with Intravenous techniques
In a comparison between patient-controlled epidural
analgesia (PCEA) with lidocaine, and nurse-controlled
IV fentanyl, pain scores (unvalidated method), and
PONV were lower in the epidural group (297). A single
dose of epidural morphine 30 lgÆkg)1 reduced postopera-
tive PCA morphine use, and VAS scores were also lower
in the epidural morphine group, and there was no differ-
ence in the incidence of severe pruritus or PONV (237).
Peripheral nerve block vs intravenous techniques
Comparisons between peripheral nerve blocks and
intravenous morphine in pelvic osteotomy (283) and
patella realignment surgery (284) demonstrate reduced
pain scores, reduced morphine consumption and a
reduction in the incidence of sedation with the use of
peripheral nerve blocks.
A number of successful series of peripheral nerve
blocks have been described, including popliteal nerve
block (288,290,292–294,303), fascia iliaca compartment
block (288,303,304), sciatic nerve block(289,291,295,305),
psoas compartment block (287,293), and femoral nerve
block (284,304).
Continuous LA infusion vs PCRA/PCEA
PCRA (Ropivacaine 0.2%) showed similar efﬁcacy to
a continuous regional technique, with a lower total
dose of LA for popliteal and fascia iliaca blocks (303).
In a comparison of PCEA vs CEA, again efﬁcacy was
similar and a lower dose of LA used (306).
Systemic analgesia with NSAID and paracetamol
can be combined with intravenous opioid or regional
analgesia. In one study, a combination of paracetamol
and ketoprofen signiﬁcantly decreased pain scores and
IV morphine requirements compared to either drug
alone (299). In a case series of patients undergoing
club foot surgery and long bone osteotomy, ketorolac
reduced IV morphine usage and associated GI effects
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(298). Ketorolac did not inﬂuence bony union in a case
series of lower limb osteotomies (307).
Adjuvant analgesics
The use of intravenous magnesium (50 mgÆkg)1 bolus
followed by an infusion of 15 mgÆkg)1Æh)1) reduced
postoperative pain scores and analgesic consumption
in children with cerebral palsy undergoing femoral os-
teotomy.
Analgesia Table 5.8.1 Lower Limb surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Peripheral nerve block 1+
Caudal Epidural 1) 1)
Lumbar Epidural 1+
Opioid IV infusion 1+
NSAIDa 1+
Paracetamola 1+
Clonidine Peripheral nerve block 3
aAs part of a multi-modal technique.
5.8.2 Upper limb surgery
Surgery on the upper limb is most commonly performed
for plastic and orthopedic procedures of hand and fore-
arm, often following trauma. Local anesthesia of the
brachial plexus prior to surgery is frequently used.
There is some controversy regarding the most safe and
reliable approach to the brachial plexus. See section 5.1
for the general management of postoperative pain.
Recommendations
Brachial plexus blocks provide satisfactory analgesia for
hand and forearm surgery extending into the postopera-
tive period: Grade B (308–313).
The axillary, infraclavicular, supraclavicular, and inter-
scalene approach are feasible and effective: Grade B
(291,294,308,310–315).
Evidence
Analgesia following upper limb surgery has not been
well studied, and few investigations of postoperative
pain management have been undertaken. Brachial
plexus block appears to be effective, but differences
between techniques have not been investigated. The
axillary approach to the brachial plexus is theoretically
less likely to lead to accidental pneumothorax. There
are no comparisons between brachial plexus block and
other alternatives such as intravenous opioid.
Axillary brachial plexus block was the most studied
approach; postoperatively patients were generally man-
aged with oral analgesia. There was no difference in
postoperative efﬁcacy (time to 1st analgesia, analgesic
consumption, pain score) between 0.2% ropivacaine
and 0.25% bupivacaine when used for axillary brachial
plexus block (312). There was no beneﬁt to using a
fractionated dose of LA compared to a single injection
for axillary brachial plexus block, nor in placing the
block prior to or after surgery (309,316).
Other studies have examined the feasibility of the
different approaches to brachial plexus block. The in-
fraclavicular (311,313,315), the supraclavicular
approach (310), and the interscalene approach (291)
are effective, and there were no incidences of pneumo-
thorax in these studies (412 patients).
A comparison between peripheral nerve block at the
wrist and intravenous alfentanil demonstrated superior
analgesia and a reduction in adverse events in the
block group (317).
Analgesia Table 5.8.2 Upper Limb surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Brachial plexus block 1+
Opioid Intravenous 1+
Oral 1+
NSAIDa 1+
Paracetamola 1+
Clonidine Brachial plexus block 3
aAs part of a multi-modal technique.
5.8.3 Spinal surgery
Surgery to correct spinal deformity requires extensive
exposure of the spine which may be achieved posteri-
orly, anteriorly via thoracotomy or thoraco-abdomi-
nal approach, or by a combined anterior–posterior
approach. Postoperative pain can be severe and pro-
longed, necessitating the use of potent intravenous or
neuraxial analgesic techniques for 3–5 days postopera-
tively. The use of intravenous opioid analgesia has
not been well studied; however, the success of neurax-
ial techniques in controlling postoperative pain in
children has led to an interest in their use for spinal
surgery.
The patient population requiring spinal surgery
includes healthy adolescents and patients with severe
underlying medical conditions such as Duchenne’s
muscular dystrophy and cerebral palsy. The choice of
analgesic technique will be inﬂuenced by both patient
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and surgical factors in addition to local circumstances,
for example, neuraxial techniques are not suitable for
some patients. The involvement of the surgeon in the
choice of analgesic technique is especially important in
spinal surgery as it must also enable early and frequent
assessment of neurological function, and epidural LA
is not usually administered following surgery until nor-
mal neurological function has been demonstrated. See
section 5.1 for the general management of postopera-
tive pain.
Good practice point
There is no evidence from studies in children that
NSAIDs have a deleterious effect on bone fusion. The
analgesic beneﬁt of short-term NSAID use has been
demonstrated and may frequently outweigh any hypo-
thetical risk.
Recommendations
Epidural techniques produce a modest improvement in
pain control, compared with intravenous opioids in
patients undergoing corrective surgery for adolescent idi-
opathic scoliosis: Grade B (318–322).
Intrathecal opioids decrease intra-operative blood loss
and IV opioid consumption postoperatively. The duration
of action is 18–24 h: Grade C (318,323–326).
Dual catheter epidural techniques should be considered,
as this permits coverage of multiple spinal levels: Grade
C (319,327–329).
The use of LA + lipophilic opioid in the epidural space
with a single epidural catheter does not show an analge-
sic beneﬁt over intravenous opioid techniques: Grade C
(330,331).
The use of LA + hydrophilic opioids in the epidural
space has a favorable analgesic proﬁle compared with
IV opioid, but at the expense of increase adverse effects:
Grade D (332,333).
Evidence
The majority of studies have been conducted in adoles-
cents, and some studies have also included young adults
up to the age of 22 years. Neuraxial techniques have
been the most investigated. Intrathecal (IT) opioids: sin-
gle doses of IT opioids can reduce intraoperative blood
loss and postoperative analgesic requirements. IT mor-
phine plus sufentanil decreased intra-operative blood
loss compared with IV sufentanil (323). IT morphine
5 lgÆkg)1 also decreased intra-operative blood loss
compared with 2 lgÆkg)1 IT or saline controls (324).
The time to ﬁrst analgesic use, 6–24 h postoperatively,
was signiﬁcantly increased in proportion to dose of IT
morphine in these studies (323,324,334). Pain scores
were also lower with intrathecal morphine (318,324).
However, the use of a high-dose intrathecal opioid
regime (15 lgÆkg)1 morphine + 1 lgÆkg)1 sufentanil)
did not improve analgesic efﬁcacy or enhance the reduc-
tion in blood loss compared with a low-dose regimen
(5 lgÆkg)1 morphine + 1 lgÆkg)1 sufentanil) (325).
Several studies have found no increase in respiratory
depression with IT opioids up to a maximum dose of
20 lgÆkg)1 of morphine compared with intravenous
techniques (323,324), and no difference in level of
sedation, nausea and vomiting or pruritus (324). How-
ever, intrathecal morphine in excess of 20 lgÆkg)1 was
associated with respiratory depression (326). IT opiates
did not affect the ability to monitor spinal sensory
evoked potentials (SSEPs) (335).
A meta-analysis of epidural analgesia in adolescent
scoliosis surgery demonstrated a statistical, but clinically
modest improvement in pain scores in patients receiving
epidural analgesia compared with intravenous opioids
on all ﬁrst three postoperative days. One hundred and
twenty patients from four studies were included in the
analysis which also concluded that patient satisfaction
was higher in the epidural group. The papers included in
the meta-analysis differ in the regimens used: two papers
report the use of a single catheter midthoracic epidural
infusion of bupivacaine and fentanyl and show no dif-
ference in pain sores compared PCA morphine
(330,331). The remaining two papers report the use of a
dual catheter technique infusing ropivacaine without
opiod in patients following posterior (329) and anterior
(319) spinal surgery. Signiﬁcantly lower pain scores were
recorded compared with continuous IV morphine infu-
sion. A prospective comparison between PCEA with bi-
pvacaine 0.1% and hydromorphone 10 lg/ml)1 and
PCA hydromorphone demonstrated a reduction in pain
scores in the epidural group. There have also been sev-
eral retrospective series demonstrating reduced pain
scores with epidural analgesia compared with IV opioid:
A single epidural catheter infusing bupivacaine with
hydromorphone compared with a group receiving PCA
morphine (613 patients); the epidural group had a
higher incidence of side effects (333). Dual epidural
catheters infusing 0.1% bupivacaine with fentanyl
2 lgÆml)1 compared with an opioid PCA, no difference
in adverse effects (322). Single epidural infusing bupiva-
caine 0.1% and hydromorphone compared with PCA
morphine compared with intrathecal and PCA mor-
phine: intrathecal morphine controlled pain equally as
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well as the epidural technique for the ﬁrst 24 h, but epi-
dural was superior at 36 and 48 h (138 patients) (318).
Case series have demonstrated effective analgesia with
the following regimes: bupivacaine 0.0625–0.1% with
fentanyl, hydromorphone or morphine, 0.1% ropiva-
caine with hydromorphone, bupivacaine 0.0625–0.125%
with morphine, bupivacaine 0.0625% with fentanyl and
clonidine (332,336–339). Several authors commented
that placement of the epidural catheter by direct visuali-
sation during surgery was important.
Both 0.0625% bupivacaine with fentanyl and with
clonidine and ropivacaine with hydromorphone have
also been reported as successful using a dual catheter
technique (327,328). Epidural analgesia may be associ-
ated with a more rapid return in GI function
(318,330). The use of an epidural technique did not
compromise neurological assessment (336). There was
one report of a wound infection occurring in a patient
receiving epidural analgesia (330) but no reports of
epidural hematoma or abscess.
NSAIDS: There have been two retrospective reviews
looking at the use of NSAIDS following spinal surgery.
There was no difference in the incidence of nonunion in
patients who had received ketorolac (221 patients) com-
pared to controls (306 patients) (333,340).
Adjuvant analgesics: The use of gabapentin
(15 mgÆkg)1 preoperatively followed by 5 mgÆkg)1 tds
for 5 days) reduced opioid consumption on postopera-
tive days 1 and 2 and reduced pain scores on day 1
compared with placebo, no difference was seen beyond
day 2 and no difference was seen in side effects (341).
No difference was seen in pain scores or morphine
consumption when low-dose ketamine was adminis-
tered intra-operatively (0.5 mgÆkg)1 loading dose fol-
lowed by an infusion of 4 lgÆkg)1Æmin)1) compared
with placebo (342). A retrospective review of the addi-
tion of dexmedetomidine (0.4 lgÆkg)1Æh)1) to PCA
morphine was unable to demonstrate a signiﬁcant
difference in pain scores or morphine consumption
compared with PCA morphine alone (343).
Analgesia Table 5.8.3 Spinal surgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Thoracic Epidural 1+
LA Lumbo-thoracic 2 Catheter 1+
Opioid Intrathecal 1+
Opioid IV infusion 1+
Clonidine Epidural 3
NSAIDa 1+
Paracetamola 1+
Gabapentin 1+
aAs part of a multi-modal technique.
5.8.4 Cleft lip and palate and related procedures
This section includes a range of procedures such as
repair of Cleft Lip and Palate, Otoplasty, and Alveolar
bone grafting. See section 5.1 for the general manage-
ment of postoperative pain.
Recommendation
Infraorbital nerve block provides effective analgesia
for cleft lip repair in the early postoperative period:
Grade A (344–348).
Evidence
The evidence base supporting the efﬁcacy of analgesic
strategies is weak for this group of procedures and
postoperative analgesic requirements are not clear.
Many patients appear to be successfully managed with
intraoperative local anesthesia followed by NSAIDs,
paracetamol, and low doses of opioid postoperatively.
Cleft Lip Repair: infra-orbital nerve block for cleft lip
surgery is feasible, and studies have demonstrated lower
pain scores in patients who received infra-orbital nerve
block compared with IV fentanyl (347,348) peri-inci-
sional inﬁltration of local anesthetic (344,345) and rectal
Paracetamol (346). Blocks were performed with 0.25%
bupivacaine in all these studies. The addition of opioids
pethidine or fentanyl signiﬁcantly prolonged the dura-
tion of the block in two studies (349,350). Clonidine
added to bupivacaine resulted in a moderate improve-
ment in postoperative analgesia in another (351).
Cleft Palate Surgery: Local inﬁltration (352), pala-
tine nerve block (353), and bilateral suprazygomatic
maxillary nerve block (354) have been associated with
low pain scores following cleft palate repair. The effect
of NSAIDs on peri-operative bleeding was reviewed in
one small case series (20 patients), and there was no
effect associated with diclofenac 1 mgÆkg)1 b.d. (355).
Alveolar Bone Graft: Morphine PCA requirements
are low (<0.4 mgÆkg)1), and there was no improve-
ment in analgesic efﬁcacy with the addition of IV ket-
orolac 0.5 mgÆkg)1 qid (356). Continuous infusion of
bupivacaine (357,358) and the placement of a bupiva-
caine-soaked absorbable sponge (358) have been used
to reduce pain from the iliac crest donor site.
Otoplasty: regional nerve blockade with bupivacaine
0.5% showed no improvement in analgesia compared
with local inﬁltration of the operative ﬁeld with Lido-
caine 1% and adrenaline (359).
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Analgesia Table 5.8.4 Plastic surgery procedures of head and neck
Agent Technique
Direct
evidence
Indirect
evidence
LA Local infiltration 1+
LA Infraorbital nerve blocka 1+
Opioidb 1+
NSAIDb 1+
Paracetamolb 1+
aRepair of cleft lip alone.
bAs part of a multi-modal technique.
5.9 Cardiothoracic surgery
5.9.1 Cardiac surgery (sternotomy)
Classically, cardiac surgery with cardiopulmonary by-
pass (CPB) will involve division of the bony sternum
to obtain access to the heart and great vessels. Antico-
agulation with heparin is maintained throughout CPB,
which has implications for the use of regional tech-
niques. Postoperative patients are nursed in ICU areas,
often with a short period of mechanical ventilation
prior to extubation of the trachea. Postoperative anal-
gesia with intravenous opioids, most frequently mor-
phine or fentanyl, has been standard practice for more
than 20 years in many institutions. See section 5.1 for
the general management of postoperative pain.
Recommendation
Epidural and intrathecal techniques with opioid and/or
LA are effective for sternotomy pain, but only marginal
beneﬁts have been demonstrated, and there are insufﬁcient
data concerning the incidence of serious complications:
Grade B (360–368).
Evidence
Intravenous opioids are the standard to which other
analgesic techniques are to be compared. A comparison
of morphine and tramadol NCA found no difference in
efﬁcacy between the two, although tramadol caused less
sedation in the early postoperative period (369).
There has been an increasing interest in regional
analgesic techniques because of their potential to
reduce stress responses and facilitate earlier tracheal
extubation with possible improvements in clinical out-
come and economic cost reduction. The relatively
small size of studies precludes accurate prediction of
very rare but serious side effects such as epidural
hematoma and consequent neurological damage.
Intrathecal opioid: morphine or fentanyl produce
equivalent analgesia (and side effects) to intravenous
morphine with lower overall analgesic consumption
(364,365).
Intrathecal opioid + LA: improved pain scores
compared with bolus IV fentanyl alone with lower
overall fentanyl consumption but no difference in opi-
oid related side effects (366).
Epidural: case series have demonstrated the feasibil-
ity and efﬁcacy of epidural catheter techniques from
caudal, lumbar or thoracic approaches with few and
modest improvements in outcomes (360–362,368).
There is a single case report of epidural hematoma
requiring surgical decompression in an 18-year-old
with TEB who remained anticoagulated following aor-
tic valve surgery (370).
NSAIDS: ketorolac commenced 6 h postoperatively
did not increase postoperative bleeding, nor affect IV
morphine requirements or reduce time to extubation in
one study (371).
Analgesia Table 5.9.1 Cardiac Surgery (sternotomy)
Agent Technique
Direct
evidence
Indirect
evidence
LA Caudal epidural catheter 3
LA Thoracic epidural (TEB) 1)
LA Intrathecal (SAB) 1)
Opioid IV infusion 1+
Opioid Caudal 2)
Opioid Thoracic epidural (TEB) 2)
Opioid Intrathecal 1+
NSAIDa 1+
Paracetamola 1+
aAs part of a multi-modal technique.
5.9.2 Thoracotomy
Access to the lungs, pleura, and intrathoracic structures
is obtained by an intercostal incision and separation and
retraction of the ribs. Typical procedures include ligation
of patent ductus arteriosus (PDA) resection of aortic
coarctation, lung biopsy, or partial resection, pneumo-
nectomy, repair of tracheoesphageal ﬁstula. Considerable
pain can be expected following classical thoracotomy
incision. Recently, VATS (video assisted thoracoscopic
surgery), a minimally invasive technique, has been used
for some relatively minor thoracic procedures, for exam-
ple lung biopsy or smaller lung resections.
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Good practice point
A multi-modal analgesic approach, including a local
anesthetic technique and/or opioid with NSAID and
paracetamol, is suitable for postthoracotomy pain.
Recommendation
Epidural analgesia is effective for postthoracotomy pain:
Grade D (225,226,231,257,372).
Evidence
Thoracotomy is frequently included in studies of
analgesia for major surgery in combination with
other procedures such as abdominal and spinal sur-
gery, making interpretation of ﬁndings difﬁcult.
Either epidural analgesia or intravenous opioids as
part of a multimodal strategy including NSAID and
paracetamol have been used extensively for posttho-
racotomy pain. Paravertebral block has also been
described.
There are few studies comparing regional and sys-
temic techniques directly, or with other more novel
regimens. Although it might be anticipated that pain
following VATS would differ from classical thoracot-
omy, there are no studies exploring this issue.
Epidural analgesia is frequently recommended for
postthoracotomy pain; however, there is no conclusive
evidence that any particular regimen is more effective.
Epidural LA: plain bupivacaine and ropivacaine
solutions have been found to be effective for major
abdominal and thoracic surgery in neonates and
infants (225,231). Analgesia was reported as equivalent
in a case series (272 patients, 29 thoracic) comparing
children who received either plain ropivacaine or bupi-
vacaine + diamorphine as part of a multimodal anal-
gesic strategy (226).
LA + opioid: bupivacaine with fentanyl, morphine,
diamorphine, or other opioids is effective for posttho-
racotomy pain, by continuous infusion or PCEA
(226,257,372,373).
Epidural opioid without LA: single-dose thoracic
epidural morphine was equivalent to intravenous mor-
phine infusion in the ﬁrst 24 h after thoracotomy
(374). Single-dose caudal morphine with or without
LA was less effective than thoracic epidural Mor-
phine + LA infusion; infusion patients also had better
nonpain outcomes, for example earlier oral intake, less
PONV, and shorter ICU stay (373).
Intrathecal opioid as part of a multimodal technique
has been described in a small case series (375).
Paravertebral block has been described as effective
in a number of small case series of neonates, infants,
and children (376–382). There have been no compari-
sons with other techniques.
Intercostal nerve block: increased the time to further
analgesia when compared with a single dose of pethi-
dine at skin closure (383).
Opioids: intravenous infusion of opioid is frequently
used for severe postoperative pain including posttho-
racotomy (384,385). PCA/NCA has been described in
studies that have included a small number of posttho-
racotomy patients (220,221,223). Data on the efﬁcacy
of opioids for thoracotomy are inadequate to allow
conclusive evaluation, and the role of multimodal anal-
gesia has also not been sufﬁciently evaluated. In a
comparison of PCA and continuous infusion of mor-
phine without supplementary NSAID and paraceta-
mol, there was no difference between the groups, but
20–40% of patients in each group had pain scores in
the ‘severe’ range on the ﬁrst postoperative day (220).
Analgesia Table 5.9.2 Thoracotomy
Agent Technique
Direct
evidence
Indirect
evidence
LA Thoracic epidurala 3
LA Paravertebral block 3
LA Intercostal blockb 3
LA + opioid Thoracic epidurala 3
Opioid Thoracic epiduralc 1)
Opioid Intrathecalb 3
Opioid Intravenous 2)
NSAIDb 1+
Paracetamolb 1+
aCaudal, lumbar and thoracic catheter insertion sites.
bAs part of a multi-modal technique.
c1st 24 h.
5.10 Neurosurgery
Neurosurgical procedures in children include drainage
of hydrocephalus and insertion or replacement of an
extra cranial shunt, craniotomy, craniofacial surgery,
and surgery for intracranial aneurism or other vascular
malformation. There has been little investigation of
analgesic requirements or analgesia for this group of
patients, but it is frequently asserted that severe post-
operative pain is not a prominent feature, even follow-
ing major neurosurgical interventions, this has been
disputed (386). Postoperatively, many neurosurgical
patients are admitted to ICU or high dependency areas
for monitoring; opioid analgesia must be used judi-
ciously as excessive sedation may mask signs of acute
changes in intracranial pressure or interfere with the
patient’s ability to co-operate with neurological assess-
ments. As the risk of postoperative bleeding is rela-
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tively high and potentially disastrous following some
procedures, NSAIDs are sometimes withheld during
the ﬁrst 24 h. See also section 5.1 on the general man-
agement of postoperative pain, and section 5.10.1 for
the management of craniotomy and major neurosur-
gery.
Good practice point
Analgesia following neurosurgery requires good
communication and close co-operation between
members of the peri-operative team. Frequent pain
assessments should be a routine part of postopera-
tive care. A multi-modal analgesic approach is suit-
able, which may include the use of LA inﬁltration,
paracetamol, NSAID (when not contraindicated),
and parenteral or oral opioid as determined by
assessed analgesic requirements.
5.10.1 Craniotomy and major neurosurgery
Craniotomy is most frequently performed for tumor
surgery, repair of vascular anomalies and surgery for
epilepsy. Posterior fossa craniotomy, a relatively inva-
sive approach, is more frequently indicated in children
than adults yet in common with other pediatric neuro-
surgical procedures postoperative pain and analgesia
requirements have been little studied.
Evidence
The literature informing the management of postopera-
tive pain after neurosurgery is limited. There have been
few studies comparing standard analgesic regimens.
Opioids: the use of parenteral opioids following cra-
niotomy and major neurosurgery has been described
(387–390). PCA with fentanyl plus a continuous
infusion of midazolam has been described (391). NCA
was reportedly used successfully in a small number
of patients <6 years old following neurosurgical
procedures as part of a large case series, but results for
these patients were not reported separately (221,223).
The effective use of codeine has also been described
(388,389), in a pharmacokinetic study comparing IM
and PR codeine following craniotomy high pain scores
were reported for both groups (392).
Analgesia Table 5.10.1 Craniotomy and major neurosurgery
Agent Technique
Direct
evidence
Indirect
evidence
LA Infiltration 1)
Opioid IV infusion 2)
Opioid PCA/NCA 3
Opioid (Codeine) Intramuscular 2)
Opioid Intrathecal 2)
NSAIDa 1+
Paracetamola 1+
aAs part of a multi-modal technique.
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6.1 Analgesia
This section describes some of the important proper-
ties, dosing regimens, interactions, and adverse effects
of analgesics for acute pain in children.
Local anesthetics, opioids, NSAIDs, and paracetamol
form the pharmacological basis for the majority of anal-
gesic regimens. Ketamine, a dissociative anesthetic with
analgesic properties and clonidine, an alpha-2-agonist,
are used to provide systemic or neuraxial analgesia
alone or as adjuncts to other agents. For painful proce-
dures, inhaled nitrous oxide has an important role, and
in neonatology intra-oral sucrose solution is used. The
availability of speciﬁc opioids, NSAIDs, and local anes-
thetics can vary from country to country.
The detailed pharmacology and formulations of
these drugs are available in standard textbooks. For
more comprehensive prescribing information, summa-
ries of product characteristics, and license status of
speciﬁc agents for children in the UK, please consult
resources such as the British National Formulary for
Children (2012) available at http://bnfc.org/bnfc and
the Electronic Medicines Compendium available at
http://emc.medicines.org.uk/.
6.2 Local anesthetics
Most widely used local anesthetics are amides with the
exception of tetracaine (amethocaine), which is an ester
(1–4). They all act by reversibly blocking sodium chan-
nels in nerves. They vary in onset, potency, potential for
toxicity, and duration of effect. Formulations are avail-
able for topical application to mucosae or intact skin,
for local installation or inﬁltration, for peripheral nerve
or plexus blockade, for epidural injection or infusion,
and for subarachnoid administration. Vasoconstrictors
may be added to reduce the systemic absorption of local
anesthetic and to prolong the neural blockade. Neuraxi-
al analgesics such as the a-2-agonist clonidine, the phen-
cyclidine derivative ketamine, or opioids such as
fentanyl may be co-administered with the local anes-
thetic to prolong the effect of central nerve blocks.
6.2.1 Bupivacaine, levobupivacaine, and ropiva-
caine
(i) Preparations and routes
Bupivacaine is an amide LA with a slow onset and a
long duration of action, which may be prolonged by
the addition of a vasoconstrictor. It is used mainly for
inﬁltration anesthesia and regional nerve blocks, par-
ticularly epidural block, but is contraindicated for
intravenous regional anesthesia (Bier’s block). Bupiva-
caine is a racemic mixture but the S())-isomer
levobupivacaine is also commonly used. A carbonated
solution of bupivacaine, with faster onset of action, is
also available for injection in some countries. Bupiva-
caine is used in solutions containing the equivalent of
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0.0625–0.75% (0.625–7.5 mg ml)1). In recommended
doses, bupivacaine produces complete sensory block-
ade, and the extent of motor blockade depends on
concentration. Solutions of 0.0625% or 0.125% are
associated with a very low incidence of motor block, a
0.25% solution generally produces incomplete motor
block, a 0.5% solution will usually produce more
extensive motor block, and complete motor block and
muscle relaxation can be achieved with a 0.75% solu-
tion. Hyperbaric solutions of 0.5% bupivacaine may
be used for spinal intrathecal block.
Levobupivacaine is the S-enantiomer of bupivacaine,
and it is equipotent but toxicity is slightly less. It is
available in the same concentrations as bupivacaine
and is used for similar indications; like bupivacaine, it
is contraindicated for use in intravenous regional anes-
thesia (Bier’s block).
Ropivacaine is an amide LA with an onset and dura-
tion of sensory block that is generally similar to that
obtained with bupivacaine but motor block may be
slower in onset, shorter in duration, and less intense. It
is available in solutions of 0.2%, 0.75%, and 1%.
(ii) Dosage, side effects, and toxicity
The dosage of bupivacaine, levobupivacaine, and ropiva-
caine depends on the site of injection, the procedure,
and the status of the patient: suggested maxima are
given in Table 6.2.1. A test dose may help to detect
inadvertent intravascular injection, and doses should
be given in small increments. Slow accumulation
occurs with repeat administration and continuous infu-
sions, especially in neonates.
Table 6.2.1 Suggested maximum dosages of bupivacaine, levobupi-
vacaine, and ropivacaine
Single bolus injection Maximum dosage (mgÆkg)1)
Neonates 2
Children 2.5
Continuous infusion
(postoperative use)
Maximum infusion rate (mgÆkg)1Æh)1)
Neonates 0.2
Children 0.4
Bupivacaine is 95% bound to plasma proteins with
a half-life of 1.5–5.5 h in adults and 8 h in neonates. It
is metabolized in the liver and is excreted in the urine
mainly as metabolites with only 5–6% as unchanged
drug. Bupivacaine is distributed into breast milk in
small quantities. It crosses the placenta but the ratio of
fetal concentrations to maternal concentrations is rela-
tively low. Bupivacaine also diffuses into the CSF.
The toxic threshold for bupivacaine is in the plasma
concentration range of 2–4 mgÆml)1. The two major
binding proteins for bupivacaine in the blood are a1-
acid glycoprotein, the inﬂuence of which is predomi-
nant at low concentrations, and albumin, which plays
the major role at high concentrations. Reduction in
pH from 7.4 to 7.0 decreases the afﬁnity of the a1-acid
glycoprotein for bupivacaine but has no effect on albu-
min afﬁnity. For epidural infusion techniques in neo-
nates, the reduced hepatic clearance of amide local
anesthetics is the more important factor causing accu-
mulation of bupivacaine than reduced protein binding
capacity, particularly as protein levels tend to increase
in response to surgery.
Bupivacaine is more cardio toxic than other amide
local anesthetics and there is an increased risk of myo-
cardial depression in overdose and when bupivacaine
and antiarrhythmics are given together. Propranolol
reduces the clearance of bupivacaine. Levobupivacaine
is slightly less cardio toxic and therefore safer but
maximum recommended doses are similar to those of
buivacaine.
Ropivacaine is about 94% bound to plasma proteins.
The terminal elimination half-life is around 1.8 h, and
it is extensively metabolized in the liver by the cyto-
chrome P450 isoenzyme CYP1A2. Prolonged use of
ropivacaine should be avoided in patients treated with
potent CYP1A2 inhibitors, such as the selective seroto-
nin reuptake inhibitor (SSRI) ﬂuvoxamine. Plasma
concentrations of ropivacaine may be reduced by
enzyme-inducing drugs such as rifampicin. Metabolites
are excreted mainly in the urine; about 1% of a dose
is excreted as unchanged drug. Some metabolites also
have a local anesthetic effect but less than that of ropi-
vacaine. Ropivacaine crosses the placenta.
6.2.2 Lidocaine, prilocaine, and EMLA
(i) Preparations
Lidocaine is an amide LA, which is used for inﬁltration
anesthesia and regional nerve blocks. It has a rapid
onset of action and anesthesia is obtained within a few
minutes; it has an intermediate duration of action. The
addition of a vasoconstrictor reduces systemic absorp-
tion and increases both the speed of onset and the
duration of action. Lidocaine is a useful surface anes-
thetic but it may be rapidly and extensively absorbed
following topical application to mucous membranes,
and systemic effects may occur. Hyaluronidase may
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enhance systemic absorption. Lidocaine is included in
some injections, such as depot corticosteroids, to pre-
vent pain and itching caused by local irritation.
Prilocaine is an amide local anesthetic with a similar
potency to lidocaine. However, it has a slower onset of
action, less vasodilator activity, and a slightly longer
duration of action; it is also less toxic. Prilocaine is
used for inﬁltration anesthesia and nerve blocks in
solutions of 0.5%, 1%, and 2%. A 1% or 2% solution
is used for epidural anesthesia; for intravenous regio-
nal anesthesia, 0.5% solutions are used. For dental
procedures, a 3% solution with the vasoconstrictor
felypressin or a 4% solution without is used. A 4%
solution with epinephrine (1 in 200 000) is also used
for dentistry in some countries. Carbonated solutions
of prilocaine have also been used for epidural and bra-
chial plexus nerve blocks. Prilocaine is used for surface
anesthesia in a eutectic mixture with lidocaine EMLA.
(ii) Doses, side effects, and toxicity
The dose of lidocaine depends on the site of injection
and the procedure but in general, the maximum dose
should not exceed 3 mgÆkg)1 (maximum 200 mg)
unless vasoconstrictor is also used. Lidocaine hydro-
chloride solutions containing epinephrine (1 in
200 000) for inﬁltration anesthesia and nerve blocks
are available; higher concentrations of epinephrine are
seldom necessary, except in dentistry, where solutions
of lidocaine hydrochloride with epinephrine 1 in
80 000 are traditionally used. The maximum dose of
epinephrine should be 5 microgm/kg)1 and of lidocaine
5 mgÆkg)1. Epinephrine-containing solutions should
not be used near extremities such as for digital or
penile blocks. Lidocaine may be used in a variety of
formulations for surface anesthesia. Lidocaine oint-
ment is used for anesthesia of skin and mucous mem-
branes. Gels are used for anesthesia of the urinary
tract and for analgesia of aphthous ulcers. Topical
solutions are used for surface anesthesia of mucous
membranes of the mouth, throat, and upper gastroin-
testinal tract. For painful conditions of the mouth and
throat, a 2% solution may be used or a 10% spray
can be applied to mucous membranes. Eye drops con-
taining lidocaine hydrochloride 4% with ﬂuorescein
are used in tonometry. Other methods of dermal deliv-
ery include a transdermal patch of lidocaine 5% for
the treatment of pain associated with postherpetic neu-
ralgia and an iontophoretic drug delivery system incor-
porating lidocaine and epinephrine.
Lidocaine is bound to plasma proteins, including a1-
acid glycoprotein (AAG). The extent of binding is var-
iable but is about 66%. Plasma protein binding of
lidocaine depends in part on the concentrations of
both lidocaine and AAG. Any alteration in the con-
centration of AAG can greatly affect plasma concen-
trations of lidocaine. Plasma concentrations decline
rapidly after an intravenous dose with an initial half-
life of <30 min; the elimination half-life is 1–2 h but
may be prolonged if infusions are given for longer
than 24 h or if hepatic blood ﬂow is reduced. Lido-
caine is largely metabolized in the liver, and any alter-
ation in liver function or hepatic blood ﬂow can have
a signiﬁcant effect on its pharmacokinetics and dosage
requirements. First-pass metabolism is extensive and
bioavailability is about 35% after oral doses. Metabo-
lism in the liver is rapid and about 90% of a given
dose is dealkylated to form monoethylglycinexylidide
and glycinexylidide. Both of these metabolites may
contribute to the therapeutic and toxic effects of lido-
caine and because their half-lives are longer than that
of lidocaine, accumulation, particularly of glycinexyli-
dide, may occur during prolonged infusions. Further
metabolism occurs and metabolites are excreted in the
urine with <10% of unchanged lidocaine. Reduced
clearance of lidocaine has been found in patients with
heart failure or severe liver disease. Drugs that alter
hepatic blood ﬂow or induce drug-metabolizing micro-
somal enzymes can also affect the clearance of lido-
caine. Renal impairment does not affect the clearance
of lidocaine but accumulation of its active metabolites
can occur. Lidocaine crosses the placenta and blood–
brain barrier; it is distributed into breast milk.
Lidocaine is considered to be unsafe in patients with
porphyria because it has been shown to be porphyrino-
genic in animals.
The clearance of lidocaine may be reduced by pro-
pranolol and cimetidine. The cardiac depressant effects
of lidocaine are additive with those of beta blockers
and of other antiarrhythmics. Additive cardiac effects
may also occur when lidocaine is given with intrave-
nous phenytoin, mexilitene, or amiodarone; however,
the long-term use of phenytoin and other enzyme in-
ducers such as barbiturates may increase dosage
requirements of lidocaine. Hypokalaemia produced by
acetazolamide, loop diuretics, and thiazides antago-
nizes the effect of lidocaine.
Prilocaine dosage for children over 6 months of age
is up to 5 mgÆkg)1. For dental inﬁltration or dental
nerve blocks, the 4% solution with epinephrine
(1:200 000) is often used. Children under 10 years gen-
erally require about 40 mg (1 ml). The dose of prilo-
caine hydrochloride with felypressin 0.03 international
unitsÆml)1 as a 3% solution for children under 10 years
is 30–60 mg (1–2 ml).
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Prilocaine has relatively low toxicity compared with
most amide-type local anesthetics. It is 55% bound to
plasma proteins and is rapidly metabolized mainly in
the liver and kidneys and is excreted in the urine. One
of the principal metabolites is o-toluidine, which is
believed to cause the methemoglobinemia observed
after large doses. It crosses the placenta and dur-
ing prolonged epidural anesthesia may produce
methemoglobinemia in the fetus. It is distributed into
breast milk. The peak serum concentration of prilo-
caine associated with CNS toxicity is 20 mgÆml)1.
Symptoms usually occur when doses of prilocaine
hydrochloride exceed about 8 mgÆkg)1 but the very
young may be more susceptible. Methemoglobinemia
has been observed in neonates whose mothers received
prilocaine shortly before delivery and it has also been
reported after prolonged topical application of a prilo-
caine/lidocaine eutectic mixture in children. Methemo-
globinemia may be treated by giving oxygen followed,
if necessary, by IV methylthioninium chloride.
Prilocaine should be used with caution in patients
with anemia, congenital or acquired methemoglobine-
mia, cardiac or ventilatory failure, or hypoxia. Prilo-
caine has been associated with acute attacks of
porphyria and is considered unsafe in porphyric
patients. Methemoglobinemia may occur at lower
doses of prilocaine in patients receiving therapy with
other drugs known to cause such conditions (e.g., sulf-
onamides such as sulfamethoxazole in co-trimoxazole).
(iii) EMLA
Lidocaine forms a mixture with prilocaine that has a
melting point lower than that of either ingredient. This
eutectic mixture containing lidocaine 2.5% and prilo-
caine 2.5% can produce local anesthesia when applied
to intact skin as a cream. It is used extensively for pro-
cedural pain including venepuncture, intravenous or
arterial cannulation, lumbar puncture, minor dermato-
logical procedures, and others (see section 4.0). The
eutectic cream is usually applied to skin under an
occlusive dressing for at least 60 min and a maximum
of 5 h. Transient paleness, redness, and edema of the
skin may occur following application.
Eutectic mixtures of lidocaine and prilocaine are
used in neonates and are safe in single doses. There
has been concern that excessive absorption (particu-
larly of prilocaine) might lead to methemoglobinemia
particularly after multiple applications. For this rea-
son, the maximum number of doses per day should be
limited in the neonate. In some countries, EMLA has
been licensed for use in neonates provided that their
gestational age is at least 37 weeks, and that methemo-
globin values are monitored in those aged 3 months or
less. In fact, systemic absorption of both drugs from
the eutectic cream appears to be minimal across intact
skin even after prolonged or extensive use. However,
EMLA should not be used in infants under 1 year
who are receiving methemoglobin-inducing drugs; it
should not be used on wounds or mucous membranes
or for atopic dermatitis. EMLA should not be applied
to or near the eyes because it causes corneal irritation,
and it should not be instilled into the middle ear. It
should be used with caution in patients with anemia or
congenital or acquired methemoglobinemia.
6.2.3 Tetracaine (amethocaine)
(i) Preparations
Tetracaine is a potent, para-aminobenzoic acid ester
local anesthetic used for surface anesthesia and spinal
block. It is highly lipophilic and can penetrate intact
skin. Its use in other local anesthetic techniques is
restricted by its systemic toxicity.
For anesthesia of the eye, solutions containing 0.5–
1% tetracaine hydrochloride and ointments containing
0.5% tetracaine have been used. Instillation of a 0.5%
solution produces anesthesia within 25 s that lasts for
15 min or longer and is suitable for use before minor
surgical procedures.
A 4% gel (Ametop) is used as a percutaneous local
anesthetic. This formulation of 4% tetracaine produces
more rapid and prolonged surface anesthesia than
EMLA and is signiﬁcantly better in reducing pain
caused by laser treatment of port wine stains and for
venous cannulation. A transdermal patch is effective,
and patches containing a mixture of lidocaine and tet-
racaine have also been tried. Tetracaine has been
incorporated into a mucosa-adhesive polymer ﬁlm to
relieve the pain of oral lesions resulting from radiation
and antineoplastic therapy. Liposome-encapsulated tet-
racaine can provide adequate surface anesthesia.
LAT (LET) 4% lidocaine, 0.1% epinephrine, and
0.5% tetracaine have been combined in a gel and
applied as a surface anesthetic to lacerations of the
skin especially the face and scalp. It is less a painful
alternative to LA inﬁltration prior to suture of lacera-
tions.
(ii) Dosage side effects and toxicity
Tetracaine: A stinging sensation may occur when tetra-
caine is used in the eye. Absorption of tetracaine from
mucous membranes is rapid, and adverse reactions can
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occur abruptly without the appearance of prodromal
signs or convulsions; systemic toxicity is high and
fatalities have occurred. It should not be applied to
inﬂamed, traumatized, or highly vascular surfaces and
should not be used to provide anesthesia for bronchos-
copy or cystoscopy, as there are safer alternatives, such
as lidocaine.
Tetracaine gel: The gel is applied to the center of the
area to be anesthetized and covered with an occlusive
dressing. Gel and dressing are removed after 30 min
for venepuncture and 45 min for venous cannulation.
A single application provides anesthesia for 4–6 h. Tet-
racaine is 15% bioavailable after application of 4% gel
to intact skin, with a mean absorption and elimination
half-life of about 75 min. It is rapidly metabolized by
esterases in the skin, in plasma, and on red cells. Mild
erythema at the site of application is frequently seen
with topical use; slight edema or pruritus occur less
commonly and blistering of the skin may occur. It has
been used safely in the premature neonate from
28 weeks gestation.
LAT: 1–3 ml of the solution is applied directly to
the wound for 15–30 min using a cotton-tipped appli-
cator. The solution and gel have been used in chil-
dren aged 1-year old and above. There are no reports
of toxicity but application of preparations of tetra-
caine to highly vascular surfaces, mucous membranes,
and wounds larger than 6 cm is not recommended. If
lidocaine is injected following LAT, the maximum
dose of lidocaine (5 mgÆkg)1) should not be exceeded.
6.3 Neuraxial analgesic drugs
Drugs that produce a speciﬁc spinally mediated analge-
sic effect following epidural or intrathecal administra-
tion are referred to as neuraxial analgesic drugs (other
terms include spinal adjuvants, caudal additives) (5–9).
Analgesia is not mediated by systemic absorption of
the drug as spinal dose requirements, and associated
plasma concentrations are lower than those required
for an analgesic effect following systemic administra-
tion. These agents modulate pain transmission in the
spinal cord by:
l reducing excitation, for example, ketamine
(NMDA antagonist)
l enhancing inhibition, for example, opioids; cloni-
dine (alpha2 agonist); neostigmine (anticholinester-
ase); midazolam (GABAA agonist)
In pediatric practice, these drugs are most com-
monly administered as single-dose caudal injections
and are often used in combination with local anesthe-
sia to improve and prolong analgesia, reducing the
dose requirement for local anesthetic and thereby
unwanted effects such as motor block or urinary
retention. There is conﬂicting data about the ability
to produce a selective spinally mediated effect in chil-
dren. Caudal administration of tramadol has been
reported to produce lower serum concentrations of
metabolites but no difference in analgesia when com-
pared with IV administration. Many studies that
compare the effect of neuraxial drugs are hampered
by poor study design, such as:
l inadequate power and sample size. If the sample
size is small, it is difﬁcult to conﬁrm any change in
the incidence of side effects, particularly those that
are less common.
l insensitive outcome measures. No difference may
be found between two active treatments (e.g.,
LA ± additive; different doses; different routes
such as caudal versus systemic) if pain scores and
supplemental analgesic requirements are low in
both groups. Measures of side effects such as seda-
tion and respiratory depression are often insensitive
and not standardized.
The use of ketamine and clonidine is described here:
tramadol and other opioids are discussed in section
6.4. Neostigmine and tramadol increase the duration
of analgesia when added to caudal local anesthetic,
but also increase the probability of postoperative nau-
sea or vomiting.
6.3.1 Ketamine and clonidine
(i) Preparations and pharmacology
Ketamine
Ketamine is an NMDA antagonist that can produce
general anesthesia following intramuscular injection
or intravenous bolus and/or infusion. Ketamine pro-
duces dissociative anesthesia characterized by a
trance-like state, amnesia, and marked analgesia
which may persist into the recovery period. There is
often an increase in muscle tone and the patient’s
eyes may remain open for all or part of the period of
anesthesia; it can also produce unpleasant emergence
phenomena, including hallucinations. Ketamine is a
racemic mixture, and the S-isomer has approximately
twice the analgesic potency of the racemate. Ketamine
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undergoes hepatic biotransformation to an active
metabolite norketamine and is excreted mainly in the
urine as metabolites. Subanesthetic doses of ketamine
produce analgesia. Oral administration has been uti-
lized for sedation/premedication. Caudal/epidural
administration of ketamine produces analgesia but
concern has been expressed regarding potential neuro-
toxicity.
Clonidine
Clonidine is an alpha2-adrenergic agonist and has sed-
ative, anxiolytic, and analgesic properties. As a result,
potential perioperative beneﬁts include use for preme-
dication, reduction in general anesthetic requirements,
analgesia, and management of opioid withdrawal
symptoms. Clonidine can be given orally, transdermal-
ly, intravenously, or epidurally. Clonidine is rapidly
absorbed. After oral administration, about 50% is
metabolized in the liver, and it is excreted in the urine
as unchanged drug and metabolites. Clearance in neo-
nates is about one-third of adult levels. The elimina-
tion half-life has been variously reported to range
between 6 and 24 h, and extended up to 41 h in
patients with renal impairment. Clonidine crosses the
placenta and is distributed into breast milk. The hypo-
tensive effect of clonidine may be enhanced by diuret-
ics, other antihypertensives, and drugs that cause
hypotension. The sedative effect of clonidine may be
enhanced by CNS depressants. Clonidine has been
associated with impaired atrioventricular conduction in
a few patients, although some of these may have had
underlying conduction defects and had previously
received digitalis, which may have contributed to their
condition.
(ii) Doses
Ketamine
For anesthesia, 2 mgÆkg)1 given intravenously over
60 s usually produces surgical anesthesia within 30 s of
the end of the injection and lasting for 5–10 min.
Addition of ketamine 0.25–0.5 mgÆkg)1 to caudal
local anesthetic (compared with a local anesthetic
alone) prolongs the time to ﬁrst analgesia and reduces
postoperative rescue analgesia requirements.
Clonidine
Clonidine is rapidly absorbed after oral administration
and doses of 4 mcgÆkg)1 have been used for premedi-
cation. Clonidine has an established role as a spinal
adjuvant analgesic in pediatric practice, and clonidine
via the intrathecal or caudal/epidural route has a
greater effect than the same dose intravenously. Addi-
tion of 1–2 mcgÆkg)1 clonidine to caudal local anes-
thetic prolongs analgesia and reduces postoperative
analgesic requirements, when compared to local anes-
thetic alone. Sensitivity to side effects (apnea, oxygen
desaturation, and bradycardia) is greater in neonates,
and cardiovascular and sedative side effects have been
reported following doses of 5 lgÆkg)1 caudal clonidine
in children. Epidural clonidine 0.08–0.12 lgÆkg)1Æh)1
produces dose-dependent analgesia when added to
local anesthetic infusion, and higher doses of clonidine
alone (0.2 lgÆkg)1Æh)1 preceded by bolus of 2 lgÆkg)1)
provide analgesia at rest following abdominal surgery.
(iii) Neuroxicity
Severe complications following pediatric regional tech-
niques are rare, but the incidence is higher in neonates
and infants (0.4% vs 0.1% for all regional blocks or
1.1% vs 0.49% for epidural blocks alone). Rates of
neurological injury following neuraxial analgesia range
from 0.13 to 0.4 per 1000 in large series, with higher
rates following epidural catheter techniques than single
shot caudals. Issues relating to the potential neurotox-
icity of some spinally administered drugs and the ethi-
cal use of unlicensed routes of administration have
been debated for many years.
General anesthetics with NMDA antagonist and/or
GABA agonist activity increase neuronal apoptosis in
the developing brain in rodents and primates and have
led to a number of clinical studies evaluating neurocog-
nitive outcomes following exposure to general anesthesia
in early life. The potential for additional developmen-
tally regulated spinal toxicity has been the impetus for
studies assessing histopathology and apoptosis in the
spinal cord following intrathecal drugs in neonatal
rodent models. Intrathecal bupivacaine produces dense
spinal analgesia but does not increase apoptosis in the
brain or spinal cord of neonatal and infant rats. Systemi-
cally administered opioids have not been associated with
increased apoptosis in the brain, and similarly intrathe-
cal morphine did not increase apoptosis or produce his-
topathology in the neonatal or infant spinal cord.
Ketamine: In adult models, spinal cord toxicity has
been demonstrated following intrathecal administration
of ketamine in adult swine, rabbits, and dogs. Although
some studies have attributed changes to the preserva-
tive, administration of preservative-free S-ketamine for
7 days produced necrotizing lesions with cellular
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inﬁltrates in the cord and a 28-day infusion of preserva-
tive-free racemic ketamine produced pathologic changes
ranging from mild inﬂammation and demyelination to
marked necrosis. Intrathecal administration of preserva-
tive-free ketamine in neonatal rats has been shown to
increase apotosis and produce persistent changes in sen-
sory threshold in the same dose range as analgesia.
Clonidine: The neurotoxicity of epidural clonidine
has been more extensively studied. Repeated bolus or
extended continuous epidural and intrathecal delivery
of clonidine in adult dogs or rats did not result in tox-
icity. Similarly, maximal tolerated doses of intrathecal
clonidine (300 times analgesic dose) did not increase
apoptosis, produce histopathology in the spinal cord,
or produce persistent changes in sensory thresholds.
Table 6.3.1 Typical doses of epidural neuraxial analgesics
Drug
Single dose
microgm.kg)1
Infusion
microgm.kg)1.hr)1 Side effects
Clondine 1–2 0.08–0.2 Sedation; dose
related hypotension
and bradycardia
(5 mcgÆkg)1); delayed
respiratory
depression
and bradycardia in
neonates
Ketamine 250–500 Hallucinations at higher
doses
Morphine 15–50 0.2–0.4 Nausea and vomiting;
urinary retention;
pruritis; delayed
respiratory
depression
Fentanyl 0.5–1 0.3–0.8 Nausea and vomiting
Tramadol 500–2000 Nausea and vomiting
6.4 Opioids
Opioids remain the most powerful and widely used
group of analgesics. They can be given by many routes
of administration and are considered safe, provided
accepted dosing regimens are used and appropriate
monitoring and staff education are in place. Morphine
is the prototype opioid, and diamorphine, tramadol,
oxycodone, and hydromorphone are alternatives to
morphine in the postoperative period. Fentanyl, sufen-
tanil, alfentanil, and remifentanil have a role during
and after major surgery and in intensive care practice
and can be used to ameliorate the stress response to
surgery. Codeine and dihydrocodeine can be used for
short-term treatment of moderate pain. Pethidine
(meperidine) is not recommended in children owing to
the adverse effects of its main metabolite, nor-pethi-
dine. Opioid infusions can provide adequate analgesia
with an acceptable level of side effects. Patient-con-
trolled opioid analgesia is now widely used in children
as young as age 5 years and compares favorably with
continuous morphine infusion in the older child. NCA
where a nurse is allowed to press the demand button
within strictly set guidelines can provide ﬂexible anal-
gesia for children who are too young or unable to use
PCA. This technology can also be used in neonates
where a bolus dose without a background infusion
allows the nurse to titrate the child to analgesia or to
anticipate painful episodes while producing a pro-
longed effect because of the slower clearance of mor-
phine. Neuraxial administration of opioids has a place
where extensive analgesia is needed, for example, after
major abdominal surgery, spinal surgery, or when ade-
quate spread of epidural local anesthetic blockade can-
not be achieved within dosage limits.
Table 6.4.1 Opioid potency relative to morphine
Drug
Relative
potency
Single
dose (oral)
mg/kg
Continuous
infusion (IV)
micrograms.kg)1.hr)1
Tramadol 0.1 1–2 100–400
Codeine 0.1–0.12 0.5)1 N/A
Morphine 1 0.2–0.4 10–40
Hydromorphone 5 0.04–0.08 2–8
Fentanyl 50–100 N/A 0.1–0.2 mgÆkg)1Æmin)1
or use TCIa system
Remifentanil 50–100 N/A 0.05–4 mcgÆkg)1Æmin)1
or use TCIa system
aTarget controlled infusion.
6.4.1 Opioid preparations, dosages, and routes
Morphine
Morphine is the most widely used and studied opioid
in children. Its agonist activity is mainly at l opioid
receptors (10,11). It can be given by the oral, subcuta-
neous, intramuscular, intravenous, epidural, intraspi-
nal, and rectal routes. Parenteral administration may
be intermittent injection; continuous or intermittent
infusion of the dose is adjusted according to individual
analgesic requirements. Using accepted dosing regi-
mens, morphine has been shown to be safe and effec-
tive in children of all ages.
The pharmacokinetics of morphine in children is
generally considered similar to those in adults but in
neonates and into early infancy the clearance and pro-
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tein binding are reduced and the half-life is increased.
These differences, which are dependent on gestational
age and birth weight, are mainly due to reduced
metabolism and immature renal function in the devel-
oping child. This younger age group demonstrates an
enhanced susceptibility to the effects, and the side
effects of morphine and dosing schedules must be
altered to take this into account. Morphine has poor
oral bioavailability as it undergoes extensive ﬁrst-pass
metabolism in the liver and gut.
Morphine dosing schedules
An appropriate monitoring protocol should be used
dependent on the route of administration and age of
the child. For neuraxial dosing, see section 6.2.
Oral:
Neonate: 80 mcgÆkg)1 4–6 hourly
Child: 200–500 mcgÆkg)1 4 hourly
Intravenous or subcutaneous loading dose: (titrated
according to response)
Neonate: 25 mcgÆkg)1 increments
Child: 50 mcgÆkg)1 increments
Intravenous or subcutaneous infusion:
10–40 mcgÆkg)1Æh)1
Patient-controlled analgesia (PCA):
Bolus (demand) dose: 10–20 mcgÆkg)1
Lockout interval: 5–10 min
Background infusion: 0–4 mcgÆkg)1Æh)1
Nurse controlled analgesia (NCA):
Bolus (demand) dose: 10–20 mcgÆkg)1
Lockout interval: 20–30 min
Background infusion: 0–20 mcgÆkg)1Æh (<5 kg use
no background)
Diamorphine
Diamorphine hydrochloride is an acetylated morphine
derivative and is a more potent opioid analgesic than
morphine. It is much more lipid soluble and has a
more rapid onset and shorter duration of action than
morphine. Diamorphine can be given by the oral,
intranasal, subcutaneous, intramuscular, intravenous,
and epidural and intrathecal routes. Because of its
abuse potential, the supply of diamorphine is carefully
controlled and in many countries it is not available for
clinical use.
On injection, diamorphine is rapidly converted to
the active metabolite 6-O-monoacetylmorphine (6-acet-
ylmorphine) in the blood and then to morphine. Oral
doses are subject to extensive ﬁrst-pass metabolism to
morphine. As with morphine, neonates and infants
have altered pharmacokinetics and an increased sus-
ceptibility to the opioid effects of diamorphine.
Diamorphine dosing schedules
An appropriate monitoring protocol should be used
dependent on the route of administration and age of
the child.
Oral: >1 year 100–200 mcgÆkg)1 4 hourly
Intravenous or subcutaneous loading dose: (titrated
according to response)
Neonate: 10–25 mcgÆkg)1 increments
Child: 25–100 mcgÆkg)1 increments
Intravenous or subcutaneous infusion:
2.5–25 mcgÆkg)1Æh)1
Intranasal:
100 mcgÆkg)1 in 0.2 ml sterile water instilled into
one nostril.
Hydromorphone
Hydromorphone is an opioid analgesic related to mor-
phine but with a greater analgesic potency and is used
for the relief of moderate-to-severe pain. It is a useful
alternative to morphine for subcutaneous use because its
greater solubility in water allows a smaller dose volume.
Hydromorphone dosing schedules
Oral: 40–80 microg/kg 4 hourly
Intravenous or subcutaneous loading dose: (titrated
according to response)
Child <50 kg: 10–20 microg/kg increments
Intravenous or subcutaneous infusion: 2-8 microg/kg/
hÆkg)1Æh)1
Codeine
Codeine is much less efﬁcacious than morphine and is
used for the relief of mild-to-moderate pain. It is often
given in combination with NSAIDs or paracetamol.
Codeine can also be given by intramuscular injection, in
doses similar to those by mouth; the intravenous route
should not be used as severe hypotension may occur.
The analgesic effect of codeine is unpredictable. Its
effects may be wholly or mainly due to metabolism to
morphine. The enzyme responsible for this conversion,
CYP2D6, shows signiﬁcant genetic variation and
across populations the amount of codeine converted to
morphine is very variable. Development may also
affect CYP2D6 activity with lower levels of activity
found in neonates and infants.
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Codeine dosing schedules
Oral, intramuscular or rectal:
Neonate or child: 0.5–1 mgÆkg)1 4–6 hourly (care
with repeated doses in neonates)
Dihydrocodeine
Dihydrocodeine is an opioid analgesic related to
codeine. It is used for the relief of moderate-to-severe
pain, often in combination with paracetamol. The
analgesic effect of dihydrocodeine appears to be pri-
marily due to the parent compound (unlike codeine); it
is metabolized in the liver via the cytochrome P450 iso-
enzyme CYP2D6 to dihydromorphine, which has
potent analgesic activity, and some is also converted
via CYP3A4 to nordihydrocodeine.
Dihydrocodeine dosing schedules
Oral or intramuscular:
>1 year: 0.5–1 mgÆkg)1 4–6 hourly
Oxycodone
Oxycodone can be given by mouth or by subcutaneous
or intravenous injection for the relief of moderate-to-
severe pain (12). It can be given by continuous infu-
sion or PCA. The oral potency is about twice that of
morphine, whereas intravenously it is about 1.5 times
as potent. Although not widely used at present in the
United Kingdom, it may be a useful and safe alterna-
tive to morphine and codeine as an oral opioid.
Oxycodone dosing schedules
Oral: 100–200 mgÆkg)1 4–6 hourly
Tramadol
Tramadol hydrochloride is an opioid analgesic with
noradrenergic and serotonergic properties that may
contribute to its analgesic activity (13,14). Tramadol
can be given by mouth, intravenously, or as a rectal
suppository. It has also been given by infusion or as
part of a PCA system.
Tramadol is increasingly used in children of all ages
and has been shown to be effective against mild-to-
moderate pain. It may produce fewer typical opioid
adverse effects such as respiratory depression, sedation,
and constipation; though, it demonstrates a relatively
high rate of nausea and vomiting.
Tramadol dosing schedules:
Oral, rectal, or intravenous: 1–2 mgÆkg)1 4–6 hourly
Fentanyl
Fentanyl is a potent opioid analgesic related to pethi-
dine and is primarily a l-opioid agonist. It is more
lipid soluble than morphine and it has a rapid onset
and short duration of action. Because of its high lipo-
philicity, fentanyl can also be delivered via the trans-
dermal (±iontophoresis) or transmucosal routes.
Small intravenous bolus doses can be injected immedi-
ately after surgery for postoperative analgesia and
PCA systems have been used.
After transmucosal delivery, about 25% of the dose is
rapidly absorbed from the buccal mucosa; the remaining
75% is swallowed and slowly absorbed from the gastro-
intestinal tract. Some ﬁrst-pass metabolism occurs via
this route. The absolute bioavailability of transmucosal
delivery is 50% of that for intravenous fentanyl.
Absorption is slow after transdermal application.
The clearance is decreased and the half-life of fenta-
nyl is prolonged in neonates. As with morphine, neo-
nates are more susceptible to the adverse effects of
fentanyl, and appropriate monitoring and safety proto-
cols should be implemented when fentanyl is used in
this age group. There are differences in pharmacoki-
netics between bolus doses and prolonged infusion
with highly lipophilic drugs such as fentanyl; the con-
text-sensitive half-time progressively increases with the
duration of infusion.
Fentanyl dosing schedules
An appropriate monitoring protocol should be used
dependent on the route of administration and age of
the child. For neuraxial dosing, see section 6.3.
Intravenous dose: titrated according to response
0.5–1.0 mcgÆkg)1 (decrease in neonates)
Intravenous infusion: 0.5–2.5 mcgÆkg)1Æh)1
Transdermal: 12.5–100 mcgÆh)1
Remifentanil
Remifentanil is a potent short-acting l-receptor opioid
agonist used for analgesia during induction and/or
maintenance of general anesthesia. It has also been used
to provide analgesia into the immediate postoperative
period. Remifentanil is given intravenously, usually by
infusion. Its onset of action is within 1 min and the
duration of action is 5–10 min. Remifentanil is metabo-
lized by esterases and so its half-life is independent of
the dose, duration of infusion, and age of child.
Remifantanil is a strong respiratory depressant. It
can be used in the spontaneously breathing patient as
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a low-dose infusion but the child must be nursed in an
appropriate area with adequate monitoring. When
appropriate, alternative analgesics should be given
before stopping remifentanil, in sufﬁcient time to pro-
vide continuous and more prolonged pain relief.
6.4.2 Opioid toxicity and side effects
Opioids have a wide range of effects on a number of dif-
ferent organ systems (See Table 6.4.2). These provide
not only clinically desirable analgesic effects but also the
wide range of adverse effects associated with opioid use.
The proﬁle of side effects is not uniform between the
opioids or even between patients taking the same opi-
oid. The incidence and severity of side effects in an
individual patient are inﬂuenced by a number of
genetic and developmental factors and therefore appro-
priate monitoring and adverse effect management
should be performed with the use of opioids.
Table 6.4.2 Physiological effects of opioids
Central nervous system
Analgesia
Sedation
Dysphoria and euphoria
Nausea and vomiting
Miosis
Seizures
Pruritis
Psychomimetic behaviors, excitation
Respiratory system
Antitussive
Respiratory depression
ﬂ respiratory rate
ﬂ tidal volume
ﬂ ventilatory response to carbon dioxide
Cardiovascular system
Minimal effects on cardiac output
Heart rate
Bradycardia seen on most occasions
Vasodilation, venodilation
Morphine other opioids ? histamine effect
Gastrointestinal system
ﬂ intestinal motility and peristalsis
› sphincter tone
Sphincter of oddi
Ileocolic
Urinary system
› Tone
Uterus
Bladder
Detrusor muscles of the bladder
Musculoskeletal system
› chest wall rigidity
6.5 Nonsteroidal anti-inflammatory drugs
(NSAIDs)
NSAIDs are effective for the treatment of mild or
moderate pain in children. In addition to analgesia,
they have anti-inﬂammatory and antipyretic effects.
They are opioid sparing. The combination of NSA-
IDs and paracetamol produces better analgesia than
either drug alone. Their mechanism of action is the
inhibition of cyclooxygenase (COX) activity, thereby
blocking the synthesis of prostaglandins and throm-
boxane. Aspirin, a related compound, is not used in
children because of the potential to cause Reye’s
syndrome.
6.5.1 NSAID preparations, dose, and routes
A number of convenient NSAID formulations are
available:
l Ibuprofen tablet and syrup formulations for oral
administration and a dispersible tablet for sublingual
administration
l Diclofenac tablet (dispersible and enteric coated),
suppository and parenteral formulations
l Ketorolac for intravenous use
l Naproxen oral tablets
l Piroxicam oral tablets and a dispersible sublingual
formulation
l Ketoprofen oral tablets and syrup, parenteral for-
mulations
Selective COX 2 inhibitors have been developed with
the expectation that the analgesic and anti-inﬂamma-
tory effects of NSAIDs would be retained while reduc-
ing the risk of gastric irritation and bleeding.
However, in adult studies potential improvements in
safety have been offset by an increase in the incidence
of adverse cerebral and cardiac thrombotic events.
Reports of the use of selective COX-2 inhibitors in
children are appearing in the literature, which demon-
strate equal efﬁcacy with nonselective NSAIDs. How-
ever, their role in pediatric practice is yet to be
established. Pharmacokinetic data for the neonatal use
of ibuprofen have been established from its use in pat-
ent ductus arteriosus closure. Clearance is reduced and
the volume of distribution is increased. However, its
use as an analgesic below age 3 months is not recom-
mended, see section 6.5.3.
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Table 6.5.1
NSAID
Dose
mgÆkg)1
Interval
hours
Maximum daily dose
mgÆkg)1Æday)1
Licensed
from age
Ibuprofen 5–10 6–8 30 3 months
Diclofenac 1 8 3 6 months
Ketorolaca 0.5 6 2
Naproxen 7.5 12 15
Piroxicama 0.5 24 0.5 N/R
Ketoprofena 1 6 4
aHigh incidence of GI complications. Not licensed for acute
pain.
6.5.2 NSAID toxicity and side effects
Because of their mechanism of action, NSAIDs have
the potential to cause adverse effects at therapeutic
plasma levels.
l Hypersensitivity reactions
l NSAIDs reduce platelet aggregation and prolong
bleeding time. Therefore, they are usually contrain-
dicated in children with coagulation disorders or in
those who are receiving anticoagulant therapy.
l NSAIDs can inhibit prostaglandin-mediated renal
function, and this effect is greater in the presence of
renal disease and dehydration. Ibuprofen has been
shown to reduce the glomerular ﬁltration rate in
neonates by 20%. NSAIDs should not be adminis-
tered concurrently with nephrotoxic agents. Renal
toxicity is low in healthy children.
l NSAIDs can cause gastric irritation and bleeding.
They are therefore relatively contraindicated in chil-
dren with a history of peptic ulcer disease. Ibuprofen
has the lowest potential for gastric irritation. The risk
of adverse GI effects is low when NSAID use is limited
to 1–3 days in the postoperative period; it may be fur-
ther reduced by co-prescription of proton pump inhibi-
tors, for example, omeprazole and H2 antagonists in
patients at higher risk. Piroxicam, ketorolac, and keto-
profen are known to be especially likely to causeGI side
effects particularly in the elderly. In the UK, piroxicam
is no longer licensed for acute indications and is subject
to special prescribing andmonitoring restrictions.
l Owing to excess leukotriene production, NSAIDs
have the potential to exacerbate asthma in a predis-
posed subset of asthmatics. It is estimated that 2% of
asthmatic children are susceptible to aspirin-induced
bronchospasm and 5% of this subgroup are likely to
be cross-sensitive to other NSAIDs, that is, 1:1000.
The incidence of asthma in children is increasing, and
it is important that children who are not sensitive are
not denied the beneﬁts of NSAIDs. History of previ-
ous uneventful NSAID exposure should be estab-
lished in asthmatic children whenever possible.
Studies have provided some reassuring data regarding
the safety of short-term use of ibuprofen and diclofe-
nac in asthmatic children. NSAIDs should be avoided
in children with severe acute asthma.
l NSAIDs should be used with caution in children
with severe eczema, multiple allergies, and in those
with nasal polyps. NSAIDs should be avoided in liver
failure
l Animal studies using high doses of Ketorolac dem-
onstrated delayed bone fusion. This has led to concern
that the use of NSAIDs in children may delay bone
healing following fracture or surgery. This has not
been supported by human studies, and the analgesic
beneﬁts of short-term NSAID use outweigh the hypo-
thetical risk of delayed bone healing: see section 5.8.
l NSAIDs are not currently recommended for anal-
gesia in neonates due to concerns that they may
adversely affect cerebral and pulmonary blood ﬂow
regulation.
Of the NSAIDs currently available, ibuprofen has the
fewest side effects and the greatest evidence to support
its safe use in children. In a large community-based
study in children with fever, the risk of hospitalization
for GI bleeding, renal failure, and anaphylaxis was no
greater for children given ibuprofen than those given
paracetamol (15).
6.6 Paracetamol
Paracetamol is a weak analgesic (16,17). On its own, it
can be used to treat mild pain; in combination with
NSAIDs or a weak opioid such as codeine, it can be
used to treat moderate pain. Studies have demon-
strated an opioid sparing effect when it is administered
postoperatively.
6.6.1 Paracetamol preparations, doses, and
routes
Paracetamol is available for oral administration in
syrup, tablet, and dispersible forms. Following oral
administration, maximum serum concentrations are
reached in 30–60 min. As the mechanism of action is
central, there is a further delay before maximum analge-
sia is achieved. Suppositories are available; however,
there is wide variation in the bioavailability of paraceta-
mol following rectal administration. Studies have dem-
onstrated the need for higher loading doses (of the
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order of 40 mgÆkg)1) to achieve target plasma concen-
trations of 10 mgÆl)1 following rectal administration.
The time to reach maximum serum concentration fol-
lowing rectal administration varies between 1 and 2.5 h.
Rectal administration of drugs is contraindicated in
neutropenic patients because of the risk of causing sep-
sis. Recently, an intravenous preparation of paraceta-
mol has become available. Initial experience with IV
paracetamol is that the higher effect site concentration
achieved following intravenous administration is associ-
ated with higher analgesic potency. When administered
IV, it should be given as an infusion over 15 min.
There are several published dosage regimens for par-
acetamol (perhaps indicating that the optimum regi-
men is still to be determined). The regimen used will
depend on the age of the child, the route of adminis-
tration, and the duration of treatment. The clearance
in neonates is reduced and the volume of distribution
is increased. The dose of paracetamol therefore needs
to be reduced in neonates – see Table 1. Bioavailability
following rectal administration is higher in the neo-
nate. The current recommendations stated in the BNFc
are shown in Tables 6.6.1 and 6.6.2.
6.6.2 Paracetamol toxicity and side effects
When the maximum daily dose of paracetamol is
observed, it is well tolerated. The maximum daily dose
is limited by the potential for hepatotoxicity that can
occur following overdose (exceeding 150 mgÆkg)1).
Multiple doses may lead to accumulation in children
who are malnourished or dehydrated. The mechanism
of toxicity in overdosage is the production of N-acetyl-
p-benzoquinoneimine (NABQI). The amount of NAB-
QI produced following therapeutic doses of paraceta-
mol is completely detoxiﬁed by conjugation with
glutathione. In overdosage, glutathione stores become
depleted allowing NABQI to accumulate and damage
hepatocytes. Acetylcysteine and methionine replenish
stores of glutathione and are therefore used in the
treatment of toxicity.
6.7 Nitrous oxide (N2O)
6.7.1 Preparations, dosage, and administration
Nitrous oxide is supplied compressed in metal cylin-
ders labeled and marked according to national stan-
dards (18). It is a weak anesthetic with analgesic
properties rapidly absorbed on inhalation. The blood/
gas partition coefﬁcient is low, and most of the inhaled
N2O is rapidly eliminated unchanged through the
lungs. Premixed cylinders with 50% N2O in oxygen
are available, but it is also occasionally administered
at inspired concentrations up to 70% with oxygen.
Nitrous oxide inhalation using a self-administration
with a face mask or mouthpiece and ‘demand valve’
system is widely used for analgesia during procedures
such as dressing changes, venepuncture, as an aid to
postoperative physiotherapy, and for acute pain in
emergency situations, see section 4.0. It is also used in
dentistry. The system is only suitable for children able
to understand and operate the valve, generally those
over 5 years of age. Heathcare workers must be speciﬁ-
cally trained in the safe and correct technique of
administration of N2O.
Nitrous oxide is given using a self-administration
demand ﬂow system operated by the patient unaided
such that sedation leads to cessation of inhalation.
Analgesia is usually achieved after 3 or 4 breaths.
Recovery is rapid once the gas is discontinued.
Continuous ﬂow techniques of administration, where
the facemask is held by a healthcare worker rather
than the patient, is capable of producing deep sedation
and unconsciousness, and therefore the use of this
method is not included in this guideline.
6.7.2 Side effects and toxicity
Nitrous oxide potentiates the CNS depressant effects
of other sedative agents. There is a risk of increased
Table 6.6.1 Paracetamol dosing guide – oral and rectal administra-
tion
Age Route
Loading
dose
(mgÆkg)1)
Maintenance
dose
(mgÆkg)1)
Interval
(h)
Maximum
daily dose
(mgÆkg)1)
Duration at
maximum
dose (h)
28–32
weeks
PCA
Oral 20 10–15 8–12 30 48
Rectal 20 15 12
32–52
weeks
PCA
Oral 20 10–15 6–8 60 48
Rectal 30 20 8
>3
months
Oral 20 15 4 90 48
Rectal 40 20 6
PCA, postconceptual age.
Table 6.6.2 IV Paracetamol dosing guide
Weight (kg) Dose Interval (h) Maximum daily dose
<5 (term neonate) 7.5 mgÆkg)1 4–6 30 mgÆkg)1
5–10 10 mgÆkg)1 4–6 40 mgÆkg)1
10–50 15 mgÆkg)1 4–6 60 mgÆkg)1
>50 1 g 4–6 4 g
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pressure and volume from the diffusion of nitrous
oxide into closed air-containing cavities and is there-
fore contraindicated in the presence of pneumo-
thorax. Frequent side effects include euphoria,
disinhibition, dizziness, dry mouth, and disorienta-
tion. Nausea and vomiting can occur. Excessive seda-
tion is managed by discontinuation of the gas,
oxygen administration, and basic airway management.
Prolonged or frequent use may affect folate metabo-
lism leading to megaloblastic changes in the bone
marrow, megaloblastic anemia, and peripheral neu-
ropathy. Depression of white cell formation may also
occur. Patients who receive N2O more frequently
than twice every 4 days should have regular blood
cell examination for megaloblastic changes and neu-
trophil hypersegmentation.
Exposure to prolonged high concentrations of N2O
has been associated with reduced fertility in men and
women. It should only be used in a well-ventilated
environment, which should be monitored and main-
tained below the UK Occupational Exposure Standard
for atmospheric levels of N2O that is <100 ppm.
6.8 Sucrose
Sucrose solutions reduce many physiological and
behavioral indicators of stress and pain in neonates
(19,20). The effects of sucrose appear to be directly
related to the sweet taste of the solution with very low
volumes (0.05–2 ml) in concentrations of 12–24%
being effective within 2 min of administration.
6.8.1 Sucrose dosage and administration
Sucrose should be administered in a 24% solution 1–
2 min before a painful stimulus and may be repeated
during the painful procedure if necessary. It can be
given using a paciﬁer or directly dripped (one drop at a
time) onto the tongue using a syringe; the number of
applications is decided according to the infant’s
response. Upper volume limits per procedure have been
suggested according to the gestational age in weeks:
27–31 0.5 ml maximum
32–36 1.0 ml maximum
>37 2.0 ml maximum
Each ‘dip’ of the paciﬁer is estimated to be 0.2 ml.
The effectiveness of sucrose appears to decrease with
age, at present it’s use as a primary analgesic should
be conﬁned to the neonatal period until further infor-
mation is available.
6.8.2 Sucrose side effects and toxicity
Coughing, choking, gagging, and transient oxygen de-
saturations have been reported; when using the syringe
method, the solution should be applied carefully to the
tongue one drop at a time. There is some evidence that
adverse effects of sucrose, including a temporary
increase in ‘Neurobiologic Risk’ score, is more fre-
quent in very premature infants, particularly those
<27 and 28–31 weeks gestational age.
6.9 Nonpharmacological strategies
There is increasing interest in the use of nonpharmaco-
logical pain management strategies in acute pain. Skin
to skin contact and other forms of tactile stimulation
have been shown to be effective for needle related pro-
cedural pain in neonates (21,22). There is growing evi-
dence supporting the use of psychological interventions
for a variety of acute pain indications. Psychological
interventions for acute pain include a wide variety of
physiological, behavioral, and cognitive techniques
aimed at reducing pain and pain-related distress
through the modulation of thoughts, behaviors, and
sensory information. Some of the most strongly sup-
ported are guided imagery, distraction, and hypnosis
(23). Some of the terms most commonly used to
describe these techniques are detailed below:
l Behavioral interventions are deﬁned as interventions
based on principles of behavioral science as well as
learning principles by targeting speciﬁc behaviors.
l Cognitive interventions are deﬁned as interventions
that involve identifying and altering negative thinking
styles related to anxiety about the painful situation, and
replacing them with more positive beliefs and attitudes,
leading to more adaptive behavior and coping styles.
l Distraction includes cognitive techniques to shift
attention away from the pain or speciﬁc counter activi-
ties (e.g., counting, listening to music, playing video-
games, talking about something else other than pain
or the medical procedure).
l Hypnosis is a psychological state of heightened
awareness and focused attention, in which critical fac-
ulties are reduced and susceptibility and receptiveness
to ideas is greatly enhanced.
l Psychological preparation refers to speciﬁc interven-
tions designed to provide information about the proce-
dure and reduce anxiety. Often three types of
information is provided: information about the proce-
dure itself (i.e., steps that children must perform and
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steps that health care professionals will perform); the
sensations the patient can expect to feel (e.g., sharp
scratch, numbness); and about how to cope with the
procedure.
l Relaxation is a state of relative freedom from anxi-
ety and skeletal muscle tension, a quieting or calming
of the mind and muscles.
Further reading
BNFC: The British National Formulary for Children,
Vol. 2nd Edition. London: BMJ Publishing Group
Ltd, 2012.
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